Celanese (CE) 10-K 21 Feb 25 2024 FY Annual report Financial data

Cover Page

Cover Page - USD ($)	12 Months Ended
	Dec. 31, 2024	Feb. 17, 2025	Jun. 30, 2024
Entity Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2024
Document Transition Report	false
Entity File Number	001-32410
Entity Registrant Name	CELANESE CORPORATION
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	98-0420726
Entity Address, Address Line One	222 W. Las Colinas Blvd., Suite 900N
Entity Address, City or Town	Irving
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75039-5421
City Area Code	972
Local Phone Number	443-4000
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Small Reporting Company	false
Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 14,686,088,441
Entity Common Stock, Shares Outstanding		109,332,326
Entity Central Index Key	0001306830
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Amendment Flag	false
Common Stock
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	CE
Security Exchange Name	NYSE
4.777% Senior Notes due 2026
Entity Information [Line Items]
Title of 12(b) Security	4.777% Senior Notes due 2026
Trading Symbol	CE /26A
Security Exchange Name	NYSE
2.125% Senior Notes due 2027
Entity Information [Line Items]
Title of 12(b) Security	2.125% Senior Notes due 2027
Trading Symbol	CE /27
Security Exchange Name	NYSE
0.625% Senior Notes due 2028
Entity Information [Line Items]
Title of 12(b) Security	0.625% Senior Notes due 2028
Trading Symbol	CE /28
Security Exchange Name	NYSE
5.337% Senior Notes due 2029
Entity Information [Line Items]
Title of 12(b) Security	5.337% Senior Notes due 2029
Trading Symbol	CE /29A
Security Exchange Name	NYSE

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2024
Auditor Information [Abstract]
Auditor Name	KPMG LLP
Auditor Location	Dallas, TX
Auditor Firm ID	185

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Net sales	$ 10,280	$ 10,940	$ 9,673
Cost of sales	(7,924)	(8,337)	(7,293)
Gross profit	2,356	2,603	2,380
Selling, general and administrative expenses	(1,030)	(1,075)	(824)
Amortization of intangible assets	(159)	(164)	(62)
Research and development expenses	(130)	(146)	(112)
Other (charges) gains, net	(1,744)	(68)	(8)
Foreign exchange gain (loss), net	24	32	(1)
Gain (loss) on disposition of businesses and assets, net	(14)	505	5
Operating profit (loss)	(697)	1,687	1,378
Equity in net earnings (loss) of affiliates	196	102	220
Non-operating pension and other postretirement employee benefit (expense) income	(20)	(69)	17
Interest expense	(676)	(720)	(405)
Refinancing expense	0	(7)	0
Interest income	33	39	69
Dividend income - equity investments	128	126	133
Other income (expense), net	40	25	9
Earnings (loss) from continuing operations before tax	(996)	1,183	1,421
Income tax (provision) benefit	(510)	790	489
Earnings (loss) from continuing operations	(1,506)	1,973	1,910
Earnings (loss) from operation of discontinued operations	(10)	(12)	(9)
Income tax (provision) benefit from discontinued operations	2	3	1
Earnings (loss) from discontinued operations	(8)	(9)	(8)
Net earnings (loss)	(1,514)	1,964	1,902
Net (earnings) loss attributable to noncontrolling interests	(8)	(4)	(8)
Net earnings (loss) attributable to Celanese Corporation	(1,522)	1,960	1,894
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations	(1,514)	1,969	1,902
Earnings (loss) from discontinued operations	(8)	(9)	(8)
Net earnings (loss) attributable to Celanese Corporation	$ (1,522)	$ 1,960	$ 1,894
Earnings (loss) per common share - basic
Continuing operations - basic (in dollars per share)	$ (13.86)	$ 18.09	$ 17.55
Discontinued operations - basic (in dollars per share)	(0.07)	(0.08)	(0.07)
Net earnings (loss) - basic (in dollars per share)	(13.93)	18.01	17.48
Earnings (loss) per common share - diluted
Continuing operations - diluted (in dollars per share)	(13.86)	18	17.41
Discontinued operations - diluted (in dollars per share)	(0.07)	(0.08)	(0.07)
Net earnings (loss) - diluted (in dollars per share)	$ (13.93)	$ 17.92	$ 17.34
Weighted average shares - basic (in shares)	109,273,779	108,848,962	108,380,082
Weighted average shares - diluted (in shares)	109,273,779	109,379,664	109,235,376

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Net earnings (loss)	$ (1,514)	$ 1,964	$ 1,902
Other comprehensive income (loss), net of tax
Foreign currency translation gain (loss)	(99)	(213)	(217)
Gain (loss) on derivative hedges	0	(6)	21
Pension and postretirement benefits	(5)	(7)	7
Total other comprehensive income (loss), net of tax	(104)	(226)	(189)
Total comprehensive income (loss), net of tax	(1,618)	1,738	1,713
Comprehensive (income) loss attributable to noncontrolling interests	(6)	(4)	(8)
Comprehensive income (loss) attributable to Celanese Corporation	$ (1,624)	$ 1,734	$ 1,705

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions		Dec. 31, 2024	Dec. 31, 2023
Current Assets
Cash and cash equivalents		$ 962	$ 1,805
Trade receivables - third party and affiliates		1,121	1,243
Non-trade receivables, net		493	541
Inventories		2,284	2,357
Other assets		285	272
Total current assets		5,145	6,218
Investments in affiliates		1,217	1,220
Property, plant and equipment (net of accumulated depreciation - 2024: $4,562; 2023: $4,080)		5,273	5,584
Operating lease right-of-use assets		388	422
Deferred income taxes		1,251	1,677
Other assets		555	524
Goodwill	[1]	5,387	6,977
Intangible assets, net		3,641	3,975
Total assets		22,857	26,597
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates		1,501	1,383
Trade payables - third party and affiliates		1,228	1,510
Other liabilities		1,120	1,154
Income taxes payable		4	25
Total current liabilities		3,853	4,072
Long-term debt, net of unamortized deferred financing costs		11,078	12,301
Deferred income taxes		933	999
Uncertain tax positions		286	300
Benefit obligations		396	457
Operating lease liabilities		294	325
Other liabilities		408	591
Commitments and Contingencies
Shareholders' Equity
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2024 and 2023: 0 issued and outstanding)		0	0
Common stock, $0.0001 par value, 400,000,000 shares authorized (2024: 170,827,196 issued and 109,327,556 outstanding; 2023: 170,476,740 issued and 108,906,426 outstanding)		0	0
Treasury stock, at cost (2024: 61,499,640 shares; 2023: 61,570,314 shares)		(5,486)	(5,488)
Additional paid-in capital		409	394
Retained earnings		11,100	12,929
Accumulated other comprehensive income (loss), net		(848)	(744)
Total Celanese Corporation shareholders' equity		5,175	7,091
Noncontrolling interests		434	461
Total equity		5,609	7,552
Total liabilities and equity		$ 22,857	$ 26,597
[1] Includes accumulated impairment losses of $1.5 billion in the Engineered Materials segment as of December 31, 2024. There were no accumulated impairment losses as of December 31, 2023.

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Accumulated depreciation, depletion and amortization, property, plant, and equipment	$ 4,562	$ 4,080
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, shares issued (in shares)	170,827,196	170,476,740
Common stock, shares outstanding (in shares)	109,327,556	108,906,426
Treasury stock, shares (in shares)	61,499,640	61,570,314

Consolidated Statements of Equi

Consolidated Statements of Equity - USD ($) $ in Millions	Total	Common Stock	Treasury Stock, Common	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss), Net	Noncontrolling Interests
Balance as of the beginning of the period (in shares) at Dec. 31, 2021		108,023,735	61,736,289
Balance as of the beginning of the period at Dec. 31, 2021		$ 0	$ (5,492)	$ 333	$ 9,677	$ (329)
Stock option exercises (in shares)		0
Stock awards (in shares)		450,197
Stock awards		$ 0
Issuance of treasury stock under stock plans (in shares)			(74,796)
Issuance of treasury stock under stock plans			$ 1
Balance as of the end of the period (in shares) at Dec. 31, 2022		108,473,932	61,661,493
Balance as of the end of the period at Dec. 31, 2022	$ 5,637	$ 0	$ (5,491)	372	11,274	(518)
Stock-based compensation, net of tax				39
Stock option exercises, net of tax		$ 0		0
Net earnings (loss) attributable to Celanese Corporation	1,894				1,894
Common stock dividends					(297)
Other comprehensive income (loss), net of tax	(189)					(189)	$ 0
Balance as of the beginning of the period, noncontrolling interest at Dec. 31, 2021							348
Net earnings (loss) attributable to noncontrolling interests	(8)						(8)
Distributions/dividends to noncontrolling interests							13
Acquisition of noncontrolling interests							125
Balance as of the end of the period, noncontrolling interest at Dec. 31, 2022							468
Balance as of the end of the period at Dec. 31, 2022	6,105
Stock option exercises (in shares)		968
Stock awards (in shares)		431,526
Stock awards		$ 0
Issuance of treasury stock under stock plans (in shares)			(91,179)
Issuance of treasury stock under stock plans			$ 3
Balance as of the end of the period (in shares) at Dec. 31, 2023		108,906,426	61,570,314
Balance as of the end of the period at Dec. 31, 2023	7,091	$ 0	$ (5,488)	394	12,929	(744)
Stock-based compensation, net of tax				22
Stock option exercises, net of tax		$ 0		0
Net earnings (loss) attributable to Celanese Corporation	1,960				1,960
Common stock dividends					(305)
Other comprehensive income (loss), net of tax	(226)					(226)	0
Net earnings (loss) attributable to noncontrolling interests	(4)						(4)
Distributions/dividends to noncontrolling interests							11
Acquisition of noncontrolling interests							0
Balance as of the end of the period, noncontrolling interest at Dec. 31, 2023	461						461
Balance as of the end of the period at Dec. 31, 2023	7,552
Stock option exercises (in shares)		10,088
Stock awards (in shares)		411,042
Stock awards		$ 0
Issuance of treasury stock under stock plans (in shares)			(70,674)
Issuance of treasury stock under stock plans			$ 2
Balance as of the end of the period (in shares) at Dec. 31, 2024		109,327,556	61,499,640
Balance as of the end of the period at Dec. 31, 2024	5,175	$ 0	$ (5,486)	409	11,100	(848)
Stock-based compensation, net of tax				14
Stock option exercises, net of tax		$ 0		$ 1
Net earnings (loss) attributable to Celanese Corporation	(1,522)				(1,522)
Common stock dividends					$ (307)
Other comprehensive income (loss), net of tax	(104)					$ (104)	(2)
Net earnings (loss) attributable to noncontrolling interests	(8)						(8)
Distributions/dividends to noncontrolling interests							33
Acquisition of noncontrolling interests							0
Balance as of the end of the period, noncontrolling interest at Dec. 31, 2024	434						$ 434
Balance as of the end of the period at Dec. 31, 2024	$ 5,609

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024		Dec. 31, 2023	Dec. 31, 2022
Statement of Cash Flows [Abstract]
Net earnings (loss)	$ (1,514)		$ 1,964	$ 1,902
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities
Asset impairments	1,639	[1]	15	14
Depreciation, amortization and accretion	823		739	478
Pension and postretirement net periodic benefit cost	6		13	(85)
Pension and postretirement contributions	(54)		(49)	(48)
Actuarial (gain) loss on pension and postretirement plans	37		66	81
Pension curtailments and settlements, net	(9)		1	0
Deferred income taxes, net	216		(967)	(835)
(Gain) loss on disposition of businesses and assets, net	13		(501)	(8)
Stock-based compensation	32		40	60
Undistributed earnings in unconsolidated affiliates	(33)		55	(3)
Other, net	19		9	11
Operating cash provided by (used in) discontinued operations	(5)		(2)	(28)
Changes in operating assets and liabilities
Trade receivables - third party and affiliates, net	92		105	218
Inventories	11		398	(253)
Other assets	(10)		277	(13)
Trade payables - third party and affiliates	(234)		20	(84)
Other liabilities	(63)		(284)	412
Net cash provided by (used in) operating activities	966		1,899	1,819
Investing Activities
Capital expenditures on property, plant and equipment	(435)		(568)	(543)
Acquisitions, net of cash acquired	0		52	(10,589)
Proceeds from sale of businesses and assets, net	0		480	48
Settlement of cross-currency swap agreement	17		0	0
Other, net	(52)		(98)	(57)
Net cash provided by (used in) investing activities	(470)		(134)	(11,141)
Financing Activities
Net change in short-term borrowings with maturities of 3 months or less	15		(278)	36
Proceeds from short-term borrowings	160		452	500
Repayments of short-term borrowings	(418)		(603)	0
Proceeds from long-term debt	328		3,001	10,769
Repayments of long-term debt	(1,033)		(3,660)	(526)
Purchases of treasury stock, including related fees	0		0	(17)
Stock option exercises	1		0	0
Common stock dividends	(307)		(305)	(297)
Distributions/dividends to noncontrolling interests	(33)		(11)	(13)
Issuance cost of bridge facility	0		0	(63)
Other, net	(26)		(52)	(99)
Net cash provided by (used in) financing activities	(1,313)		(1,456)	10,290
Exchange rate effects on cash and cash equivalents	(26)		(12)	4
Net increase (decrease) in cash and cash equivalents	(843)		297	972
Cash and cash equivalents as of beginning of period	1,805		1,508	536
Cash and cash equivalents as of end of period	$ 962		$ 1,805	$ 1,508
[1] Primarily related to non-cash impairment losses on goodwill and certain trade names, primarily Zytel ® , arising from the Company's goodwill and indefinite-lived intangible assets impairment tests ( Note 9 ).

Description of the Company and

Description of the Company and Basis of Presentation	12 Months Ended
	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of the Company and Basis of Presentation	Description of the Company and Basis of Presentation Description of the Company Celanese Corporation and its subsidiaries (collectively, the "Company") is a global chemical and specialty materials company. The Company produces high performance engineered polymers that are used in a variety of high-value applications, as well as acetyl products, which are intermediate chemicals for nearly all major industries. The Company also engineers and manufactures a wide variety of products essential to everyday living. The Company's broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, medical, consumer electronics, energy storage, filtration, paints and coatings, paper and packaging, industrial applications and textiles. Definitions In this Annual Report on Form 10-K ("Annual Report"), the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The term "Celanese U.S." refers to the Company's subsidiary, Celanese US Holdings LLC, a Delaware limited liability company, and not its subsidiaries. Basis of Presentation The consolidated financial statements contained in this Annual Report were prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for all periods presented and include the accounts of the Company, its majority owned subsidiaries over which the Company exercises control and, when applicable, variable interest entities in which the Company is the primary beneficiary. The consolidated financial statements and other financial information included in this Annual Report, unless otherwise specified, have been presented to separately show the effects of discontinued operations. In the ordinary course of business, the Company enters into contracts and agreements relative to a number of topics, including acquisitions, dispositions, joint ventures, supply agreements, product sales and other arrangements. The Company endeavors to describe those contracts or agreements that are material to its business, results of operations or financial position. Investors should not assume the Company has described all contracts and agreements relative to the Company's business in this Annual Report. For those consolidated ventures in which the Company owns or is exposed to less than 100% of the economics, the outside shareholders' interests are shown as noncontrolling interests.

Summary of Accounting Policies

Summary of Accounting Policies	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Summary of Accounting Policies	Summary of Accounting Policies Critical Accounting Policies Recoverability of Goodwill and Indefinite-Lived Intangible Assets The Company assesses the recoverability of the carrying amount of its reporting unit goodwill and other indefinite-lived intangible assets either qualitatively or quantitatively annually during the third quarter of its fiscal year using June 30 balances or whenever events or changes in circumstances indicate that the carrying amount of the asset may not be fully recoverable. Recoverability of the carrying amount of goodwill is measured at the reporting unit level. The Company assesses the recoverability of finite-lived intangible assets in the same manner as for property, plant and equipment. Impairment losses are generally recorded in Other (charges) gains, net in the consolidated statements of operations. When assessing the recoverability of goodwill and other indefinite-lived intangible assets, the Company may first assess qualitative factors in determining whether it is more likely than not that the fair value of a reporting unit, including goodwill, or another indefinite-lived intangible asset is less than its carrying amount. The qualitative evaluation is an assessment of multiple factors, including the current operating environment, financial performance and market considerations. The Company may elect to bypass this qualitative assessment for some or all of its reporting units or other indefinite-lived intangible assets and perform a quantitative test, based on management's judgment. In performing a quantitative analysis of goodwill, the Company measures the recoverability of goodwill for each reporting unit using the income approach based on a discounted cash flow model incorporating discount rates commensurate with the risks involved or a combination of the income approach and the market approach using the guideline public company method, which is classified as a Level 3 fair value measurement. The key assumptions used in the discounted cash flow valuation model include discount rates, revenue growth rates, tax rates, cash flow projections and terminal value rates. Discount rates, revenue growth rates and cash flow projections are the most sensitive and susceptible to change as they require significant management judgment. Discount rates used are similar to the rates estimated by the weighted average cost of capital ("WACC") considering any differences in company-specific risk factors. Revenue growth rates and cash flow projections are based on historical trends and expected growth drivers such as macroeconomic trends in the industries and territories in which the reporting units operate. The Company may engage third-party valuation consultants to assist with this process. Management tests other indefinite-lived intangible assets for impairment quantitatively utilizing the relief from royalty method under the income approach to determine the estimated fair value for each indefinite-lived intangible asset, which is classified as a Level 3 fair value measurement. The relief from royalty method estimates the Company's theoretical royalty savings from ownership of the intangible asset. The key assumptions used in this model include discount rates, royalty rates, revenue growth rates, tax rates, sales projections and terminal value rates. Discount rates, royalty rates, revenue growth rates and sales projections are the assumptions most sensitive and susceptible to change as they require significant management judgment. Discount rates used are similar to the rates estimated by the WACC considering any differences in company-specific risk factors. Royalty rates are established by management and are periodically substantiated by third-party valuation consultants. Revenue growth rates and sales projections are based on historical trends and expected growth drivers such as macroeconomic trends in the industries and territories in which the indefinite-lived intangible assets operate. Tax rates consider the operating structure of the Company and tax rates in jurisdictions in which the indefinite-lived intangible assets operate. Pension and Other Postretirement Obligations The Company recognizes a balance sheet asset or liability for each of its pension and other postretirement benefit plans equal to the plan's funded status as of a December 31 measurement date. The amounts recognized in the consolidated financial statements related to pension and other postretirement benefits are determined on an actuarial basis. Various assumptions are used in the calculation of the actuarial valuation of the employee benefit plans. These assumptions include the discount rate, compensation levels, expected long-term rates of return on plan assets and trends in health care costs. In addition, actuarial consultants use factors such as withdrawal and mortality rates to estimate the projected benefit obligation. The Company applies the long-term expected rate of return to the fair value of plan assets and immediately recognizes in operating results the change in fair value of plan assets and net actuarial gains and losses annually in the fourth quarter of each fiscal year and whenever a plan is required to be remeasured. Events requiring a plan remeasurement will be recognized in the quarter in which such remeasurement event occurs. The remaining components of pension and other postretirement plan net periodic benefit costs are recorded on a monthly basis. The Company allocates the service cost and amortization of prior service cost (or credit) components of its pension and postretirement plans to its business segments. Interest cost, expected return on assets and net actuarial gains and losses are considered financing activities managed at the corporate level and are recorded to Other Activities. The Company believes the expense allocation appropriately matches the cost incurred for active employees to the respective business segment. Other postretirement benefit plans provide medical and life insurance benefits to retirees who meet minimum age and service requirements. The key determinants of the accumulated postretirement benefit obligation are the discount rate and the health care cost trend rate. • Discount Rate As of the measurement date, the Company determines the appropriate discount rate used to calculate the present value of future cash flows currently expected to be required to settle the pension and other postretirement benefit obligations. The discount rate is generally based on the yield on high-quality corporate fixed-income securities. The Company engages third-party consultants to assist with this process. In the U.S., the rate used to discount pension and other postretirement benefit plan liabilities is based on a yield curve developed from market data of approximately 400 Aa-grade non-callable bonds (unless accompanied by a make whole provision) at the measurement date. This yield curve has discount rates that vary based on the duration of the obligations. The estimated future cash flows for the pension and other benefit obligations were matched to the corresponding rates on the yield curve to derive a weighted average discount rate. Outside of the U.S., a similar approach of discounting pension and other postretirement benefit plan liabilities is used based on the high quality corporate bonds available in each market. There are some exceptions to this methodology, namely in locations where there is a sparse corporate bond market, and in such cases the discount rate takes into account yields of government bonds at the appropriate duration. • Expected Long-Term Rate of Return on Assets The Company determines the long-term expected rate of return on plan assets by considering the current target asset allocation, as well as the historical and expected rates of return on various asset categories in which the plans are invested. A single long-term expected rate of return on plan assets is then calculated for each plan as the weighted average of the target asset allocation and the long-term expected rate of return assumptions for each asset category within each plan. The expected rate of return is assessed annually. • Investment Policies and Strategies The investment objectives for the Company's pension plans are to earn, over a moving 20-year period, a long-term expected rate of return, net of investment fees and transaction costs, sufficient to satisfy the benefit obligations of the plan, while at the same time maintaining adequate liquidity to pay benefit obligations and proper expenses, and meet any other cash needs, in the short- to medium-term. The equity and debt securities objectives are to provide diversified exposure across the U.S. and global equity and fixed income markets, and to manage the risks and returns of the plans through the use of multiple managers and strategies. The fixed income strategies are designed to reduce liability-related interest rate risk by investing in bonds that match the duration and credit quality of the plan liabilities where possible. The financial objectives of the qualified pension plans are established in conjunction with a comprehensive review of each plan's liability structure. The Company's asset allocation policy is based on detailed asset/liability analysis. In developing investment policy and financial goals, consideration is given to each plan's demographics, the returns and risks associated with current and alternative investment strategies and the current and projected cash, expense and funding ratios of each plan. Investment policies must also comply with local statutory requirements as determined by each country. A formal asset/liability study of each plan is undertaken approximately every three to five years or whenever there has been a material change in plan demographics, benefit structure or funding status and investment market. The Company has adopted a long-term investment horizon such that the risk and duration of investment losses are weighed against the long-term potential for appreciation of assets. Although there cannot be complete assurance that these objectives will be realized, it is believed that the likelihood for their realization is reasonably high, based upon the asset allocation chosen and the historical and expected performance of the asset classes utilized by the plans. The intent is for investments to be broadly diversified across asset classes, investment styles, market sectors, investment managers, developed and emerging markets and securities in order to moderate portfolio volatility and risk. Investments may be in separate accounts, commingled trusts, mutual funds and other pooled asset portfolios provided they all conform to fiduciary standards. External investment managers are hired to manage pension assets. Investment consultants assist with the screening process for each new manager hired. Over the long-term, the investment portfolio is expected to earn returns that exceed a composite of market indices that are weighted to match each plan's target asset allocation. The portfolio return should also (over the long-term) meet or exceed the return used for actuarial calculations in order to meet the future needs of each plan. Income Taxes The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and net operating loss and tax credit carryforwards. The amount of deferred taxes on these temporary differences is determined using the tax rates that are expected to apply to the period when the asset is realized or the liability is settled, as applicable, based on tax rates and laws in the respective tax jurisdiction enacted as of the balance sheet date. The Company reviews its deferred tax assets for recoverability and establishes a valuation allowance based on historical taxable income, projected future taxable income, remaining carryforward periods, applicable tax strategies and the expected timing of the reversals of existing temporary differences. A valuation allowance is provided when it is more likely than not (likelihood of greater than 50%) that some portion or all of the deferred tax assets will not be realized. The Company considers many factors when evaluating and estimating its tax positions and tax benefits, which may require periodic adjustments and which may not accurately anticipate actual outcomes. Tax positions are recognized only when it is more likely than not (likelihood of greater than 50%), based on technical merits, that the positions will be sustained upon examination. Tax positions that meet the more-likely-than-not threshold are measured using a probability weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement. Whether the more-likely-than-not recognition threshold is met for a tax position is a matter of judgment based on the individual facts and circumstances of that position evaluated in light of all available evidence and technical authorities in the relevant jurisdiction. The Company recognizes interest and penalties related to uncertain tax positions in Income tax (provision) benefit in the consolidated statements of operations. Other Accounting Policies Consolidation Principles The consolidated financial statements have been prepared in accordance with U.S. GAAP for all periods presented and include the accounts of the Company and its majority owned subsidiaries over which the Company exercises control. All intercompany accounts and transactions have been eliminated in consolidation. Estimates and Assumptions The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of net sales, expenses and allocated charges during the reporting period. Significant estimates pertain to impairments of goodwill, intangible assets and other long-lived assets, purchase price allocations, restructuring costs and other (charges) gains, net, income taxes, pension and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates. Purchase Accounting The Company recognizes the identifiable tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date. The excess of purchase price over the aggregate fair values is recorded as goodwill. Intangible assets are valued using the relief from royalty, multi-period excess earnings and discounted cash flow methodologies, which are considered Level 3 measurements. The relief from royalty method estimates the Company's theoretical royalty savings from ownership of the intangible asset. Key assumptions used in this method include discount rates, royalty rates, growth rates, sales projections and terminal value rates. Key assumptions used in the multi-period excess earnings method include discount rates, retention rates, growth rates, sales projections, expense projections and contributory asset charges. Key assumptions used in the discounted cash flow valuation model include discount rates, growth rates, tax rates, cash flow projections and terminal value rates. All of these methodologies require significant management judgment and, therefore, are susceptible to change. The Company calculates the fair value of the identifiable tangible and intangible assets acquired and liabilities assumed to allocate the purchase price at the acquisition date. The Company may use the assistance of third-party valuation consultants. Variable Interest Entities The Company assesses whether it has a variable interest in legal entities in which it has a financial relationship and, if so, whether or not those entities are variable interest entities ("VIEs"). A VIE is an entity with insufficient equity at risk for the entity to finance its activities without additional subordinated financial support or in which equity investors lack the characteristics of a controlling financial interest. If an entity is determined to be a VIE, the Company evaluates whether it is the primary beneficiary. The primary beneficiary analysis is a qualitative analysis based on power and economics. The Company concludes that it is the primary beneficiary and consolidates the VIE if the Company has both (i) the power to direct the activities of the VIE that most significantly influence the VIE's economic performance, and (ii) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. The Company has a joint venture, Fairway Methanol LLC ("Fairway"), with Mitsui & Co., Ltd., of Tokyo, Japan ("Mitsui"), in which the Company owns 50% of Fairway, for the production of methanol at the Company's integrated chemical plant in Clear Lake, Texas. Fairway is a VIE in which the Company is the primary beneficiary. Accordingly, the Company consolidates the venture and records a noncontrolling interest for the share of the venture owned by Mitsui. Fairway is included in the Company's Acetyl Chain segment. As of December 31, 2024 and 2023, the carrying amount of the total assets associated with Fairway included in the consolidated balance sheets were $574 million and $626 million, respectively, made up primarily of $491 million and $529 million, respectively, of property, plant and equipment. The Company holds variable interests in entities that supply certain raw materials and services to the Company. The variable interests primarily relate to cost-plus contractual arrangements with the suppliers and recovery of capital expenditures for certain plant assets plus a rate of return on such assets. Liabilities for such supplier recoveries of capital expenditures have been recorded as finance lease obligations. The entities are not consolidated because the Company is not the primary beneficiary of the entities as it does not have the power to direct the activities of the entities that most significantly impact the entities' economic performance. The Company's maximum exposure to loss as a result of its involvement with these VIEs as of December 31, 2024 and 2023 was $208 million, related primarily to the recovery of capital expenditures for certain property, plant and equipment. Fair Value Measurements The Company determines fair value based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers assumptions that market participants would use when pricing the asset or liability. Market participant assumptions are categorized by a three-tiered fair value hierarchy which prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. If a financial instrument uses inputs that fall in different levels of the hierarchy, the instrument will be categorized based upon the lowest level of input that is significant to the fair value calculation. Valuations for fund investments, such as pooled-type investments and registered investment companies, which do not have readily determinable fair values, are typically estimated using a net asset value provided by a third party as a practical expedient. The levels of inputs used to measure fair value are as follows: Level 1 - unadjusted quoted prices for identical assets or liabilities in active markets accessible by the Company Level 2 - inputs that are observable in the marketplace other than those inputs classified as Level 1 Level 3 - inputs that are unobservable in the marketplace and significant to the valuation Cash and Cash Equivalents All highly liquid investments with original maturities of three months or less are considered cash equivalents. Inventories Inventories, including stores and supplies, are stated at the lower of cost and net realizable value. Cost for inventories is determined using the first-in, first-out method. Cost includes raw materials, direct labor and manufacturing overhead. Cost for stores and supplies is primarily determined by the average cost method. Investments in Affiliates Investments in equity securities where the Company can exercise significant influence over operating and financial policies of an investee, which is generally considered when an investor owns 20% or more of the voting stock of an investee, are accounted for under the equity method of accounting. Investments in equity securities where the Company does not exercise significant influence are accounted for at fair value or, if such investments do not have a readily determinable fair value, an election may be made to measure them at cost after considering observable price changes for similar instruments, minus impairment, if any. The Company determined it cannot exercise significant influence over certain investments where the Company owns greater than a 20% interest due to local government investment in and influence over these entities, limitations on the Company's involvement in the day-to-day operations and the present inability of the entities to provide timely financial information prepared in accordance with U.S. GAAP. Further, these investments were determined not to have a readily determinable fair value. Accordingly, these investments are accounted for using the alternative measure described above. In certain instances, the financial information of the Company's equity investees is not available on a timely basis. Accordingly, the Company records its proportional share of the investee's earnings or losses on a consistent lag of no more than one quarter. When required to assess the recoverability of its investments in affiliates, the Company estimates fair value using a discounted cash flow model. The Company may engage third-party valuation consultants to assist with this process. Property, Plant and Equipment, Net Land is recorded at historical cost. Buildings, machinery and equipment, including capitalized interest, and property under finance lease agreements, are recorded at cost less accumulated depreciation. The Company records depreciation and amortization in its consolidated statements of operations as either Cost of sales, Selling, general and administrative expenses or Research and development expenses consistent with the utilization of the underlying assets. Depreciation is calculated on a straight-line basis over the following estimated useful lives of depreciable assets: Land improvements 20 years Buildings and improvements 30 years Machinery and equipment 20 years Leasehold improvements are amortized over 10 years or the remaining life of the respective lease, whichever is shorter Accelerated depreciation is recorded when the estimated useful life is shortened. Ordinary repair and maintenance costs, including costs for planned maintenance turnarounds, that do not extend the useful life of the asset are charged to earnings as incurred. Fully depreciated assets are retained in property and depreciation accounts until sold or otherwise disposed. In the case of disposals, assets and related depreciation are removed from the accounts, and the net amounts, less proceeds from disposal, are included in earnings. The Company assesses the recoverability of the carrying amount of its property, plant and equipment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. An impairment loss would be assessed when estimated undiscounted future cash flows from the operation and disposition of the asset group are less than the carrying amount of the asset group. Asset groups have identifiable cash flows and are largely independent of other asset groups. Measurement of an impairment loss is based on the excess of the carrying amount of the asset group over its fair value. The Company calculates the fair value using a discounted cash flow model incorporating discount rates commensurate with the risks involved for the asset group, which is classified as a Level 3 fair value measurement. The key assumptions used in the discounted cash flow valuation model include discount rates, growth rates, tax rates, cash flow projections and terminal value rates. Discount rates, growth rates and cash flow projections involve significant judgment and are based on management's estimate of current and forecasted market conditions and cost structure. Impairment losses are generally recorded in Other (charges) gains, net in the consolidated statements of operations. Definite-lived Intangible Assets Customer-related intangible assets and other intangible assets with finite lives are amortized on a straight-line basis over their estimated useful lives, which range from eight Derivative and Hedging Instruments The Company manages its exposures to interest rates, foreign exchange rates and commodity prices through a risk management program that includes the use of derivative financial instruments. The Company does not use derivative financial instruments for speculative trading purposes. The fair value of derivative instruments other than foreign currency forwards and swaps is recorded as an asset or liability on a net basis at the balance sheet date. • Interest Rate Risk Management The Company entered into a forward-starting interest rate swap to mitigate the risk of variability in the benchmark interest rate for debt issued in 2021. The interest rate swap agreement was designated as a cash flow hedge. Accordingly, to the extent the cash flow hedges were effective, changes in the fair value of the interest rate swap were included in gain (loss) from cash flow hedges within Accumulated other comprehensive income (loss), net in the consolidated balance sheets. • Foreign Exchange Risk Management Certain subsidiaries of the Company have assets and liabilities denominated in currencies other than their respective functional currencies, which creates foreign exchange risk. The Company also is exposed to foreign currency fluctuations on transactions with third-party entities as well as intercompany transactions. The Company minimizes its exposure to foreign currency fluctuations by entering into foreign currency forwards and swaps. These foreign currency forwards and swaps are generally not designated as hedges. Gains and losses on foreign currency forwards and swaps entered into to offset foreign exchange impacts on intercompany balances are included in Other income (expense), net in the consolidated statements of operations. Gains and losses on foreign currency forwards and swaps entered into to offset foreign exchange impacts on all other assets and liabilities are included in Foreign exchange gain (loss), net in the consolidated statements of operations. The Company uses non-derivative financial instruments that may give rise to foreign currency transaction gains or losses to hedge the foreign currency exposure of net investments in foreign operations. Accordingly, the effective portion of gains and losses from remeasurement of the non-derivative financial instrument is included in foreign currency translation within Accumulated other comprehensive income (loss), net in the consolidated balance sheets. Gains and losses are reclassified to earnings in the period the hedged investment is sold or liquidated. The Company entered into cross-currency swaps to synthetically convert certain United States dollar ("USD") borrowings to euro ("EUR") borrowings in 2019 and 2022. The cross-currency swap agreements are designated as a net investment hedge. Accordingly, to the extent the net investment hedges are effective, changes in the fair value of the cross-currency swap are included in foreign currency translation within Accumulated other comprehensive income (loss), net in the consolidated balance sheets. Gains and losses are reclassified to earnings in the period the hedged investment is sold or liquidated. The Company entered into cross-currency swaps to effectively convert certain USD borrowings to Japanese yen ("JPY") and EUR borrowings in 2023. The cross-currency swap agreements were designated as fair value hedges. Accordingly, to the extent the fair value hedges are effective, changes in the fair value attributable to changes in the excluded components are included in gain (loss) from fair value hedges within Accumulated other comprehensive income (loss), net in the consolidated balance sheets. The value of the excluded components is recognized in earnings using a systematic and rational method by accruing the current-period swap settlements into earnings each reporting period. The Company entered into cross-currency swaps to synthetically convert certain USD borrowings to Chinese yuan ("CNY") borrowings in 2024. The cross-currency swap agreements are designated as a net investment hedge. Accordingly, to the extent the net investment hedges are effective, changes in the fair value of the cross-currency swap are included in foreign currency translation within Accumulated other comprehensive income (loss), net in the consolidated balance sheets. Gains and losses are reclassified to earnings in the period the hedged investment is sold or liquidated. • Commodity Risk Management The Company has exposure to the prices of commodities in its procurement of certain raw materials. The Company manages its exposure to commodity risk primarily through the use of long-term supply agreements, multi-year purchasing and sales agreements and forward purchase contracts. The Company regularly assesses its practice of using forward purchase contracts and other raw material hedging instruments in accordance with changes in economic conditions. Forward purchases and swap contracts for raw materials are principally settled through physical delivery of the commodity. For qualifying contracts, the Company has elected to apply the normal purchases and normal sales exception based on the probability at the inception and throughout the term of the contract that the Company would not net settle and the transaction would result in the physical delivery of the commodity. Accordingly, realized gains and losses on these contracts are included in the cost of the commodity upon the settlement of the contract. The Company also uses commodity swaps to hedge the risk of fluctuating price changes in certain raw materials and in which physical settlement does not occur. These commodity swaps fix the variable fee component of the price of certain commodities. All or a portion of these commodity swap agreements may be designated as cash flow hedges. Accordingly, to the extent the cash flow hedges are effective, changes in the fair value of commodity swaps are included in gain (loss) from cash flow hedges within Accumulated other comprehensive income (loss), net in the consolidated balance sheets. Gains and losses are reclassified to earnings in the period that the hedged item affects earnings. Asset Retirement Obligations Periodically, the Company will conclude a site no longer has an indeterminate life based on long-lived asset impairment triggering events and decisions made by the Company. Accordingly, the Company will record asset retirement obligations associated with such sites. To measure the fair value of the asset retirement obligations, the Company will use the expected present value technique, which is classified as a Level 3 fair value measurement. The expected present value technique uses a set of cash flows that represent the probability-weighted average of all possible cash flows based on the Company's judgment. The Company uses the following inputs to determine the fair value of the asset retirement obligations based on the Company's experience with fulfilling obligations of this type and the Company's knowledge of market conditions: (a) labor costs; (b) allocation of overhead costs; (c) profit on

Recent Accounting Pronouncement

Recent Accounting Pronouncements	12 Months Ended
	Dec. 31, 2024
Accounting Standards Update and Change in Accounting Principle [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements The following table provides a brief description of recent Accounting Standard Updates ("ASU") issued by the Financial Accounting Standards Board ("FASB") and final rules issued by the Securities and Exchange Commission ("SEC"): Standard/Final Rule Description Effective Date Effect on the Financial Statements or Other Significant Matters In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses (DISE) and on January 6, 2025, the FASB issued ASU 2025-01, Clarifying the Effective Date. The new guidance requires a public business entity ("PBE") to disclose, on an annual and interim basis, additional information about certain costs and expenses in the notes to financial statements. Specifically, in a tabular disclosure, the amounts of (a) purchases of inventory; (b) employee compensation; (c) depreciation; (d) intangible asset amortization; and (e) depreciation, depletion, and amortization recognized as part of oil- and gas-producing activities (or other amounts of depletion expense) included in each relevant expense caption. Within the same tabular disclosure, a PBE is required to include certain expense, gain, or loss amounts that are already required to be disclosed under U.S. GAAP. Additionally, a PBE is required to disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. The guidance also requires a PBE to disclose the total amount of selling expenses and, in annual reporting periods, an entity's definition of selling expenses. Effective for annual periods beginning after December 15, 2026, and interim periods within annual periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the adoption on its financial statement disclosures. Standard/Final Rule Description Effective Date Effect on the Financial Statements or Other Significant Matters In March 2024, the SEC issued Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors . The final rule will require the disclosure of Scope 1 and Scope 2 greenhouse gas emissions, if material, which will be subject to phased-in assurance requirements, governance of climate-related risks, risk management processes and climate-related targets and goals. Within the notes to financial statements, the final rule requires disclosure of certain climate-related financial statement effects and metrics. Phased-in and effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The SEC stayed the effectiveness of the final rule in April 2024 pending judicial review. The Company is currently evaluating the impact of the adoption on its financial statement disclosures. In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures. The new guidance requires an entity to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Additionally, the guidance requires an entity to disclose annual income taxes paid (net of refunds received) disaggregated by federal (national), state and foreign taxes and disaggregate the information by jurisdiction based on a quantitative threshold. The guidance also requires an entity to disclose income (loss) from continuing operations before income tax expense (benefit) disaggregated between domestic and foreign and income tax expense (benefit) from continuing operations disaggregated by federal (national), state and foreign. Effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact of the adoption on its financial statement disclosures. In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures. The new guidance requires an entity to disclose, on an annual and interim basis, significant segment expenses that are regularly provided to the chief operating decision maker ("CODM") and included within segment profit or loss, as well as an amount of other segment items by reportable segment and a description of its composition. Additionally, the guidance requires an entity to disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The update is required to be applied retrospectively to prior periods presented, based on the significant segment expense categories identified and disclosed in the period of adoption. Effective for annual periods beginning after December 15, 2023, and for interim periods beginning after December 15, 2024. Early adoption is permitted. The Company adopted the new guidance effective for the year ended December 31, 2024. The adoption of the new guidance did not have a material impact to the Company.

Acquisitions, Dispositions and

Acquisitions, Dispositions and Plant Closures	12 Months Ended
	Dec. 31, 2024
Acquisitions, Dispositions and Plant Closures [Abstract]
Acquisitions, Dispositions and Plant Closures	Acquisitions, Dispositions and Plant Closures Acquisitions • Mobility & Materials In November 2022, the Company acquired 100% ownership of entities and assets consisting of a majority of the Mobility & Materials business ("M&M") of DuPont de Nemours, Inc. ("DuPont") (the "M&M Acquisition") for a purchase price of $11.0 billion, subject to transaction adjustments, in an all-cash transaction. The Company acquired a global production network of 29 facilities, including compounding and polymerization, customer and supplier contracts and agreements, an intellectual property portfolio, including approximately 850 patents with associated technical and R&D assets, and approximately 5,000 employees across the manufacturing, technical, and commercial organizations. This acquisition of M&M enhances the engineered materials product portfolio by adding new polymers, brands, product technology, and backward integration in critical polymers, allowing the Company to accelerate growth in high-value applications including future mobility, connectivity and medical. The acquisition was accounted for as a business combination and the acquired operations are included in the Engineered Materials segment. The Company allocated the purchase price of the acquisition to identifiable assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date. The excess of the purchase price over the aggregate fair values was recorded as goodwill. During the measurement period, there were no adjustments that materially impacted the Company's goodwill initially recorded. The following unaudited pro forma financial information presents the consolidated results of operations as if the M&M Acquisition had occurred at the beginning of 2021. M&M's pre-acquisition results have been added to the Company's historical results. The pro forma results contained in the table below include adjustments for (i) increased depreciation expense as a result of acquisition date fair value adjustments, (ii) amortization of acquired intangibles, (iii) interest expense and amortization of debt issuance costs of $366 million related to borrowings entered into during the year ended December 31, 2022 and the issuance of $9.0 billion of senior unsecured notes registered under the Securities Act in July 2022 as if these had taken place at the beginning of 2021 for the year ended December 31, 2022, and (iv) net total inventory step up of inventory amortized to Cost of sales of $66 million for the year ended December 31, 2022. These pro forma results have been prepared for comparative purposes only and are not necessarily indicative of the results of operations as they would have been had the acquisition occurred on the assumed date, nor are they necessarily an indication of future operating results. Year Ended 2022 (In $ millions) Unaudited Consolidated Pro Forma Results Proforma Net sales 12,614 Proforma Earnings (loss) from continuing operations before tax 888 The amount of M&M Net sales and Earnings (loss) from continuing operations before tax consolidated by the Company since the acquisition date through December 31, 2022 were $430 million and $(80) million, respectively. During the year ended December 31, 2022, transaction related costs of $117 million were expensed as incurred to Selling, general and administrative expenses in the consolidated statements of operations. • Nutrinova Joint Venture In September 2023, the Company formed a food ingredients joint venture with Mitsui under the name Nutrinova. The Company contributed receivables, inventory, property, plant and equipment, certain other assets, liabilities, technology and employees of its food ingredients business while retaining a 30% interest in the joint venture. Mitsui acquired the remaining 70% interest in the food ingredients business for a purchase price of $503 million, subject to transaction adjustments. The Company is accounting for its interest in the joint venture as an equity method investment, and its portion of the results continues to be included in the Engineered Materials segment. A gain on the transaction of $515 million was included in Gain (loss) on disposition of businesses and assets, net in the consolidated statements of operations for the year ended December 31, 2023. Plant Closures • Uentrop, Germany In October 2023, the Company announced the intended closure of its Polyamide 66 ("PA66") and High-Performance Nylon ("HPN") polymerization units at its facility in Uentrop, Germany to optimize production costs across its global network. These operations are included in the Company's Engineered Materials segment. The Company fully ceased operation of the PA66 polymerization unit and partially ceased operation of the HPN polymerization units during the year ended December 31, 2024. The exit and shutdown costs related to the closure of the PA66 and HPN polymerization units in Uentrop, Germany were as follows: Year Ended 2024 (In $ millions) Restructuring (1) 16 Accelerated depreciation expense (2) 36 Total 52 ______________________________ (1) Included in Other (charges) gains, net in the consolidated statements of operations ( Note 24 ). (2) Included in Cost of sales in the consolidated statements of operations. • Mechelen, Belgium On February 29, 2024, the Company announced the intended closure of its facility in Mechelen, Belgium to optimize production costs across its global network. This operation is included in the Company's Engineered Materials segment. The Company fully ceased operations during the year ended December 31, 2024. The exit and shutdown costs related to the closure of the facility in Mechelen, Belgium were as follows: Year Ended 2024 (In $ millions) Restructuring (1) 55 Accelerated depreciation expense (2) 35 Total 90 ______________________________ (1) Included in Other (charges) gains, net in the consolidated statements of operations ( Note 24 ). (2) Included in Cost of sales in the consolidated statements of operations. The Company expects to incur additional exit and shutdown costs related to the closure of the facility in Mechelen, Belgium of approximately $20 million, inclusive of estimated employee termination costs, through 2028.

Receivables, Net

Receivables, Net	12 Months Ended
	Dec. 31, 2024
Receivables [Abstract]
Receivables, Net	Receivables, Net As of December 31, 2024 2023 (In $ millions) Trade receivables - third party and affiliates 1,137 1,255 Allowance for doubtful accounts - third party and affiliates (16) (12) Trade receivables - third party and affiliates, net 1,121 1,243 As of December 31, 2024 2023 (In $ millions) Non-income taxes receivable 266 270 Income taxes receivable 53 57 Other (1) 174 214 Non-trade receivables, net 493 541 ____________________________ (1) Includes $42 million of non-trade receivables related to the M&M Acquisition as of December 31, 2023.

Inventories

Inventories	12 Months Ended
	Dec. 31, 2024
Inventory Disclosure [Abstract]
Inventories	Inventories As of December 31, 2024 2023 (In $ millions) Finished goods 1,605 1,604 Work-in-process 119 160 Raw materials and supplies 560 593 Total 2,284 2,357

Investments in Affiliates

Investments in Affiliates	12 Months Ended
	Dec. 31, 2024
Investments in and Advances to Affiliates, Schedule of Investments [Abstract]
Investments in Affiliates	Investments in Affiliates Entities in which the Company has an investment accounted for under the equity method of accounting or equity investments without readily determinable fair values are considered affiliates; any transactions or balances with such companies are considered affiliate transactions. Equity Method In September 2023, the Company formed a food ingredients joint venture with Mitsui under the name Nutrinova. The Company accounted for its interest in the joint venture as an equity method investment. See Note 4 for additional information. As a part of the M&M Acquisition, the Company acquired certain equity method investments and ownership interests. The Company has ownership interests in 14 equity method investments ranging from 22% to 50% at December 31, 2024. Equity method investments by business segment are as follows: Carrying Share of Dividends and 2024 2023 2024 2023 2022 2024 2023 2022 (In $ millions) Engineered Materials (1) 893 898 182 88 209 (149) (145) (204) Other Activities 56 56 14 14 11 (11) (12) (13) Total 949 954 196 102 220 (160) (157) (217) ____________________________ (1) Engineered Materials includes an equity method investment with losses in excess of its carrying amount due to the Company's guarantee of various debt obligations under agreements with third parties related to an equity affiliate ( Note 19 ). This equity method investment was recorded in Current Other liabilities ( Note 10 ) as of December 31, 2024 and 2023. Equity Investments Without Readily Determinable Fair Values The Company has ownership interests in 4 equity investments without readily determinable fair values ranging from 8% to 31% at December 31, 2024. Equity investments without readily determinable fair values by business segment are as follows: Carrying Dividend 2024 2023 2024 2023 2022 (In $ millions) Engineered Materials Acetyl Chain 165 165 127 125 132 Other Activities 5 5 1 1 1 Total 170 170 128 126 133 Transactions with Affiliates The Company owns manufacturing facilities at the InfraServ location in Frankfurt am Main-Hoechst, Germany and has contractual agreements with its InfraServ equity affiliates and certain other equity affiliates and investees accounted for at cost less impairment, adjusted for observable price changes for an identical or similar investment of the same issuer. These contractual agreements primarily relate to energy purchases, site services and purchases of product for consumption and resale. Transactions and balances with affiliates are as follows: Year Ended December 31, 2024 2023 2022 (In $ millions) Purchases 452 490 590 Sales and other credits 89 212 72 As of December 31, 2024 2023 (In $ millions) Trade receivables 11 7 Non-trade receivables 30 40 Current notes receivables 65 57 Total due from affiliates 106 104 Short-term borrowings (1) 37 23 Trade payables 25 52 Current Other liabilities 34 34 Total due to affiliates 96 109 ______________________________ (1) The Company has agreements with certain affiliates whereby excess affiliate cash is lent to and managed by the Company at variable interest rates governed by those agreements.

Property, Plant and Equipment,

Property, Plant and Equipment, Net	12 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment, Net [Abstract]
Property, Plant and Equipment, Net	Property, Plant and Equipment, Net As of December 31, 2024 2023 (In $ millions) Land 240 260 Land improvements 91 85 Buildings and building improvements 1,059 1,082 Machinery and equipment 7,745 7,157 Construction in progress 700 1,080 Gross asset value 9,835 9,664 Accumulated depreciation (4,562) (4,080) Net book value 5,273 5,584 Assets under finance leases, net, included in the amounts above were $119 million and $154 million as of December 31, 2024 and 2023, respectively. Capitalized interest costs and depreciation expense are as follows: Year Ended December 31, 2024 2023 2022 (In $ millions) Capitalized interest 30 37 18 Depreciation expense 640 540 399 During 2024, 2023 and 2022, certain long-lived assets were impaired ( Note 24 ).

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Net	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets, Net	Goodwill and Intangible Assets, Net Goodwill Engineered Acetyl Total (In $ millions) As of December 31, 2022 6,775 367 7,142 Acquisitions ( Note 4 ) (107) — (107) Dispositions ( Note 4 ) (80) — (80) Exchange rate changes 14 8 22 As of December 31, 2023 (1) 6,602 375 6,977 Impairment losses (1,517) — (1,517) Exchange rate changes (60) (13) (73) As of December 31, 2024 (1) 5,025 362 5,387 ______________________________ (1) Includes accumulated impairment losses of $1.5 billion in the Engineered Materials segment as of December 31, 2024. There were no accumulated impairment losses as of December 31, 2023. The Company assesses the recoverability of the carrying amount of its reporting unit goodwill either qualitatively or quantitatively annually during the third quarter of its fiscal year using June 30 balances or whenever events or changes in circumstances indicate that the carrying amount of the asset may not be fully recoverable. During the three months ended September 30, 2024, the Company completed qualitative evaluations on its reporting units, with the exception of the engineered materials reporting unit, and concluded that it was more likely than not that the fair value of these reporting units exceeded their carrying value. The engineered materials reporting unit was tested quantitatively as the Company experienced decreased demand, identified near-term negative trends in the automotive and industrial end-markets and experienced other challenging current macroeconomic conditions during the three months ended September 30, 2024. Based on the quantitative test, the estimated fair value of the engineered materials reporting unit exceeded the carrying amount of its underlying assets. Therefore, the Company did not record an impairment loss to goodwill during the nine months ended September 30, 2024. Although no impairment of the engineered materials reporting unit was identified during the nine months ended September 30, 2024, the estimated fair value exceeded its carrying value by less than 10% as of September 30, 2024. During the three months ended December 31, 2024, the Company experienced a significant and sustained decrease in the Company's share price. Further, due to extended weakness in the macroeconomic environment, specifically the auto and industrial end-markets, which deepened general demand softness during the three months ended December 31, 2024, thereby impacting pricing and volume, the Company updated its engineered materials reporting unit forecast model for the 2025 fiscal year which showed additional deterioration in the projected financial results for the 2025 fiscal year compared to the analyses prepared during the three months ended September 30, 2024. While the long-term projections beyond 2025 include recovery, the lower projections in 2025 do have an impact on the forecast model beyond 2025 by applying forecasted growth rates to a lower anticipated 2025 base revenue. The updated 2025 projections continue to reflect industry wide challenges including demand softness across the majority of end uses resulting in lower pricing. Based on the sustained decrease in the share price and updated projections, the Company determined that there were indicators that the engineered materials reporting unit's goodwill may be impaired and, accordingly, performed an interim quantitative test of the engineered materials reporting unit during the three months ended December 31, 2024. The results of the test determined that the carrying amount of the engineered materials reporting unit exceeded its estimated fair value primarily due to the downward adjustments in the forecast model, as well as an increase in the discount rate. As such, the Company recorded a non-cash goodwill impairment loss of $1.5 billion in Other charges (gains), net ( Note 24 ) within the Engineered Materials segment. The quantitative evaluations of the engineered materials reporting unit were performed using an equal weighting of the income approach based on the discounted estimated future cash flows of the reporting unit and market approach using the guideline public company method. The key assumptions used in the discounted cash flow valuation model include the discount rate, revenue growth rate, tax rate, cash flow projections and terminal value rate. The discount rates were based on market participant data, including the Company's weighted average cost of capital adjusted for risks specific to the reporting unit. The revenue growth rates and cash flow projections were based on historical trends and expected growth drivers such as macroeconomic trends in the industries and territories in which the reporting unit operates. The tax rates considered the operating structure of the reporting unit and tax rates in jurisdictions in which the reporting unit operates. A terminal value rate was applied to the final year of the projected periods to reflect continued stable, perpetual growth. Under the market approach, the Company utilized earnings multiples for public companies similar to the engineered materials reporting unit adjusted for a control premium. While the Company believes the assumptions used in the impairment tests were reasonable, changes in market conditions or key assumptions made in future quantitative tests, including discount rates, revenue growth rates, tax rates, cash flow projections and terminal value rates, could negatively impact the results of future impairment testing for any of the Company's reporting units and could result in the recognition of additional impairment charges. Such charges could be material to the statements of operations and balance sheets in the period(s) recorded. No events or changes in circumstances occurred during the three months ended December 31, 2024 that indicated the fair values of the Company's remaining reporting units were reduced below their carrying amounts. Accordingly, no additional impairment analysis was performed during that period. Intangible Assets, Net Finite-lived intangible assets are as follows: Licenses Customer- Developed Covenants Total (In $ millions) Gross Asset Value As of December 31, 2022 42 2,455 601 55 3,153 Disposition ( Note 4 ) — (60) (1) — (61) Exchange rate changes (1) 42 1 — 42 As of December 31, 2023 41 2,437 601 55 3,134 Exchange rate changes (1) (31) (14) — (46) As of December 31, 2024 40 2,406 587 55 3,088 Accumulated Amortization As of December 31, 2022 (39) (567) (50) (40) (696) Amortization — (120) (43) (1) (164) Disposition ( Note 4 ) — 59 1 — 60 Exchange rate changes 1 (11) (3) (1) (14) As of December 31, 2023 (38) (639) (95) (42) (814) Amortization — (116) (42) (1) (159) Exchange rate changes 1 27 3 — 31 As of December 31, 2024 (37) (728) (134) (43) (942) Net book value 3 1,678 453 12 2,146 Indefinite-lived intangible assets are as follows: Trademarks (In $ millions) As of December 31, 2022 1,648 Dispositions ( Note 4 ) (14) Exchange rate changes 21 As of December 31, 2023 1,655 Impairment losses (117) Exchange rate changes (43) As of December 31, 2024 1,495 The Company assesses the recoverability of the carrying amount of its indefinite-lived intangible assets either qualitatively or quantitatively annually during the third quarter of its fiscal year using June 30 balances or whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable. During the three months ended September 30, 2024, the Company completed qualitative evaluations on its indefinite-lived intangible assets, with the exception of those assigned to the engineered materials reporting unit, and concluded that it was more likely than not that the fair value of these indefinite-lived intangible assets exceeded their carrying value. Indefinite-lived intangible assets assigned to the engineered materials reporting unit were tested quantitatively. In connection with the Company's annual indefinite-lived intangible assets impairment test, the Company recorded a non-cash impairment loss of $34 million during the three months ended September 30, 2024, in Other charges (gains), net ( Note 24 ) to impair the net book value of certain trade names, primarily Zytel ® , included in the Engineered Materials segment. Additionally, in conjunction with the goodwill impairment test in the three months ended December 31, 2024, the Company performed an interim impairment test on the indefinite-lived intangible assets assigned to the engineered materials reporting unit. The Company recorded a non-cash impairment loss of $83 million in Other charges (gains), net ( Note 24 ) to impair the net book value of certain trade names, primarily Zytel ® , included in the Engineered Materials segment. Indefinite-lived intangible assets assigned to the engineered materials reporting unit were tested quantitatively utilizing the relief from royalty method under the income approach to determine the estimated fair value for each indefinite-lived intangible asset. The key assumptions used in this model include discount rates, royalty rates, revenue growth rates, tax rates, sales projections and terminal value rates. The discount rates were based on the Company's weighted average return on assets adjusted for risks specific to the indefinite-lived intangible assets. Royalty rates are established by management using the most recent third party valuations and are periodically substantiated by third-party valuation consultants. The revenue growth rates and sales projections were based on historical trends and expected growth drivers such as macroeconomic trends in the industries and territories in which the indefinite-lived intangible assets operate. The tax rates considered the operating structure of the Company and tax rates in jurisdictions in which the indefinite-lived intangible assets operate. A terminal value rate was applied to the final year of the projected period to reflect continued stable, perpetual growth. While the Company believes the assumptions used in the impairment tests were reasonable, changes in market conditions or key assumptions made in future quantitative tests, including discount rates, royalty rates, revenue growth rates, tax rates, sales projections and terminal value rates, could negatively impact the results of future impairment testing and could result in the recognition of additional impairment losses. Such charges could be material to the statements of operations and balance sheets in the period(s) recorded. No events or changes in circumstances occurred during the three months ended December 31, 2024 that indicated the carrying amount of the Company's remaining indefinite-lived intangible assets may not be fully recoverable. Accordingly, no additional impairment analysis was performed during that period. During the year ended December 31, 2024, the Company did not renew or extend any intangible assets. Estimated amortization expense for the succeeding five fiscal years is as follows: (In $ millions) 2025 162 2026 162 2027 162 2028 162 2029 157

Current Other Liabilities

Current Other Liabilities	12 Months Ended
	Dec. 31, 2024
Other Liabilities, Current [Abstract]
Current Other Liabilities	Current Other Liabilities As of December 31, 2024 2023 (In $ millions) Benefit obligations ( Note 12 ) 25 25 Customer rebates 92 96 Derivatives ( Note 17 ) 93 90 Interest ( Note 11 ) 222 246 Legal ( Note 19 ) 10 34 Operating leases ( Note 16 ) 79 89 Restructuring ( Note 24 ) 63 18 Salaries and benefits 166 175 Sales and use tax/foreign withholding tax payable 150 128 Investment in affiliates ( Note 7 ) 98 96 Other 122 157 Total 1,120 1,154

Debt

Debt	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Debt	Debt As of December 31, 2024 2023 (In $ millions) Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates Current installments of long-term debt 1,393 1,025 Short-term borrowings, including amounts due to affiliates (1) 53 146 Revolving credit facilities (2) 55 212 Total 1,501 1,383 ______________________________ (1) The weighted average interest rate was 2.1% and 2.9% as of December 31, 2024 and 2023, respectively. (2) The weighted average interest rate was 3.1% and 3.4% as of December 31, 2024 and 2023, respectively. As of December 31, 2024 2023 (In $ millions) Long-Term Debt Senior unsecured notes due 2024, interest rate of 3.500% — 473 Senior unsecured notes due 2024, interest rate of 5.900% — 527 Senior unsecured notes due 2025, interest rate of 1.250% 311 331 Senior unsecured notes due 2025, interest rate of 6.050% 1,000 1,000 Senior unsecured notes due 2026, interest rate of 1.400% 400 400 Senior unsecured notes due 2026, interest rate of 4.777% 1,040 1,105 Senior unsecured notes due 2027, interest rate of 2.125% 518 551 Senior unsecured notes due 2027, interest rate of 6.165% 2,000 2,000 Senior unsecured term loan due 2027 (1) 880 880 Senior unsecured notes due 2028, interest rate of 0.625% 519 552 Senior unsecured notes due 2028, interest rate of 6.350% (2) 1,000 1,000 Senior unsecured notes due 2029, interest rate of 5.337% 519 552 Senior unsecured notes due 2029, interest rate of 6.330% 750 750 Senior unsecured notes due 2030, interest rate of 6.550% (2) 999 999 Senior unsecured notes due 2032, interest rate of 6.379% 1,000 1,000 Senior unsecured notes due 2033, interest rate of 6.700% (2) 1,000 1,000 Pollution control and industrial revenue bonds due at various dates through 2030 (3) 126 127 Bank loans due at various dates through 2030 (4) 320 5 Obligations under finance leases due at various dates through 2054 145 148 Subtotal 12,527 13,400 Unamortized deferred financing costs (5) (56) (74) Current installments of long-term debt (1,393) (1,025) Total 11,078 12,301 ______________________________ (1) The interest rate was 6.047% and 6.943% as of December 31, 2024 and 2023, respectively. (2) On November 14, 2024, S&P Global Ratings downgraded the Company's credit rating to BB+, which had the effect of increasing the interest rates by 25 basis points on the senior unsecured notes due 2028, senior unsecured notes due 2030 and senior unsecured notes due 2033 to 6.600%, 6.800% and 6.950%, respectively, effective November 15, 2024. (3) Interest rates range from 4.1% to 5.0%. (4) The weighted average interest rate was 2.8% and 2.6% as of December 31, 2024 and 2023, respectively. (5) Related to the Company's long-term debt, excluding obligations under finance leases. Senior Credit Facilities In March 2022, Celanese, Celanese U.S. and certain subsidiaries entered into a term loan credit agreement (as amended to date, the "March 2022 U.S. Term Loan Credit Agreement"), pursuant to which lenders provided a tranche of delayed-draw term loans due 5 years from issuance in an amount equal to $1.0 billion (the "5-year Term Loans"). Also in March 2022, Celanese, Celanese U.S. and certain subsidiaries entered into a new revolving credit agreement (as amended to date, the "U.S. Revolving Credit Agreement" and, together with the March 2022 U.S. Term Loan Credit Agreement, the "U.S. Credit Agreements") consisting of a $1.75 billion senior unsecured revolving credit facility (with a letter of credit sublimit), maturing in 2027 (the "U.S. Revolving Credit Facility"). The margin for borrowings under the U.S. Revolving Credit Facility was 1.00% to 2.00% above certain interbank rates at current Company credit ratings. On February 21, 2023, August 9, 2023, February 16, 2024, November 1, 2024 and February 17, 2025, the Company amended certain covenants in certain of the U.S. Credit Agreements, including financial ratio maintenance covenants. The U.S. Credit Agreements are guaranteed by Celanese, Celanese U.S. and domestic subsidiaries together representing substantially all of the Company's U.S. assets and business operations (the "Subsidiary Guarantors"). The Subsidiary Guarantors are listed in Exhibit 22.1 to this Annual Report. In January 2023, Celanese (Shanghai) International Trading Co., Ltd ("CSIT"), a fully consolidated subsidiary, entered into a restatement of an existing credit facility agreement (the "CSIT Revolving Credit Agreement") to upsize and modify the facility thereunder to consist of an aggregate CNY1.75 billion uncommitted senior unsecured revolving credit facility available under two tranches (with overdraft, bank guarantee and documentary credit sublimits) (the "CSIT January 2023 Facility"). Obligations bear interest at certain fixed and floating rates. On April 7, 2024, the CSIT January 2023 Facility was reduced to CNY750 million, and on December 19, 2024, the CSIT January 2023 Facility was reduced to CNY550 million. The CSIT Revolving Credit Agreement is guaranteed by Celanese U.S. Also in January 2023, CSIT entered into a senior unsecured working capital loan contract for CNY800 million (the "China Working Capital Term Loan Agreement"), payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates. The loan under the China Working Capital Term Loan Agreement was fully drawn in January 2023 and was fully repaid during the three months ended March 31, 2024. In December 2023, Celanese (Nanjing) Chemical Co., Ltd. ("CNC") entered into a senior unsecured working capital loan agreement for CNY800 million, payable on December 25, 2026 and bearing interest at 2.8% (the "CNC Working Capital Loan Agreement"). The loan under the CNC Working Capital Loan Agreement was fully drawn during the three months ended March 31, 2024. On June 28, 2024, CNC entered into a senior unsecured working capital loan agreement for CNY800 million, payable in installments until June 28, 2027 and bearing interest at 2.75% (the "CNC Three Year Working Capital Loan Agreement"). The CNC Three Year Working Capital Loan Agreement was partially drawn during the year ended December 31, 2024. On November 1, 2024, Celanese U.S. entered into a senior unsecured term loan credit agreement (the "November 2024 U.S. Term Loan Credit Agreement"), pursuant to which the lenders provided a delayed-draw term loan due 364 days from the date of borrowing in an amount up to $1.0 billion. Amounts outstanding under the November 2024 U.S. Term Loan Credit Agreement will accrue interest at a rate equal to the Secured Overnight Financing Rate with an interest period of one or three months ("Term SOFR") plus a margin of 1.300% to 2.250% per annum, or the base rate plus a margin of 0.300% to 1.250%, in each case, based on the Company's senior unsecured debt rating, subject to further changes based on such ratings. The commitments under the November 2024 U.S. Term Loan Credit Agreement will terminate by March 15, 2025. The loan under the November 2024 U.S. Term Loan Credit Agreement was not drawn during the year ended December 31, 2024. On December 10, 2024, CNC entered into a credit facility agreement (the "CNC Revolving Credit Agreement," together with the CNC Three Year Working Capital Loan Agreement, the CSIT Revolving Credit Agreement, the China Working Capital Term Loan Agreement and the CNC Working Capital Loan Agreement, the "China Credit Agreements," and the China Credit Agreements together with the U.S. Credit Agreements, the "Global Credit Agreements") for a CNY1.0 billion uncommitted senior unsecured revolving credit facility (the "CNC December 2024 Facility", and together with the CSIT January 2023 Facility and any other revolving credit facilities available to the Company's subsidiaries in China, the "China Revolving Credit Facilities"). Obligations bear interest at certain floating rates. The Company expects that the China Credit Agreements will continue to facilitate its efficient repatriation of cash to the U.S. to repay debt and effectively redomicile a portion of its U.S. debt to China at a lower average interest rate. The Company's debt balances and amounts available for borrowing under its senior unsecured revolving credit facilities are as follows: As of (In $ millions) Revolving Credit Facility Borrowings outstanding — Available for borrowing 1,750 China Revolving Credit Facilities Borrowings outstanding 55 Available for borrowing 171 On February 6, 2025, the Company drew $300 million from its U.S. Revolving Credit Facility. This borrowing and cash on hand were used primarily to repay in full the Company's senior unsecured notes due 2025, with an interest rate of 1.250%, due on February 11, 2025, and for general corporate purposes. Senior Notes The Company has outstanding senior unsecured notes, issued in public offerings registered under the Securities Act of 1933, as amended (the "Securities Act") (collectively, the "Senior Notes"). The Senior Notes were issued by Celanese U.S. and are guaranteed on a senior unsecured basis by Celanese and the Subsidiary Guarantors. Celanese U.S. may redeem some or all of each of the Senior Notes, prior to their respective maturity dates, at a redemption price of 100% of the principal amount, plus a "make-whole" premium as specified in the applicable indenture, plus accrued and unpaid interest, if any, to the redemption date. In August 2023, Celanese U.S. completed a public offering of senior unsecured notes registered under the Securities Act as follows (collectively, the "2023 Offering"): Maturity Date Aggregate Principal Discount to Par Interest Rate (In $ millions) November 15, 2028 1,000 99.986% 6.350% November 15, 2030 999 99.950% 6.550% November 15, 2033 1,000 99.992% 6.700% Also in August 2023, Celanese U.S. completed a cash tender offer for $2.25 billion in aggregate principal amount (the "Tender Offer") as follows: Maturity Date Aggregate Principal Amount Tendered Purchase price per $1,000 principal amount Total Tender Offer Consideration Accrued and Unpaid Interest (In $ millions) (In $ millions) July 5, 2024 1,473 $ 999.92 1,473 12 March 15, 2025 750 $ 1,002.85 752 20 May 8, 2024 27 $ 983.95 27 — The net proceeds from the 2023 Offering were used (i) to fund the Tender Offer and (ii) for the repayment of other outstanding indebtedness. Principal payments scheduled to be made on the Company's debt, including short-term borrowings, are as follows: (In $ millions) 2025 1,501 2026 1,571 2027 3,599 2028 1,537 2029 1,287 Thereafter 3,140 Total 12,635 On February 12, 2025, Moody's Ratings downgraded the Company's credit ratings to Ba1 which, along with the credit downgrade by S&P Global Ratings on November 14, 2024, will have the impact of increasing interest rates for certain Senior Notes by up to 50 basis points and the U.S. Credit Agreements by 25 basis points starting in the years ended December 31, 2025 and 2026, as applicable. Accounts Receivable Purchasing Facility In June 2023, the Company entered into an amendment to the amended and restated receivables purchase agreement (the "Amended Receivables Purchase Agreement") under its U.S. accounts receivable purchasing facility among certain of the Company's subsidiaries, its wholly-owned, "bankruptcy remote" special purpose subsidiary ("SPE") and certain global financial institutions ("Purchasers"). The Amended Receivables Purchase Agreement extends the term of the accounts receivable purchasing facility such that the SPE may sell certain receivables until June 18, 2025. Under the Amended Receivables Purchase Agreement, transfers of U.S. accounts receivable from the SPE are treated as sales and are accounted for as a reduction in accounts receivable because the agreement transfers effective control over and risk related to the U.S. accounts receivable to the SPE. The Company and related subsidiaries have no continuing involvement in the transferred U.S. accounts receivable, other than collection and administrative responsibilities and, once sold, the U.S. accounts receivable are no longer available to satisfy creditors of the Company or the related subsidiaries. These sales are transacted at 100% of the face value of the relevant U.S. accounts receivable, resulting in derecognition of the U.S. accounts receivables from the Company's consolidated balance sheet. The Company de-recognized $1.5 billion and $1.4 billion of accounts receivable under this agreement for the years ended December 31, 2024 and 2023, respectively, and collected $1.5 billion and $1.3 billion of accounts receivable sold under this agreement during the same periods. Unsold U.S. accounts receivable of $139 million were pledged by the SPE as collateral to the Purchasers as of December 31, 2024. Factoring and Discounting Agreements The Company has factoring agreements in Europe, Japan and Singapore with financial institutions to sell 100%, 100% and 90% of certain accounts receivable, respectively, on a non-recourse basis. The Company also has a factoring agreement in China with a financial institution to sell 100% of certain accounts receivable on a limited recourse basis. These transactions are treated as sales and are accounted for as reductions in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyer. The Company has no material continuing involvement in the transferred receivables, other than collection and administrative responsibilities and, once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. The Company de-recognized $700 million and $423 million of accounts receivable under these factoring agreements for the years ended December 31, 2024 and 2023, respectively, and collected $640 million and $407 million of accounts receivable sold under these factoring agreements during the same periods. The Company has master discounting agreements (the "Master Discounting Agreements") with financial institutions in China to discount, on a non-recourse basis, banker's acceptance drafts ("BADs"), classified as accounts receivable. Under the Master Discounting Agreements, transfers of BADs are treated as sales and are accounted for as a reduction in accounts receivable because the Master Discounting Agreements transfer effective control over and risk related to the transferred BADs to the financial institutions. The Company has no continuing involvement in the transferred BADs, and the BADs are no longer available to satisfy creditors in the event of a bankruptcy. The Company received $100 million and $45 million from the accounts receivable transferred under the Master Discounting Agreements as of December 31, 2024 and 2023, respectively. Covenants The Company's material financing arrangements contain customary covenants, such as events of default and change of control provisions, and in the case of the existing U.S. Credit Agreements the maintenance of certain financial ratios (subject to adjustment following certain qualifying acquisitions and dispositions, as set forth in the existing U.S. Credit Agreements, as amended). Failure to comply with these covenants, or the occurrence of any other event of default, could result in acceleration of the borrowings and other financial obligations. The Company is in compliance with the covenants in its material financing arrangements as of December 31, 2024.

Benefit Obligations

Benefit Obligations	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Benefit Obligations	Benefit Obligations Pension Obligations The Company sponsors defined benefit pension plans in North America, Europe and Asia. Independent trusts or insurance companies administer the majority of these plans. Pension obligations are established for benefits payable in the form of retirement, disability and surviving dependent pensions. The commitments result from participation in defined contribution and defined benefit plans, primarily in the U.S. Benefits are dependent on years of service and the employee's compensation. Supplemental retirement benefits provided to certain employees are nonqualified for U.S. tax purposes. Separate nonqualified trusts have been established for certain U.S. nonqualified plan obligations. Pension costs under the Company's retirement plans are actuarially determined. Other Postretirement Obligations Certain retired employees receive postretirement health care and life insurance benefits under plans sponsored by the Company, which has the right to modify or terminate these plans at any time. The cost for coverage is shared between the Company and the retiree. The cost of providing retiree health care and life insurance benefits is actuarially determined and accrued over the service period of the active employee group. The Company's policy is to fund benefits as claims and premiums are paid. The U.S. postretirement health care plan was closed to new participants effective January 1, 2006. Defined Contribution Plans The Company sponsors various defined contribution plans in North America, Europe and Asia covering certain employees. Employees may contribute to these plans and the Company will match these contributions in varying amounts. The Company's matching contribution to the defined contribution plans are based on specified percentages of employee contributions. The amount of costs recognized for the Company's defined contribution plans are as follows: Year Ended December 31, 2024 2023 2022 (In $ millions) Defined contribution plans 79 83 62 Summarized information on the Company's pension and postretirement benefit plans is as follows: Pension Benefits Postretirement Benefits 2024 2023 2024 2023 (In $ millions) Change in Projected Benefit Obligation Projected benefit obligation as of beginning of period 2,923 2,858 40 38 Service cost 13 11 1 — Interest cost 125 132 1 2 Net actuarial (gain) loss (1) (31) 144 (1) 2 Divestiture (2) — (4) — — Settlements (9) (16) — — Benefits paid (227) (226) (4) (3) Curtailments (7) — (2) — Special termination benefits 1 — — — Exchange rate changes (50) 24 (1) 1 Projected benefit obligation as of end of period 2,738 2,923 34 40 Change in Plan Assets Fair value of plan assets as of beginning of period 2,652 2,625 — — Actual return on plan assets 66 213 — — Employer contributions 50 46 4 3 Divestiture (2) — (2) — — Settlements (9) (16) — — Benefits paid (3) (227) (226) (4) (3) Exchange rate changes (39) 12 — — Fair value of plan assets as of end of period 2,493 2,652 — — Funded status as of end of period (245) (271) (34) (40) Amounts Recognized in the Consolidated Balance Sheets Consist of: Noncurrent Other assets 135 166 — — Current Other liabilities (22) (22) (3) (3) Benefit obligations (358) (415) (31) (37) Net amount recognized (245) (271) (34) (40) Amounts Recognized in Accumulated Other Comprehensive Income Consist of: Net actuarial (gain) loss (4) 28 24 — — Prior service (benefit) cost — — (1) (1) Net amount recognized 28 24 (1) (1) ______________________________ (1) Primarily relates to changes in discount rates. (2) Represents plan obligations and assets contributed to the Nutrinova joint venture ( Note 4 ). (3) Includes benefit payments to nonqualified pension plans of $19 million and $20 million as of December 31, 2024 and 2023, respectively. (4) Relates to the pension plans of the Company's equity method investments. The percentage of U.S. and international projected benefit obligation at the end of the period is as follows: Pension Benefits Postretirement Benefits 2024 2023 2024 2023 (In percentages) U.S. plans 71 71 38 37 International plans 29 29 62 63 Total 100 100 100 100 The percentage of U.S. and international fair value of plan assets at the end of the period is as follows: Pension Benefits 2024 2023 (In percentages) U.S. plans 74 75 International plans 26 25 Total 100 100 Pension plans with projected benefit obligations in excess of plan assets are as follows: As of December 31, 2024 2023 (In $ millions) Projected benefit obligation 711 788 Fair value of plan assets 332 352 Pension plans with accumulated benefit obligations in excess of plan assets are as follows: As of December 31, 2024 2023 (In $ millions) Accumulated benefit obligation 691 738 Fair value of plan assets 332 329 Other postretirement plans with accumulated postretirement benefit obligations in excess of plan assets are as follows: As of December 31, 2024 2023 (In $ millions) Accumulated postretirement benefit obligation 34 40 The accumulated benefit obligation for all defined benefit pension plans is as follows: As of December 31, 2024 2023 (In $ millions) Accumulated benefit obligation 2,706 2,882 The components of net periodic benefit cost are as follows: Pension Benefits Postretirement Benefits 2024 2023 2022 2024 2023 2022 (In $ millions) Service cost 13 11 12 1 — 1 Interest cost 125 132 67 1 2 1 Expected return on plan assets (135) (132) (166) — — — Recognized actuarial (gain) loss 38 63 91 (1) 3 (10) Curtailment (gain) loss (7) — — (2) — — Settlement (gain) loss — 1 — — — — Special termination benefit 1 — — — — — Total 35 75 4 (1) 5 (8) The Company maintains nonqualified pension plans funded with nonqualified trusts for certain U.S. employees as follows: As of December 31, 2024 2023 (In $ millions) Nonqualified Trust Assets Marketable securities 6 5 Noncurrent Other assets, consisting of insurance contracts 18 21 Nonqualified Pension Obligations Current Other liabilities 18 18 Benefit obligations 136 149 (Income) expense relating to the nonqualified pension plans included in net periodic benefit cost, excluding returns on the assets held by the nonqualified trusts, is as follows: Year Ended December 31, 2024 2023 2022 (In $ millions) Total 6 16 (34) Valuation The principal weighted average assumptions used to determine benefit obligation are as follows: Pension Benefits Postretirement Benefits 2024 2023 2024 2023 (In percentages) Discount Rate Obligations U.S. plans 5.6 5.1 5.5 5.1 International plans 3.1 3.1 4.4 4.1 Combined 4.8 4.5 4.8 4.5 Rate of Compensation Increase U.S. plans N/A N/A International plans 3.1 2.8 Combined 3.1 2.8 The principal weighted average assumptions used to determine net periodic benefit cost are as follows: Pension Benefits Postretirement Benefits 2024 2023 2022 2024 2023 2022 (In percentages) Discount Rate Obligations U.S. plans 5.1 5.5 2.8 5.1 5.4 2.7 International plans 3.1 3.4 1.4 4.1 4.7 2.4 Combined 4.5 4.9 2.5 4.5 5.1 2.5 Discount Rate Service Cost U.S. plans N/A N/A N/A 5.7 5.9 3.5 International plans 2.9 3.5 1.5 3.7 4.4 2.1 Combined 2.9 3.5 1.5 3.7 4.5 2.1 Discount Rate Interest Cost U.S. plans 5.1 5.4 2.2 5.1 5.3 2.0 International plans 3.0 3.4 1.2 4.1 4.7 2.1 Combined 4.5 4.8 2.0 4.4 5.0 2.1 Expected Return on Plan Assets U.S. plans 5.5 5.5 5.5 International plans 4.8 4.4 4.9 Combined 5.3 5.2 5.4 Rate of Compensation Increase U.S. plans N/A N/A N/A International plans 2.8 2.8 2.5 Combined 2.8 2.8 2.5 Interest Crediting Rate U.S. plans 4.1 4.3 1.9 International plans 1.4 1.0 1.0 Combined 4.0 4.3 1.9 The Company's health care cost trend assumptions for U.S. postretirement medical plan's net periodic benefit cost are as follows: As of December 31, 2024 2023 2022 (In percentages, except year) Health care cost trend rate assumed for next year 7.0 7.3 7.5 Health care cost trend ultimate rate 5.0 5.0 5.0 Health care cost trend ultimate rate year 2032 2032 2032 Plan Assets The weighted average target asset allocations for the Company's pension plans in 2024 are as follows: U.S. International (In percentages) Bonds - domestic to plans 84 38 Equities - domestic to plans 8 19 Equities - international to plans 8 8 Other — 35 Total 100 100 On average, the actual return on the U.S. qualified defined pension plans' assets over the long-term (20 years) has exceeded the expected long-term rate of asset return assumption. The U.S. qualified defined benefit plans' actual return on assets for the year ended December 31, 2024 was 1.3% versus an expected long-term rate of asset return assumption of 5.5%. The expected long-term rate of asset return assumption used to determine 2025 net periodic benefit cost is 5.5% for the U.S. qualified defined benefit plans. The Company's defined benefit plan assets are measured at fair value on a recurring basis ( Note 2 ) as follows: Cash and Cash Equivalents: Foreign and domestic currencies as well as short-term securities are valued at cost plus accrued interest, which approximates fair value. Equity securities, treasuries and corporate debt: Valued at the closing price reported on the active market in which the individual securities are traded. Automated quotes are provided by multiple pricing services and validated by the plan custodian. These securities are traded on exchanges as well as in the over the counter market. Derivatives: Derivative financial instruments are valued in the market using discounted cash flow techniques. These techniques incorporate Level 1 and Level 2 fair value measurement inputs such as interest rates and foreign currency exchange rates. These market inputs are utilized in the discounted cash flow calculation considering the instrument's term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation for interest rate swaps, foreign currency forwards and swaps, and options are observable in the active markets and are classified as Level 2 in the fair value measurement hierarchy. Mortgage backed securities: Fair value is estimated based on valuations obtained from third-party pricing services for identical or comparable assets. Mortgage backed securities are traded in the over the counter broker/dealer market. Insurance contracts: Valued at contributions made, plus earnings, less participant withdrawals and administrative expenses, which approximates fair value. Short-term investment funds: Composed of various funds whose portfolio is comprised of foreign and domestic currencies as well as short-term securities. Investments are valued at the net asset value of units held by the plan at year-end. Registered Investment Companies: Composed of various mutual funds and other investment companies whose diversified portfolio is comprised of foreign and domestic equities, fixed income securities and short-term investments. Investments are valued at the net asset value of units held by the plan at year-end. Pooled-type investments: Composed of various funds whose diversified portfolio is comprised of foreign and domestic equities, fixed income securities, and short-term investments. Investments are valued at the net asset value of units held by the plan at year-end. Other: Composed of real estate investment trust common stock valued at closing price as reported on the active market in which the individual securities are traded. Fair Value Measurement Quoted Prices in Significant Total As of December 31, 2024 2023 2024 2023 2024 2023 (In $ millions) Assets Cash and cash equivalents 12 7 — — 12 7 Derivatives Swaps — — 13 60 13 60 Equity securities U.S. companies 26 21 — — 26 21 International companies 126 148 — — 126 148 Fixed income Corporate debt — — 624 686 624 686 Treasuries, other debt 47 87 1,008 1,013 1,055 1,100 Mortgage backed securities — — 14 13 14 13 Insurance contracts — — 109 104 109 104 Other 3 3 21 19 24 22 Total investments, at fair value (1) 214 266 1,789 1,895 2,003 2,161 Liabilities Derivatives Swaps — — 13 60 13 60 Total liabilities — — 13 60 13 60 Total net assets (2) 214 266 1,776 1,835 1,990 2,101 ______________________________ (1) Certain investments that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy. Total investments, at fair value, for the year ended December 31, 2024 excludes investments in pooled-type investments, registered investment companies and short-term investment funds with fair values of $431 million, $34 million and $35 million, respectively. Total investments, at fair value, for the year ended December 31, 2023 excludes investments in pooled-type investments, registered investment companies and short-term investment funds with fair values of $460 million, $43 million and $31 million, respectively. (2) Total net assets excludes non-financial plan receivables and payables of $20 million and $17 million, respectively, as of December 31, 2024 and $22 million and $5 million, respectively, as of December 31, 2023. Non-financial items include due to/from broker, interest receivables and accrued expenses. Benefit obligation funding is as follows: Total (In $ millions) Cash contributions to defined benefit pension plans 30 Benefit payments to nonqualified pension plans 18 Benefit payments to other postretirement benefit plans 3 The Company's estimates of its U.S. defined benefit pension plan contributions reflect the provisions of the Pension Protection Act of 2006. Pension and postretirement benefits expected to be paid are as follows: Pension Benefit Payments (1) Company Portion of Postretirement Benefit Cost (2) (In $ millions) 2025 235 3 2026 233 3 2027 227 3 2028 225 2 2029 225 2 2030-2034 1,017 10 ______________________________ (1) Payments are expected to be made primarily from plan assets. (2) Payments are expected to be made primarily from Company assets.

Environmental

Environmental	12 Months Ended
	Dec. 31, 2024
Environmental Remediation Obligations [Abstract]
Environmental	Environmental The Company is subject to environmental laws and regulations worldwide that impose limitations on the discharge of pollutants into the air and water, establish standards for the treatment, storage and disposal of solid and hazardous wastes, and impose record keeping and notification requirements. Failure to timely comply with these laws and regulations may expose the Company to penalties. The Company believes that it is in substantial compliance with all applicable environmental laws and regulations and engages in an ongoing process of updating its controls to mitigate compliance risks. The Company is also subject to retained environmental obligations specified in various contractual agreements arising from the divestiture of certain businesses by the Company or one of its predecessor companies. The components of environmental remediation liabilities As of December 31, 2024 2023 (In $ millions) Demerger obligations ( Note 19 ) 14 14 Divestiture obligations ( Note 19 ) 14 13 Active sites 23 25 U.S. Superfund sites 10 8 Other environmental remediation liabilities 2 2 Total 63 62 Remediation Due to its industrial history and through retained contractual and legal obligations, the Company has the obligation to remediate specific areas on its own sites as well as on divested, demerger, orphan or U.S. Superfund sites (defined below). In addition, as part of the demerger agreement between the Company and Hoechst AG ("Hoechst"), a specified portion of the responsibility for environmental liabilities from a number of Hoechst divestitures was transferred to the Company ( Note 19 ). Certain of these sites, at which the Company maintains continuing involvement, were and continue to be designated as discontinued operations when closed. The Company provides for such obligations when the event of loss is probable and reasonably estimable. The Company believes that environmental remediation costs will not have a material adverse effect on the financial position of the Company, but may have a material adverse effect on the results of operations or cash flows in any given period. The Company did not record any insurance recoveries during 2024 or have any receivables for insurance recoveries related to these matters as of December 31, 2024. German InfraServ Entities The Company's InfraServ equity affiliates ( Note 7 ) are liable for any residual contamination and other pollution because they own the real estate on which the individual facilities operate. In addition, Hoechst, and its legal successors, as the responsible party under German public law, is liable to third parties for all environmental damage that occurred while it was still the owner of the plants and real estate ( Note 19 ). The contribution agreements entered into in 1997 between Hoechst and the respective operating companies, as part of the divestiture of these companies, provide that the operating companies will indemnify Hoechst, and its legal successors, against environmental liabilities resulting from the transferred businesses. Additionally, the InfraServ equity affiliates have agreed to indemnify Hoechst, and its legal successors, against any environmental liability arising out of or in connection with environmental pollution of any site. The InfraServ partnership agreements provide that, as between the partners, each partner is responsible for any contamination caused predominantly by such partner. Any liability, which cannot be attributed to an InfraServ partner and for which no third party is responsible, is required to be borne by the InfraServ partnership. Also, under lease agreements entered into by an InfraServ partner as landlord, the tenants agreed to pay certain remediation costs on a pro rata basis. If an InfraServ partner defaults on its respective indemnification obligations to eliminate residual contamination, the owners of the remaining participation in the InfraServ companies have agreed to fund such liabilities, subject to a number of limitations. To the extent that any liabilities are not satisfied by either the InfraServ equity affiliates or their owners, these liabilities are to be borne by the Company in accordance with the demerger agreement. However, Hoechst, and its legal successors, will reimburse the Company for two-thirds of any such costs. Likewise, in certain circumstances the Company could be responsible for the elimination of residual contamination on several sites that were not transferred to InfraServ companies, in which case Hoechst, and its legal successors, must also reimburse the Company for two-thirds of any costs so incurred. The Company's ownership interest and environmental liability participation percentages for such liabilities, which cannot be attributed to an InfraServ partner are as follows: As of December 31, 2024 Ownership Liability Reserves (1) (In percentages) (In $ millions) InfraServ GmbH & Co. Gendorf KG 30 10 8 InfraServ GmbH & Co. Hoechst KG 31 42 61 Yncoris GmbH & Co. KG 22 23 1 ______________________________ (1) Gross reserves maintained by the respective entity. U.S. Superfund Sites In the U.S., the Company may be subject to substantial claims brought by U.S. federal or state regulatory agencies or private individuals pursuant to statutory authority or common law. In particular, the Company has a potential liability under the U.S. Federal Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, and related state laws (collectively referred to as "Superfund") for investigation and cleanup costs at certain sites. At most of these sites, numerous companies, including the Company, or one of its predecessor companies, have been notified that the U.S. Environmental Protection Agency ("EPA"), state governing bodies or private individuals consider such companies to be potentially responsible parties ("PRP") under Superfund or related laws. The proceedings relating to these sites are in various stages. The cleanup process has not been completed at most sites, and the status of the insurance coverage for some of these proceedings is uncertain. Consequently, the Company cannot accurately determine its ultimate liability for investigation or cleanup costs at these sites. As events progress at each site for which it has been named a PRP, the Company accrues any probable and reasonably estimable liabilities. In establishing these liabilities, the Company considers the contaminants of concern, the potential impact thereof, the relationship of the contaminants of concern to its current and historic operations, its shipment of waste to a site, its percentage of total waste shipped to the site, the types of wastes involved, the conclusions of any studies, the magnitude of any remedial actions that may be necessary and the number and viability of other PRPs. Often the Company joins with other PRPs to sign joint defense agreements that settle, among PRPs, each party's percentage allocation of costs at the site. Although the ultimate liability may differ from the estimate, the Company routinely reviews the liabilities and revises the estimate, as appropriate, based on the most current information available. One such site is the Diamond Alkali Superfund Site, which is comprised of a number of sub-sites, including the Lower Passaic River Study Area ("LPRSA"), which is the lower 17-mile stretch of the Passaic River ("Lower Passaic River Site"), and the Newark Bay Study Area. The Company and 70 other companies are parties to a May 2007 Administrative Order on Consent with the EPA to perform a Remedial Investigation/Feasibility Study ("RI/FS") at the Lower Passaic River Site in order to identify the levels of contaminants and potential cleanup actions, including the potential migration of contaminants between the LPRSA and the Newark Bay Study Area. In March 2016, the EPA issued its final Record of Decision concerning the remediation of the lower 8.3 miles of the Lower Passaic River Site ("Lower 8.3 Miles"). Pursuant to the EPA's Record of Decision, the Lower 8.3 Miles must be dredged bank to bank and an engineered cap must be installed at an EPA estimated cost of approximately $1.4 billion. In September 2021, the EPA issued a Record of Decision selecting an interim remedial plan for the upper 9 miles of the Lower Passaic River ("Upper 9 Miles"). Pursuant to the EPA's Record of Decision, targeted dredging will be conducted in the Upper 9 Miles to address surface sediments with elevated contamination followed by the installation of an engineered cap at an EPA estimated cost of $441 million. The Company owned and/or operated facilities in the vicinity of the Lower 8.3 Miles, but has found no evidence that it contributed any of the contaminants of concern to the Passaic River. In June 2018, Occidental Chemical Corporation ("OCC"), the successor to the Diamond Alkali Company, sued a subsidiary of the Company and 119 other parties alleging claims for joint and several damages, contribution and declaratory relief under Section 107 and 113 of Superfund for costs to clean up the LPRSA portion of the Diamond Alkali Superfund Site, Occidental Chemical Corporation v. 21st Century Fox America, Inc., et al, No. 2:18-CV-11273 (MCA) (LDW) (U.S. District Court New Jersey) (the "2018 OCC Lawsuit"), alleging that each of the defendants owned or operated a facility that contributed contamination to the LPRSA. With respect to the Company, the 2018 OCC lawsuit is limited to the former Celanese facility that Essex County, New Jersey has agreed to indemnify the Company for and does not change the Company's estimated liability for LPRSA cleanup costs. Separately, the United States lodged a Consent Decree in U.S. District Court for the District of New Jersey in December 2022 that resolves the Company's liability (and that of more than 80 other settling defendants) to the EPA for costs to clean up both the Lower 8.3 Miles and Upper 9 Miles of the Lower Passaic River Site in exchange for a collective payment of $150 million, United States v. Alden Leeds, Inc., No. 2:22-7326 (MCA) (LDW) (U.S. District Court New Jersey) ("Consent Decree Action"). The Consent Decree also provides the Company protection from contribution claims by others for costs incurred to clean up both the Lower 8.3 Miles and Upper 9 Miles of the Lower Passaic River Site. The Company's proposed payment toward the $150 million collective settlement payment is not material to the Company's results of operations, cash flows or financial position. In March 2023, the U.S. District Court for the District of New Jersey entered an order staying and administratively terminating the 2018 OCC Lawsuit, pending resolution of the request for judicial approval of the Consent Decree in the Consent Decree Action. Also, in March 2023, OCC filed a new lawsuit against 40 parties, including a subsidiary of the Company, seeking to recover costs for remedial design work the EPA has ordered OCC to undertake for a portion of the LPRSA at an estimated cost of $71 million, Occidental Chemical Corporation v. Givaudan Fragrances Corporation, No. 2:23-cv-1699 (U.S. District Court New Jersey) (the "2023 OCC Lawsuit"). Like the earlier lawsuit, the 2023 OCC Lawsuit concerns the facility Essex County, New Jersey purchased and for which Essex County, New Jersey has agreed to defend and indemnify the Company. This new lawsuit does not change the Company's estimated liability for LPRSA cleanup costs. Like the earlier lawsuit, the 2023 OCC lawsuit also was stayed pending resolution of the request for judicial approval of the Consent Decree in the Consent Decree Action. On December 18, 2024, the U.S. District Court for the District of New Jersey granted the United States' motion to enter the Consent Decree in the Consent Decree Action. The Company anticipates that OCC will seek review of that decision. Nokia of America Corporation, which opposed the entry of the Consent Decree, filed a notice of appeal on January 9, 2025. The Company anticipates that OCC also will appeal the District Court's decision entering the Consent Decree. In the interim, the Company continues to vigorously defend these matters and continues to believe that its ultimate allocable share of the cleanup costs with respect to the Lower Passaic River Site, previously estimated at less than 1%, will not be material. Other Environmental Matters In April 2022, a methanol leak on a pipeline to the Company's Bishop, Texas facility was discovered. The release has been contained, the leak has been repaired and the pipeline has resumed operation. The Company promptly disclosed the incident to state and federal authorities, including the Texas Commission on Environmental Quality and the EPA, and remediation activities are now completed. While the Company has not received a notice of violation nor been assessed any fines or penalties to date, the Company recorded a reserve in Other current liabilities based on anticipated clean-up costs and possible penalties to state or federal authorities. The Company does not believe that resolution of this matter will have a material impact on its financial condition or results of operations.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2024
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Shareholders' Equity Common Stock The Company's Board of Directors follows a policy of declaring, subject to legally available funds, a quarterly cash dividend on each share of the Company's Common Stock, par value $0.0001 per share ("Common Stock"), unless the Company's Board of Directors, in its sole discretion, determines otherwise. The amount available to the Company to pay cash dividends is not currently restricted by its existing Global Credit Agreements and its indentures governing its senior unsecured notes. Any decision to declare and pay dividends in the future will be made at the discretion of the Company's Board of Directors and will depend on, among other things, the results of operations, cash requirements, financial condition, contractual restrictions and other factors that the Company's Board of Directors may deem relevant. The Company declared a quarterly cash dividend of $0.03 per share on its Common Stock on February 12, 2025, amounting to approximately $3 million. The cash dividend will be paid on March 11, 2025 to holders of record as of February 25, 2025. On November 4, 2024, the Company announced its intent to reduce its quarterly dividend by approximately 95% beginning in the first quarter of 2025. Treasury Stock The Company's Board of Directors authorizes repurchases of Common Stock from time to time. These authorizations give management discretion in determining the timing and conditions under which shares may be repurchased. This repurchase program does not have an expiration date. Total From Shares repurchased 69,324,429 Average purchase price per share $ 83.71 Amount spent on repurchased shares (in $ millions) $ 5,803 Aggregate Board of Directors repurchase authorizations during the period (in $ millions) $ 6,866 The purchase of treasury stock reduces the number of shares outstanding. The repurchased shares may be used by the Company for compensation programs utilizing the Company's stock and other corporate purposes. The Company accounts for treasury stock using the cost method and includes treasury stock as a component of shareholders' equity. The Company did not repurchase any Common Stock during the years ended December 31, 2024, 2023 and 2022. Other Comprehensive Income (Loss), Net Year Ended December 31, 2024 2023 2022 Gross Income Net Gross Income Net Gross Income Net (In $ millions) Foreign currency translation (39) (60) (99) (275) 62 (213) (240) 23 (217) Gain (loss) on derivative hedges 2 (2) — (12) 6 (6) 26 (5) 21 Pension and postretirement benefits gain (loss) (5) — (5) (8) 1 (7) 7 — 7 Total (42) (62) (104) (295) 69 (226) (207) 18 (189) Adjustments to Accumulated other comprehensive income (loss), net, are as follows: Foreign Gain (Loss) on Derivative Hedges ( Note 17 ) Pension and Postretirement Benefits Gain (Loss) ( Note 12 ) Accumulated (In $ millions) As of December 31, 2021 (271) (43) (15) (329) Other comprehensive income (loss) before reclassifications (240) 43 7 (190) Amounts reclassified from accumulated other comprehensive income (loss) — (17) — (17) Income tax (provision) benefit 23 (5) — 18 As of December 31, 2022 (488) (22) (8) (518) Other comprehensive income (loss) before reclassifications (275) (3) (8) (286) Amounts reclassified from accumulated other comprehensive income (loss) — (9) — (9) Income tax (provision) benefit 62 6 1 69 As of December 31, 2023 (701) (28) (15) (744) Other comprehensive income (loss) before reclassifications (39) 139 (5) 95 Amounts reclassified from accumulated other comprehensive income (loss) — (137) — (137) Income tax (provision) benefit (60) (2) — (62) As of December 31, 2024 (800) (28) (20) (848)

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes In December 2017, the Tax Cuts and Jobs Act (the "TCJA") was enacted and was effective January 1, 2018. The U.S. Treasury has issued various notices and final and proposed regulatory packages supplementing the TCJA provisions since 2018. There have been no material proposed or final regulatory packages during the year ended December 31, 2024. In August 2022, the Inflation Reduction Act (the "IRA") was enacted and included a 1% excise tax on share repurchases in excess of $1 million, and a corporate minimum tax of 15% on adjusted book earnings. The corporate minimum tax paid is creditable in future years to the extent regular tax liability exceeds the minimum tax in any given year. The Company does not expect these provisions or any newly issued administrative guidance to have a material impact to future income tax expense. The IRA also provides various beneficial credits for energy efficient related manufacturing, transportation and fuels, hydrogen/carbon recapture and renewable energy, which the Company is evaluating in regard to planned projects. The Company will continue to monitor the expected impacts of any new guidance on the Company's filing positions and will record the impacts as discrete income tax expense adjustments in the period the guidance is finalized or becomes effective. In December 2021, the Organization for Economic Co-operation and Development ("OECD") issued final Model Rules for Pillars One and Two of its Base Erosion and Profit Shifting ("BEPS") project. In general, Pillar One addresses nexus concerns and the allocation of profits among companies in which a multinational enterprise ("MNE") conducts its business. Pillar Two aims to ensure that all MNEs pay an effective tax rate of no less than 15% on their adjusted net income in each of the jurisdictions in which they have operations. Pillar Two is more impactful to the Company as it allows for assessment even if the individual countries do not enact its minimum tax provisions. In effect, Pillar Two allows any country within which an MNE operates to levy tax upon that MNE to the extent it determines that the MNE is paying less than a 15% effective tax rate on its adjusted net income. The taxes levied may then be allocated among the jurisdictions that conform to the OECD rules. In December 2022, the member states of the European Union ("EU") unanimously voted to adopt the OECD's minimum tax which was agreed to by consensus of the BEPS 2.0 (Pillars One and Two) signatory jurisdictions. Under the EU's minimum tax directive, member states are to adopt domestic legislation implementing the minimum tax rules effective for periods beginning on or after December 31, 2023, with Pillar Two's "under-taxed profit rule" to take effect for periods beginning on or after December 31, 2024. The EU effective dates are January 1, 2024, and January 1, 2025, for different aspects of the directive. Legislatures in multiple countries outside of the EU have also enacted or drafted legislation to implement the OECD's minimum tax proposals. In July 2023, the OECD published Administrative Guidance proposing certain safe harbor provisions, including an effective rate test and a routine profits test, which if satisfied effectively delay effective dates of Pillar Two to January 1, 2027. The EU and a significant number of other countries have or are expected to implement the safe harbor in local legislation. Based on these safe harbor provisions, the Company currently expects that several material jurisdictions, including the U.S., Netherlands, Switzerland, Germany, China, Singapore and Canada, will qualify for the safe harbor effectively extending the application of the global minimum tax until January 1, 2027. The Company will continue to monitor the developments and implementation of the OECD BEPS projects. Currently the Company does not meet the requirements for the application of Pillar One. After an initial assessment of the application of the safe harbor provisions on a global basis, the Company determined that there was not a material impact from the local adoption of the OECD Pillar Two proposals in 2024, but is continuing to model the effect of these provisions on its future effective tax rate and cash taxes. Income Tax Provision Earnings (loss) from continuing operations before tax by jurisdiction are as follows: Year Ended December 31, 2024 2023 2022 (In $ millions) U.S. (2,269) (163) (292) International 1,273 1,346 1,713 Total (996) 1,183 1,421 The income tax provision (benefit) consists of the following: Year Ended December 31, 2024 2023 2022 (In $ millions) Current U.S. 79 8 54 International 239 162 306 Total 318 170 360 Deferred U.S. (87) (178) (261) International 279 (782) (588) Total 192 (960) (849) Total 510 (790) (489) A reconciliation of the significant differences between the U.S. federal statutory tax rate of 21% and the effective income tax rate on income from continuing operations is as follows: Year Ended December 31, 2024 2023 2022 (In $ millions, except percentages) Income tax provision computed at U.S. federal statutory tax rate (209) 248 298 Change in valuation allowance 370 (150) (15) Equity income and dividends (41) (27) (47) (Income) expense not resulting in tax impact, net 327 (9) 2 U.S. tax effect of foreign earnings and dividends 184 384 162 Foreign tax credits (137) (73) (120) Other foreign tax rate differentials (66) (108) (43) Legislative changes (6) (44) — State income taxes, net of federal benefit 12 (8) (2) Recognition of basis differences in investments in affiliates — — 6 Asset transfers between wholly owned foreign affiliates 87 (839) (816) Other, net (11) (164) 86 Income tax provision (benefit) 510 (790) (489) Effective income tax rate (51) % (67) % (34) % In December 2022, as part of its integration efforts for the M&M Acquisition (see Note 4 ) and to simplify future cash flows for purposes of acquisition debt repayment, the Company reorganized its foreign legal entity holding structure and relocated certain of its intangible assets to align with the acquired M&M foreign operations. The transfer of these assets between wholly owned foreign affiliates, generated a net deferred tax benefit of approximately $800 million. The contractual provisions for these asset transfers provided for adjustments to the purchase price for business events occurring within the succeeding twelve months, and as a result, the Company recorded an additional deferred tax benefit of approximately $190 million in 2023. In 2023, in furtherance of its integration strategy for the M&M Acquisition, the Company continued to relocate certain intangible assets to better align with the acquired M&M foreign operations. In addition, in late 2023, as part of its overall integration approach, the Company initiated a strategy to realign its European headquarters and principal operations to Switzerland to achieve operational efficiencies by leveraging an acquired site for future growth and improved alignment of ownership of intangible assets with future technology and innovation efforts to be conducted locally. These operational efficiencies are expected to include, (i) centralized regional manufacturing, sales and operational planning, procurement and business leadership and (ii) cost and facility savings. The headquarters and principal operations realignment strategy, and the relocation of intangible assets to wholly owned foreign affiliates, generated a net deferred tax benefit of approximately $725 million. In addition, the relocation of these intangible assets resulted in the utilization of approximately $230 million of the Company's existing U.S. foreign tax credit carryforwards. These carryforwards had previously been offset by a full valuation allowance. In the second quarter of 2024, the Company completed an internal integration-related restructuring of its acquired China operations in order to align with existing operations and to optimize the Company's internal treasury operations. This restructuring of the Chinese operations consisted of a sale within the Company that resulted in a China capital gains tax of approximately $87 million. During the three months ended December 31, 2024, the Company recorded a non-cash goodwill impairment loss of $1.5 billion in the Engineered Materials segment. As of December 31, 2024, the Engineered Materials segment had goodwill of $5.0 billion (see Note 9 ). The impairment of goodwill is not deductible for tax purposes and the tax effect of this non-deductible expense in the amount of $319 million is included in the (Income) expense not resulting in tax impact, net line above. In addition, due to the changes in forecasted profits for the engineered materials reporting unit included in the impairment analysis, the Company also recorded a valuation allowance against certain local country, non-U.S. tax credit carryforwards in the amount of $338 million. Included in the Other, net line in the effective income tax rate reconciliation above are the U.S. GAAP gain in excess of the tax gain related to the formation of the Nutrinova joint venture (see Note 4 ) of $102 million for the year ended December 31, 2023 and charges of approximately $20 million related to transaction costs for the M&M Acquisition for the year ended December 31, 2022. In addition, included in the Other, net line in the effective income tax rate reconciliation above are U.S. benefits of foreign derived intangible income of $0 million, $72 million, and $0 million; and changes in uncertain tax positions of $(2) million, $5 million and $63 million for the years ended December 31, 2024, 2023 and 2022, respectively. Deferred Income Taxes Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the consolidated deferred tax assets and liabilities are as follows: As of December 31, 2024 2023 (In $ millions) Deferred Tax Assets Pension and postretirement obligations 58 61 Accrued expenses 59 56 Inventory 18 (13) Net operating loss carryforwards 752 783 Tax credit carryforwards 222 135 Intangibles and other 757 737 Subtotal 1,866 1,759 Valuation allowance (1) (1,106) (656) Total 760 1,103 Deferred Tax Liabilities Depreciation and amortization 152 152 Investments in affiliates 163 188 Other 127 85 Total 442 425 Net deferred tax assets (liabilities) 318 678 ______________________________ (1) Includes deferred tax asset valuation allowances for the Company's deferred tax assets in Switzerland, Luxembourg, the U.S., Spain, the Netherlands, the United Kingdom, Malta, Mexico, Germany, China, Singapore and France. These valuation allowances relate primarily to net operating loss carryforward benefits, foreign tax credit carryforwards and other net deferred tax assets, all of which may not be realizable. As a result of the TCJA, U.S. federal and state income taxes have been recorded on undistributed foreign earnings accumulated from 1986 through 2017. The Company's previously taxed income for its foreign subsidiaries significantly exceeds its offshore cash balances. The Company has not recorded a deferred tax liability for foreign withholding or other foreign local tax that would be due when cash is actually repatriated to the U.S. because those foreign earnings are considered permanently reinvested in the business or may be remitted substantially free of any additional local taxes. The determination of the amount of the unrecognized deferred tax liability related to the undistributed earnings is not practicable. Tax Carryforwards • Net Operating Loss and Capital Loss Carryforwards As of December 31, 2024, the Company had available U.S. federal net operating loss carryforwards of $15 million that are subject to limitation. These net operating loss carryforwards begin to expire in 2036. As of December 31, 2024, the Company also had available state net operating loss carryforwards, net of federal tax impact, of $35 million, $24 million of which are offset by a valuation allowance due to uncertain recoverability. The Company also has foreign net operating loss carryforwards available as of December 31, 2024 of $3.5 billion primarily for Switzerland, Luxembourg, Spain, the United Kingdom, Singapore, China and Hong Kong with various expiration dates. Net operating loss carryforwards of $69 million in China are scheduled to continue to expire through 2029. Net operating loss carryforwards of $1.7 billion in Switzerland are partially offset by a valuation allowance of $230 million due to uncertain recoverability and are scheduled to continue to expire through 2030. Net operating losses in most other foreign jurisdictions do not have an expiration date. The Company acquired capital loss carryforwards of $173 million as part of the M&M Acquisition ( Note 4 ) that are subject to annual limitation due to the ownership change. The Company fully offset these capital loss carryforwards with a valuation allowance due to uncertain recoverability. • Tax Credit Carryforwards The Company had available $200 million of U.S. foreign tax credit carryforwards, which are offset by a valuation allowance of $165 million due to uncertain recoverability and $18 million of alternative minimum tax credit carryforwards in the U.S. The foreign tax credit carryforwards are subject to a ten-year carryforward period and begin to expire in 2027. The alternative minimum tax credits are subject to annual limitation due to prior ownership changes but have an unlimited carryforward period and can be used to offset federal tax liability in future years. The Company evaluates its deferred tax assets on a quarterly basis to determine whether a valuation allowance is necessary. Realization of deferred tax assets ultimately depends on the existence of sufficient taxable income of the appropriate character in the applicable carryback or carryforward periods. Changes in the Company's estimates of future taxable income and prudent and feasible tax planning strategies will affect the estimate of the realization of the tax benefits of these foreign tax credit carryforwards. As such, the Company is currently evaluating tax planning strategies to enable use of the foreign tax credit carryforwards that may decrease the Company's effective tax rate in future periods as the valuation allowance is reversed. Uncertain Tax Positions Activity related to uncertain tax positions is as follows: Year Ended December 31, 2024 2023 2022 (In $ millions) As of the beginning of the year 224 275 218 Increases (decreases) in tax positions for the current year (3) 10 8 Increases in tax positions for prior years 6 9 102 Decreases in tax positions for prior years (6) (35) (45) Increases (decreases) due to settlements (8) (35) (8) As of the end of the year 213 224 275 Total uncertain tax positions that if recognized would impact the effective tax rate 236 244 274 Total amount of interest expense (benefit) and penalties recognized in the consolidated statements of operations (1) 7 22 10 Total amount of interest expense and penalties recognized in the consolidated balance sheets 77 71 59 ______________________________ (1) This amount reflects interest on uncertain tax positions and release of tax positions due to changes in assessment, statute lapses or audit closures that were reflected in the consolidated statements of operations. The increase in uncertain tax positions for the year ended December 31, 2022 was primarily due to increases in foreign tax positions related to ongoing tax examinations, partially offset by releases due to completed examinations and statute closures. The Company's tax returns have been under audit for the years 2013 through 2015 by the United States, Netherlands and Germany (the "Authorities"). In September 2021, the Company received a draft joint audit report proposing adjustments to transfer pricing and the reallocation of income between the related jurisdictions. The Authorities also proposed to apply these adjustments to open tax years through 2019. The Company and the Authorities were unable to reach an agreement jointly and therefore the audits continued on a separate jurisdictional basis. In the fourth quarter of 2022, the Company concluded settlement discussions with the Dutch tax authority. In the third quarter of 2024, the Company concluded settlement discussions with the German tax authority related to the German transfer pricing audit. The Company is engaged in continuing discussions with the U.S. tax authority on joint audit matters, as well as other separate matters, and is currently evaluating all additional potential remedies regarding the ongoing examinations. As of December 31, 2024, the Company believes that an adequate provision for income taxes has been made for all open tax years related to the examinations by the Authorities. However, the outcome of tax audits cannot be predicted with certainty. If any issues raised by the Authorities are resolved in a manner inconsistent with the Company's expectations or the Company is unsuccessful in defending its position, the Company could be required to adjust its provision for income taxes in the period such resolution occurs. If required, any such adjustments could be material to the statements of operations and cash flows in the period(s) recorded. In addition, the Company's income tax returns in Mexico are under audit for the years 2018 and 2019, in Canada for the years 2016 through 2022, and in the U.S. for the years 2016 through 2020. In August 2023, the Company negotiated a partial settlement with the Mexico tax authorities for its audit for the year 2018. The partial settlement did not have a material impact on income tax expense in the consolidated statements of operations for the year ended December 31, 2023. The Company is in discussions with the Mexican tax authorities regarding the preliminary findings in the 2019 audit. In September 2023, the Canadian tax authorities opened tax audits for the years 2019 through 2022, and the audits are in the preliminary stages. The Company is in ongoing discussions regarding the audit findings with the Canadian tax authority for the years 2016 through 2018 and does not expect a material impact to income tax expense resulting from the audit. The audit in the U.S. for the years 2016 through 2020 is in the data gathering phase. The Company's tax returns in Germany are also under audit for certain entities for years after 2007.

Leases

Leases	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Leases	Leases The components of lease expense are as follows: Year Ended December 31, Statement of Operations Classification 2024 2023 2022 (In $ millions) Lease Cost Operating lease cost 99 99 66 Cost of sales / Selling, general and administrative expenses Short-term lease cost 18 19 19 Cost of sales / Selling, general and administrative expenses Variable lease cost 17 13 15 Cost of sales / Selling, general and administrative expenses Finance lease cost Amortization of leased assets 20 21 19 Cost of sales Interest on lease liabilities 8 10 11 Interest expense Sublease income — — 2 Other income (expense), net Total net lease cost 162 162 132 Supplemental consolidated balance sheet information related to leases is as follows: As of December 31, Balance Sheet Classification 2024 2023 (In $ millions) Leases Assets Operating lease assets 388 422 Operating lease ROU assets Finance lease assets 119 154 Property, plant and equipment, net Total leased assets 507 576 Liabilities Current Operating 79 89 Current Other liabilities Finance 23 24 Short-term borrowings and current installments of long-term debt Noncurrent Operating 294 325 Operating lease liabilities Finance 122 124 Long-term debt Total lease liabilities 518 562 As of December 31, 2024 2023 Weighted-Average Remaining Lease Term (years) Operating leases 8.4 8.6 Finance leases 7.7 7.8 Weighted-Average Discount Rate Operating leases 3.3 % 3.5 % Finance leases 5.6 % 6.2 % Supplemental consolidated cash flow information related to leases is as follows: Year Ended December 31, 2024 2023 2022 (In $ millions) Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases 90 92 52 Operating cash flows from finance leases 8 10 11 Financing cash flows from finance leases 24 24 25 ROU assets obtained in exchange for finance lease liabilities ( Note 20 ) 27 2 28 ROU assets obtained in exchange for operating lease liabilities 70 58 93 Maturities of lease liabilities are as follows: As of December 31, 2024 Operating Leases Finance Leases (In $ millions) 2025 90 30 2026 74 27 2027 49 23 2028 41 20 2029 39 19 Later years 131 71 Total lease payments 424 190 Less amounts representing interest (51) (45) Total lease obligations 373 145
Leases	Leases The components of lease expense are as follows: Year Ended December 31, Statement of Operations Classification 2024 2023 2022 (In $ millions) Lease Cost Operating lease cost 99 99 66 Cost of sales / Selling, general and administrative expenses Short-term lease cost 18 19 19 Cost of sales / Selling, general and administrative expenses Variable lease cost 17 13 15 Cost of sales / Selling, general and administrative expenses Finance lease cost Amortization of leased assets 20 21 19 Cost of sales Interest on lease liabilities 8 10 11 Interest expense Sublease income — — 2 Other income (expense), net Total net lease cost 162 162 132 Supplemental consolidated balance sheet information related to leases is as follows: As of December 31, Balance Sheet Classification 2024 2023 (In $ millions) Leases Assets Operating lease assets 388 422 Operating lease ROU assets Finance lease assets 119 154 Property, plant and equipment, net Total leased assets 507 576 Liabilities Current Operating 79 89 Current Other liabilities Finance 23 24 Short-term borrowings and current installments of long-term debt Noncurrent Operating 294 325 Operating lease liabilities Finance 122 124 Long-term debt Total lease liabilities 518 562 As of December 31, 2024 2023 Weighted-Average Remaining Lease Term (years) Operating leases 8.4 8.6 Finance leases 7.7 7.8 Weighted-Average Discount Rate Operating leases 3.3 % 3.5 % Finance leases 5.6 % 6.2 % Supplemental consolidated cash flow information related to leases is as follows: Year Ended December 31, 2024 2023 2022 (In $ millions) Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases 90 92 52 Operating cash flows from finance leases 8 10 11 Financing cash flows from finance leases 24 24 25 ROU assets obtained in exchange for finance lease liabilities ( Note 20 ) 27 2 28 ROU assets obtained in exchange for operating lease liabilities 70 58 93 Maturities of lease liabilities are as follows: As of December 31, 2024 Operating Leases Finance Leases (In $ millions) 2025 90 30 2026 74 27 2027 49 23 2028 41 20 2029 39 19 Later years 131 71 Total lease payments 424 190 Less amounts representing interest (51) (45) Total lease obligations 373 145

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments Information regarding changes in the fair value of the Company's derivative and non-derivative instruments is as follows: Gain (Loss) Gain (Loss) Recognized Statement of Operations Classification Year Ended December 31, Year Ended December 31, 2024 2023 2022 2024 2023 2022 (In $ millions) Designated as Cash Flow Hedges Commodity swaps — (5) 39 (2) 2 23 Cost of sales Interest rate swaps — — — (7) (7) (7) Interest expense Foreign currency forwards — 5 2 — 5 1 Cost of sales Total — — 41 (9) — 17 Designated as Fair Value Hedges Cross-currency swaps (1) 142 (1) — 146 9 — Foreign exchange gain (loss), net Designated as Net Investment Hedges (2) Foreign currency denominated debt ( Note 11 ) 153 (106) (22) — — — N/A Cross-currency swaps ( Note 11 ) 147 (174) (92) — — — N/A Total 300 (280) (114) — — — Not Designated as Hedges Foreign currency forwards and swaps — — — (26) (19) (2) Foreign exchange gain (loss), net; Other income (expense), net ______________________________ (1) In conjunction with the 2023 Offering ( Note 11 ) in August 2023, the Company entered into a cross-currency swap to effectively convert $500 million of the issued notes into a Japanese yen-denominated borrowing at prevailing yen interest rates, maturing on July 15, 2029. The swap qualifies and has been designated as a fair value hedge of the Company's foreign currency exchange rate exposure on the long-term debt of its Japanese yen-denominated subsidiary. Additionally, in conjunction with the 2023 Offering ( Note 11 ) in August 2023, the Company entered into cross-currency swaps to effectively convert $1.0 billion of the issued notes into 5-year and 7-year euro-denominated borrowings at prevailing euro interest rates, maturing on November 15, 2028 and November 15, 2030, respectively. The swaps qualify and have been designated as fair value hedges of the Company's foreign currency exchange rate exposure on the long-term debt of its euro-denominated subsidiary. (2) Concurrently with the offering of certain unsecured notes in July 2022 ( Note 11 ), the Company entered into cross-currency swaps to effectively convert $2.0 billion and $500 million of the issued notes into a euro-denominated borrowing at prevailing euro interest rates, maturing on July 15, 2027 and July 15, 2032, respectively. The swaps and €1.5 billion of certain unsecured euro notes offered in July 2022 qualify and have been designated as net investment hedges of the Company's foreign currency exchange rate exposure on the net investments of certain of its euro-denominated subsidiaries. Additionally, on April 11, 2024, the Company entered into cross-currency swaps to effectively convert its $1.0 billion senior unsecured notes due 2033 ( Note 11 ) into Chinese yuan-denominated borrowings at prevailing yuan interest rates, maturing on November 15, 2033. The swaps qualify and have been designated as net investment hedges of the Company's foreign currency exchange rate exposure on the net investment of certain of its Chinese yuan-denominated subsidiaries. See Note 18 for additional information regarding the fair value of the Company's derivative instruments. Certain of the Company's commodity swaps, interest rate swaps, cross-currency swaps and foreign currency forwards and swaps permit the Company to net settle all contracts with the counterparty through a single payment in an agreed upon currency in the event of default or early termination of the contract, similar to a master netting arrangement. Derivatives Not Designated As Hedges Foreign Currency Forwards and Swaps Each of the contracts included in the table below will have approximately offsetting effects from actual underlying payables, receivables, intercompany loans or other assets or liabilities subject to foreign exchange remeasurement. The total U.S. dollar equivalents of net foreign exchange exposure related to (short) long foreign exchange forward contracts outstanding by currency are as follows: 2025 Maturity (In $ millions) Currency Brazilian real (36) British pound sterling 86 Canadian dollar 13 Chinese yuan 438 Euro 229 Hungarian forint 14 Indian rupee (25) Indonesian rupiah (11) Japanese yen 22 Korean won 216 Mexican peso 107 Singapore dollar 34 Swedish krona (9) Swiss franc (313) Thai baht (8) Other (6) Total 751 Information regarding the gross amounts of the Company's derivative instruments and the amounts offset in the consolidated balance sheets is as follows: As of December 31, 2024 2023 (In $ millions) Derivative Assets Gross amount recognized 250 183 Gross amount offset in the consolidated balance sheets — — Net amount presented in the consolidated balance sheets 250 183 Gross amount not offset in the consolidated balance sheets 38 40 Net amount 212 143 As of December 31, 2024 2023 (In $ millions) Derivative Liabilities Gross amount recognized 273 440 Gross amount offset in the consolidated balance sheets — — Net amount presented in the consolidated balance sheets 273 440 Gross amount not offset in the consolidated balance sheets 38 40 Net amount 235 400

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company's financial assets and liabilities are measured at fair value on a recurring basis ( Note 2 ) as follows: Derivative financial instruments include interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps and are valued in the market using discounted cash flow techniques. These techniques incorporate Level 1 and Level 2 fair value measurement inputs such as interest rates and foreign currency exchange rates. These market inputs are utilized in the discounted cash flow calculation considering the instrument's term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation for interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps are observable in the active markets and are classified as Level 2 in the fair value measurement hierarchy. Fair Value Measurement Significant Other Observable Inputs (Level 2) Other assets Other liabilities Notional Amount Current Noncurrent Current Noncurrent (In millions) (In $ millions) As of December 31, 2024 Derivatives Designated as Cash Flow Hedges Commodity swaps $ 48 4 37 — — Derivatives Designated as Fair Value Hedges Cross-currency swaps $ 1,500 46 43 11 — Derivatives Designated as Net Investment Hedges Cross-currency swaps € 4,564 88 — 56 134 Cross-currency swaps ¥ 7,268 21 — 7 26 Derivatives Not Designated as Hedges Foreign currency forwards and swaps $ 2,777 11 — 19 20 Total 170 80 93 180 As of December 31, 2023 Derivatives Designated as Cash Flow Hedges Commodity swaps $ 67 5 36 2 — Derivatives Designated as Fair Value Hedges Cross-currency swaps $ 1,500 40 — 11 61 Derivatives Designated as Net Investment Hedges Cross-currency swaps € 5,712 93 — 61 281 Derivatives Not Designated as Hedges Foreign currency forwards and swaps $ 1,954 9 — 16 8 Total 147 36 90 350 Carrying values and fair values of financial instruments that are not carried at fair value are as follows: Fair Value Measurement Carrying Significant Unobservable Total As of December 31, 2024 2023 2024 2023 2024 2023 2024 2023 (In $ millions) Equity investments without readily determinable fair values 170 170 — — — — — — Insurance contracts in nonqualified trusts 18 21 18 21 — — 18 21 Long-term debt, including current installments of long-term debt 12,527 13,400 12,470 13,514 145 148 12,615 13,662 In general, the equity investments included in the table above are not publicly traded and their fair values are not readily determinable. The Company believes the carrying values approximate fair value. Insurance contracts in nonqualified trusts consist of long-term fixed income securities, which are valued using independent vendor pricing models with observable inputs in the active market and therefore represent a Level 2 fair value measurement. The fair value of long-term debt is based on valuations from third-party banks and market quotations and is classified as Level 2 in the fair value measurement hierarchy. The fair value of obligations under finance leases, which are included in long-term debt in the consolidated balance sheets, is based on lease payments and discount rates, which are not observable in the market and therefore represents a Level 3 fair value measurement. As of December 31, 2024 and 2023, the fair values of cash and cash equivalents, receivables, trade payables, short-term borrowings and the current installments of long-term debt approximate carrying values due to the short-term nature of these instruments. These items have been excluded from the table with the exception of the current installments of long-term debt.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Commitments Guarantees Equity Affiliates The Company has directly guaranteed various debt obligations under agreements with third parties related to certain equity affiliates. At December 31, 2024, the Company had directly guaranteed $145 million and €31 million of such obligations. These amounts represent the maximum potential amount of future (undiscounted) payments that the Company could be required to make under the guarantees. The Company would be required to perform on these guarantees in the event of default by the guaranteed party. Maximum future payments under these obligations are $145 million and €31 million for bank borrowings and the guarantee will remain in force until all guaranteed obligations are paid and the underlying debt agreements entered into by certain equity affiliates are terminated. Environmental and Other Liabilities The Company has agreed to guarantee or indemnify third parties for environmental and other liabilities pursuant to a variety of agreements, including asset and business divestiture agreements, leases, settlement agreements and various agreements with affiliated companies. Although many of these obligations contain monetary and/or time limitations, others do not provide such limitations. The Company has accrued for all probable and reasonably estimable losses associated with all known matters or claims. These known obligations include the following: • Demerger Obligations In connection with the Hoechst demerger, the Company agreed to indemnify Hoechst, and its legal successors, for various liabilities under the demerger agreement, including for environmental liabilities associated with contamination arising either from environmental damage in general ("Category A") or under 19 divestiture agreements entered into by Hoechst prior to the demerger ("Category B") ( Note 13 ). The Company's obligation to indemnify Hoechst, and its legal successors, is capped under Category B at €250 million. If and to the extent the environmental damage should exceed €750 million in aggregate, the Company's obligation to indemnify Hoechst and its legal successors applies, but is then limited to 33.33% of the remediation cost without further limitations. Cumulative payments under the divestiture agreements as of December 31, 2024 are $117 million. Though the Company is significantly under its obligation cap under Category B, most of the divestiture agreements have become time barred and/or any notified environmental damage claims have been partially settled. The Company has also undertaken in the demerger agreement to indemnify Hoechst and its legal successors for (i) 33.33% of any and all Category A liabilities that result from Hoechst being held as the responsible party pursuant to public law or current or future environmental law or by third parties pursuant to private or public law related to contamination and (ii) liabilities that Hoechst is required to discharge, including tax liabilities, which are associated with businesses that were included in the demerger but were not demerged due to legal restrictions on the transfers of such items. These indemnities do not provide for any monetary or time limitations. The Company has not been requested by Hoechst to make any payments in connection with this indemnification. Accordingly, the Company has not made any payments to Hoechst and its legal successors. Based on the Company's evaluation of currently available information, including the lack of requests for indemnification, the Company cannot estimate the remaining demerger obligations, if any, in excess of amounts accrued. • Divestiture Obligations The Company and its predecessor companies agreed to indemnify third-party purchasers of former businesses and assets for various pre-closing conditions, as well as for breaches of representations, warranties and covenants. Such liabilities also include environmental liability, product liability, antitrust and other liabilities. These indemnifications and guarantees represent standard contractual terms associated with typical divestiture agreements and, other than environmental liabilities, the Company does not believe that they expose the Company to significant risk ( Note 13 ). The Company has divested numerous businesses, investments and facilities through agreements containing indemnifications or guarantees to the purchasers. Many of the obligations contain monetary and/or time limitations, which extend through 2037. The aggregate amount of outstanding indemnifications and guarantees provided for under these agreements is $102 million as of December 31, 2024. Other agreements do not provide for any monetary or time limitations. Based on the Company's evaluation of currently available information, including the number of requests for indemnification or other payment received by the Company, the Company cannot estimate the remaining divestiture obligations, if any, in excess of amounts accrued. Purchase Obligations In the normal course of business, the Company enters into various purchase commitments for goods and services. The Company maintains a number of "take-or-pay" contracts for purchases of raw materials, utilities and other services. Certain of the contracts contain a contract termination buy-out provision that allows for the Company to exit the contracts for amounts less than the remaining take-or-pay obligations. Additionally, the Company has other outstanding commitments representing maintenance and service agreements, energy and utility agreements, consulting contracts and software agreements. As of December 31, 2024, the Company had unconditional purchase obligations of $3.7 billion, of which $611 million will be paid in 2025, $484 million in 2026, $427 million in 2027, $291 million in 2028, $231 million in 2029 and the balance thereafter through 2042. Contingencies The Company is involved in legal and regulatory proceedings, lawsuits, claims and investigations incidental to the normal conduct of business, relating to such matters as product liability, land disputes, insurance coverage disputes, contracts, employment, antitrust or competition, intellectual property, personal injury, toxic tort, public nuisance and other actions in tort, workers' compensation, chemical exposure, asbestos exposure, taxes, trade compliance, acquisitions and divestitures, claims of current and legacy shareholders, past waste disposal practices and release of chemicals into the environment. The Company is actively defending those matters where the Company is named as a defendant and, based on the current facts, does not believe the outcomes from these matters would be material to the Company's results of operations, cash flows or financial position. As previously reported, in July 2020, the Company settled a European Commission competition law investigation involving certain of its subsidiaries and three other companies related to certain past ethylene purchases. Shell Chemicals Europe, another group of corporate claimants, and, most recently, TotalEnergies Petrochemicals & Refining SA have filed claims for damages with the District Court of Amsterdam against four companies, including Celanese, arising from those activities. BASF SE has filed a similar claim in the Court of Munich, Germany. The Company intends to vigorously defend itself against these claims. While it is possible that additional parties could assert demands or claims related to this matter, based on information available at this time, the Company does not expect ultimate resolution of this matter to have a material impact on its financial condition or results of operations.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	12 Months Ended
	Dec. 31, 2024
Supplemental Cash Flow Information [Abstract]
Supplemental Cash Flow Information	Supplemental Cash Flow Information Year Ended December 31, 2024 2023 2022 (In $ millions) Interest paid, net of amounts capitalized 701 780 122 Taxes paid, net of refunds 349 237 273 Noncash Investing and Financing Activities Accrued treasury stock repurchases — — (17) Finance lease obligations ( Note 16 ) 27 2 28 Accrued capital expenditures (21) (26) 40 Asset retirement obligations 2 11 3

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Segment Information	Segment Information Business Segments The Company operates through business segments according to the nature and economic characteristics of its products and customer relationships, as well as the manner in which the information is used internally by the Company's chief operating decision maker ("CODM"), who is the Company's President and Chief Executive Officer. The Company's CODM regularly reviews the Operating profit of each reportable segment to assess financial results and allocate resources. Operating profit is assessed against forecast and prior periods to evaluate and assess segment results. Operating profit is also reported on the consolidated statement of operations. The Company has disclosed for each reportable segment the significant expense categories that are reviewed by the CODM in the tables below. The Company's business segments are as follows: • Engineered Materials The Company's Engineered Materials segment includes the engineered materials business and certain strategic affiliates. The engineered materials business develops, produces and supplies a broad portfolio of high performance specialty polymers for automotive and medical applications, as well as industrial products and consumer electronics. Together with its strategic affiliates, the Company's engineered materials business participates in the global specialty polymers industry. The primary products of Engineered Materials are used in a broad range of end-use products including fuel system components, automotive safety systems, medical applications, consumer electronics, appliances, industrial products, battery separators, filtration equipment, coatings, and electrical applications and products. • Acetyl Chain The Company's Acetyl Chain segment includes the integrated chain of acetic acid, vinyl acetate monomer ("VAM"), acetic anhydride, acetate esters, emulsion polymers, ethylene vinyl acetate ("EVA") polymers, redispersible powders ("RDP"), and acetate tow businesses. The Company's acetyl chain business produces and supplies acetyl products, including acetic acid, VAM, acetic anhydride and acetate esters. These products are generally used as starting materials for colorants, paints, adhesives, coatings and pharmaceuticals. It also produces organic solvents and intermediates for pharmaceutical, agricultural and chemical products. The Company's emulsion polymers business is a leading global producer of vinyl acetate-based emulsions and develops products and application technologies to improve performance, create value and drive innovation in applications such as paints and coatings, adhesives, construction, glass fiber, textiles and paper. The Company's EVA polymers business is a leading North American manufacturer of a full range of specialty EVA resins and compounds, as well as select grades of low-density polyethylene. The Company's EVA polymers products are used in many applications, including flexible packaging films, lamination film products, hot melt adhesives, automotive parts and carpeting. The Company's RDP business is a leading global producer of redispersible polymer powders. The Company's RDP products are used in a variety of applications in the mortar industry, including decorative mortar, exterior insulation and finish systems, gypsum-based materials, plaster and render, self-leveling floor systems, skim coat and tile adhesives. The Company's acetate tow business is a leading global producer and supplier of acetate tow and acetate flake, primarily used in filter products applications. • Other Activities Other Activities primarily consists of corporate center costs, including administrative activities such as finance, taxes, information technology and human resource functions, interest income and expense associated with financing activities and results of the Company's captive insurance companies. Other Activities also includes the components of net periodic benefit cost (interest cost, expected return on assets and net actuarial gains and losses) for the Company's defined benefit pension plans and other postretirement plans not allocated to the Company's business segments. The business segment management reporting and controlling systems are based on the same accounting policies as those described in the summary of significant accounting policies ( Note 2 ). Sales transactions between business segments are generally recorded at cost plus a mark-up. Engineered Acetyl Chain Other Eliminations Consolidated (In $ millions) Year Ended December 31, 2024 Net sales 5,607 4,763 (1) — (90) 10,280 Cost of sales (4,371) (3,647) 4 90 (7,924) Gross profit 1,236 1,116 4 — 2,356 Selling, general and administrative expenses (434) (119) (477) — (1,030) Amortization of intangible assets (157) (2) — — (159) Research and development expenses (90) (40) — — (130) Other (charges) gains, net ( Note 24 ) (1,724) — (20) — (1,744) Gain (loss) on disposition of business and assets, net (10) (4) — — (14) Other segment items (2) — — 24 — 24 Operating profit (loss) (1,179) 951 (469) — (697) Depreciation and amortization 510 244 47 — 801 Equity in net earnings (loss) of affiliates 172 10 14 — 196 Capital expenditures 211 151 52 — 414 (3) As of December 31, 2024 Goodwill and intangible assets, net 8,617 411 — — 9,028 Total assets 15,496 5,265 2,096 — 22,857 Engineered Acetyl Chain Other Eliminations Consolidated (In $ millions) Year Ended December 31, 2023 Net sales 6,149 4,884 (1) — (93) 10,940 Cost of sales (4,825) (3,607) 2 93 (8,337) Gross profit 1,324 1,277 2 — 2,603 Selling, general and administrative expenses (435) (118) (522) — (1,075) Amortization of intangible assets (162) (2) — — (164) Research and development expenses (97) (40) (9) — (146) Other (charges) gains, net ( Note 24 ) (56) (4) (8) — (68) Gain (loss) on disposition of business and assets, net 509 (4) (4) — — 505 Other segment items (2) — — 32 — 32 Operating profit (loss) 1,083 1,109 (505) — 1,687 Depreciation and amortization 462 217 27 — 706 Equity in net earnings (loss) of affiliates 83 6 13 — 102 Capital expenditures 237 207 98 — 542 (3) As of December 31, 2023 Goodwill and intangible assets, net 10,525 427 — — 10,952 Total assets 17,930 5,538 3,129 — 26,597 Year Ended December 31, 2022 Net sales 4,024 5,743 (1) — (94) 9,673 Cost of sales (3,249) (4,130) (8) 94 (7,293) Gross profit 775 1,613 (8) — 2,380 Selling, general and administrative expenses (213) (125) (486) — (824) Amortization of intangible assets (57) (3) (2) — (62) Research and development expenses (71) (40) (1) — (112) Other (charges) gains, net ( Note 24 ) (7) — (1) — (8) Gain (loss) on disposition of business and assets, net 2 2 1 — 5 Other segment items (2) — — (1) — (1) Operating profit (loss) 429 1,447 (498) — 1,378 Depreciation and amortization 226 213 23 — 462 Equity in net earnings (loss) of affiliates 202 7 11 — 220 Capital expenditures 178 352 53 — 583 (3) ______________________________ (1) Includes intersegment sales of $90 million, $93 million and $94 million for the years ended December 31, 2024, 2023 and 2022, respectively. (2) Includes Foreign exchange gain (loss), net. (3) Includes a decrease in accrued capital expenditures of $21 million, a decrease in accrued capital expenditures of $26 million and an increase in accrued capital expenditures of $40 million for the years ended December 31, 2024, 2023 and 2022, respectively. (4) Includes a $515 million gain related to the formation of the Nutrinova joint venture included in Gain (loss) on disposition of businesses and assets, net in the consolidated statements of operations ( Note 4 ). Geographical Area Information The Net sales to external customers based on geographic location are as follows: Year Ended December 31, 2024 2023 2022 (In $ millions) Belgium 400 499 251 Brazil 140 140 122 Canada 127 146 120 Greater China 1,984 1,952 1,525 France 68 84 31 Germany 2,201 2,468 2,934 India 155 150 55 Italy 63 77 7 Japan 278 312 87 Mexico 344 361 359 Singapore 1,001 1,146 1,209 South Korea 140 154 68 Spain 50 58 11 Switzerland 294 223 165 United Kingdom 78 86 13 U.S. 2,748 2,821 2,562 Other 209 263 154 Total 10,280 10,940 9,673 Property, plant and equipment, net based on the geographic location of the Company's facilities is as follows: As of December 31, 2024 2023 (In $ millions) Belgium 60 112 Canada 121 121 Greater China 659 568 Germany 795 843 Italy 76 74 Japan 37 43 Mexico 42 44 Netherlands 49 48 Singapore 81 82 South Korea 70 64 Switzerland 57 58 United Kingdom 107 118 U.S. 3,001 3,286 Other 118 123 Total 5,273 5,584

Revenue Recognition (Notes)

Revenue Recognition (Notes)	12 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregated Revenue In general, the Company's business segmentation is aligned according to the nature and economic characteristics of its products and customer relationships and provides meaningful disaggregation of each business segment's results of operations. The Company manages its Engineered Materials business segment through its project management pipeline, which is comprised of a broad range of projects that are solutions-based and are tailored to each customer's unique needs. Projects are identified and selected based on success rate and may involve a number of different polymers per project for use in multiple end-use applications. Therefore, the Company is agnostic toward products and end-use markets for the Engineered Materials business segment. The Company manages its Acetyl Chain business segment by leveraging its ability to sell chemicals externally to end-use markets or downstream to its acetate tow, intermediate chemistry, emulsion polymers, redispersible powders and ethylene vinyl acetate polymers businesses. Decisions to sell externally and geographically or downstream and along the Acetyl Chain are based on market demand, trade flows and maximizing the value of its chemicals. Therefore, the Company's strategic focus is on executing within this integrated chain model and less on driving product-specific revenue. Further disaggregation of Net sales by business segment and geographic destination is as follows: Year Ended December 31, 2024 2023 2022 (In $ millions) Engineered Materials North America 1,553 1,780 1,197 Europe and Africa 1,641 1,941 1,538 Asia-Pacific 2,272 2,274 1,180 South America 141 154 109 Total 5,607 6,149 4,024 Acetyl Chain North America 1,526 1,448 1,713 Europe and Africa 1,613 1,680 1,961 Asia-Pacific 1,415 1,543 1,811 South America 119 120 164 Total (1) 4,673 4,791 5,649 ______________________________ (1) Excludes intersegment sales of $90 million, $93 million and $94 million for the years ended December 31, 2024, 2023 and 2022, respectively.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	12 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Earnings (Loss) Per Share	Earnings (Loss) Per Share Year Ended December 31, 2024 2023 2022 (In $ millions, except share data) Amounts attributable to Celanese Corporation Earnings (loss) from continuing operations (1,514) 1,969 1,902 Earnings (loss) from discontinued operations (8) (9) (8) Net earnings (loss) (1,522) 1,960 1,894 Weighted average shares - basic 109,273,779 108,848,962 108,380,082 Incremental shares attributable to equity awards (1) — 530,702 855,294 Weighted average shares - diluted 109,273,779 109,379,664 109,235,376 ______________________________ (1) Excludes options to purchase 265,922, 202,876 and 0 shares of Common Stock for the years ended December 31, 2024, 2023 and 2022, respectively, as their effect would have been antidilutive. Excludes 61, 39,465 and 154,172 equity award shares for the years ended December 31, 2024, 2023 and 2022, respectively, as their effect would have been antidilutive. For the year ended December 31, 2024, the Company incurred a net loss from continuing operations, resulting in 239,886 incremental shares attributable to equity awards being excluded from the number of weighted average shares - diluted as their effect would have been antidilutive.

Other (Charges) Gains, Net

Other (Charges) Gains, Net	12 Months Ended
	Dec. 31, 2024
Restructuring and Related Activities [Abstract]
Other (Charges) Gains, Net	Other (Charges) Gains, Net Year Ended December 31, 2024 2023 2022 (In $ millions) Restructuring (1) (107) (52) (6) Asset impairments (1,639) (2) (15) (14) Plant/office closures 2 (1) 12 Total (1,744) (68) (8) ______________________________ (1) Includes employee termination benefits related to the previously announced closure of the Company's facility in Mechelen, Belgium ( Note 4 ) and the previously announced closure of its polymerization units in Uentrop, Germany ( Note 4 ) for the year ended December 31, 2024, and employee termination benefits primarily related to Company-wide business optimization projects during the years ended December 31, 2024 and 2023. (2) Primarily related to non-cash impairment losses on goodwill and certain trade names, primarily Zytel ® , arising from the Company's goodwill and indefinite-lived intangible assets impairment tests ( Note 9 ). The changes in the restructuring liabilities by business segment are as follows: Engineered Acetyl Other Total (In $ millions) Employee Termination Benefits As of December 31, 2023 13 2 3 18 Additions 89 1 16 106 Cash payments (40) (2) (13) (55) Other changes (2) (1) — (3) Exchange rate changes (3) — — (3) As of December 31, 2024 57 — 6 63

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net earnings (loss) attributable to Celanese Corporation	$ (1,522)	$ 1,960	$ 1,894

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Insider Trading Policies and Pr

Insider Trading Policies and Procedures	12 Months Ended
	Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Cybersecurity Risk Management a

Cybersecurity Risk Management and Strategy Disclosure	12 Months Ended
	Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]	Cybersecurity, resilience and data privacy are important to maintaining our proprietary information and the trust of our customers, suppliers and employees, and we recognize the importance of working to secure our data and information systems from potential cybersecurity and data privacy incidents. We are a large global manufacturer with sites around the world, and we identify and assess our cybersecurity risk through that lens. Securing the execution and control of our manufacturing operations, to the extent implemented through digital technology, is a primary area of focus. We also face risks encountered by substantially all large global companies such as the risks of intellectual property and information being compromised, fraud, business interruption and violation of privacy or security laws. We identify, assess, manage and mitigate cybersecurity risk through a risk management program based on the NIST Cybersecurity Framework that is regularly assessed by a third party cybersecurity consultant. As part of our processes, we perform routine scanning and have an established vulnerability management program and patching policy. We have in our learning management system a comprehensive cybersecurity awareness course that is mandatory for all employees with computers and covers key topics such as identifying workplace cybersecurity hazards and attacks, and our separate CyberSAFE and Data Privacy intranets provide content to help employees identify and avoid cybersecurity and data privacy risks. We also have data privacy educational tools, policies and procedures to help employees prevent, recognize and report data privacy incidents. We perform penetration tests and vulnerability and breach assessments with third-party advisors to support our compliance with laws and regulations including those applicable to chemical manufacturing sites. We also have a third-party risk management program with a formal approach to evaluating and managing risks associated with third-party information technology solutions and software. We maintain cyber/information security insurance to protect against certain expenses and liabilities that may be incurred in the event of an incident. Cybersecurity, resilience and data privacy risks are maintained and managed on an ongoing basis as part of our broader enterprise risk management program. Specifically, a risk management workstream focused on our information technology function (including cybersecurity, resilience and data privacy) is designed to assess, identify and manage cybersecurity- resilience and data privacy-related risks and mitigation measures. Our cybersecurity risk program also includes a documented incident response plan to be used in the event of a cybersecurity incident. The incident response plan provides for certain responses based on various factors of a cybersecurity incident and integrates with our enterprise crisis management program.
Cybersecurity Risk Management Processes Integrated [Flag]	true
Cybersecurity Risk Management Processes Integrated [Text Block]	Cybersecurity, resilience and data privacy are important to maintaining our proprietary information and the trust of our customers, suppliers and employees, and we recognize the importance of working to secure our data and information systems from potential cybersecurity and data privacy incidents. We are a large global manufacturer with sites around the world, and we identify and assess our cybersecurity risk through that lens. Securing the execution and control of our manufacturing operations, to the extent implemented through digital technology, is a primary area of focus. We also face risks encountered by substantially all large global companies such as the risks of intellectual property and information being compromised, fraud, business interruption and violation of privacy or security laws.
Cybersecurity Risk Management Third Party Engaged [Flag]	true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]	true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]	false
Cybersecurity Risk Board of Directors Oversight [Text Block]	Primary responsibility for assessing and managing risks from cybersecurity threats resides with our management team, including a Chief Information Officer who has nearly 30 years of information technology experience including leadership roles at multiple large, global and/or publicly-traded companies, and a Chief Information Security Officer who has over 30 years of experience in cybersecurity with large international publicly-traded companies and who holds a Certified Information Systems Security Professional (CISSP) certification. These individuals, together with others on their teams, are informed about the monitoring, prevention, detection, mitigation, and remediation of cybersecurity incidents through their management of and participation in the cybersecurity risk management policies, processes and operations discussed above. They regularly report to and consult with the executive leadership team on such matters. At the Board level, the full Board and its Stewardship Committee (which oversees many of our operational risks related to manufacturing) are both involved in oversight of the Company's management of cybersecurity risk. Management, including the Chief Information Officer and Chief Information Security Officer, updates our Stewardship Committee and full Board on cybersecurity matters quarterly. We also have processes by which certain cybersecurity incidents are escalated within the Company and may be reviewed by a designated management committee and, where appropriate, reported in a timely manner to the Board.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]	Management, including the Chief Information Officer and Chief Information Security Officer, updates our Stewardship Committee and full Board on cybersecurity matters quarterly.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]	Primary responsibility for assessing and managing risks from cybersecurity threats resides with our management team, including a Chief Information Officer who has nearly 30 years of information technology experience including leadership roles at multiple large, global and/or publicly-traded companies, and a Chief Information Security Officer who has over 30 years of experience in cybersecurity with large international publicly-traded companies and who holds a Certified Information Systems Security Professional (CISSP) certification. These individuals, together with others on their teams, are informed about the monitoring, prevention, detection, mitigation, and remediation of cybersecurity incidents through their management of and participation in the cybersecurity risk management policies, processes and operations discussed above. They regularly report to and consult with the executive leadership team on such matters. At the Board level, the full Board and its Stewardship Committee (which oversees many of our operational risks related to manufacturing) are both involved in oversight of the Company's management of cybersecurity risk. Management, including the Chief Information Officer and Chief Information Security Officer, updates our Stewardship Committee and full Board on cybersecurity matters quarterly. We also have processes by which certain cybersecurity incidents are escalated within the Company and may be reviewed by a designated management committee and, where appropriate, reported in a timely manner to the Board.
Cybersecurity Risk Role of Management [Text Block]	These individuals, together with others on their teams, are informed about the monitoring, prevention, detection, mitigation, and remediation of cybersecurity incidents through their management of and participation in the cybersecurity risk management policies, processes and operations discussed above. They regularly report to and consult with the executive leadership team on such matters.
Cybersecurity Risk Management Positions or Committees Responsible [Flag]	true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]	Management, including the Chief Information Officer and Chief Information Security Officer
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]	Primary responsibility for assessing and managing risks from cybersecurity threats resides with our management team, including a Chief Information Officer who has nearly 30 years of information technology experience including leadership roles at multiple large, global and/or publicly-traded companies, and a Chief Information Security Officer who has over 30 years of experience in cybersecurity with large international publicly-traded companies and who holds a Certified Information Systems Security Professional (CISSP) certification.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]	Primary responsibility for assessing and managing risks from cybersecurity threats resides with our management team, including a Chief Information Officer who has nearly 30 years of information technology experience including leadership roles at multiple large, global and/or publicly-traded companies, and a Chief Information Security Officer who has over 30 years of experience in cybersecurity with large international publicly-traded companies and who holds a Certified Information Systems Security Professional (CISSP) certification. These individuals, together with others on their teams, are informed about the monitoring, prevention, detection, mitigation, and remediation of cybersecurity incidents through their management of and participation in the cybersecurity risk management policies, processes and operations discussed above. They regularly report to and consult with the executive leadership team on such matters. At the Board level, the full Board and its Stewardship Committee (which oversees many of our operational risks related to manufacturing) are both involved in oversight of the Company's management of cybersecurity risk. Management, including the Chief Information Officer and Chief Information Security Officer, updates our Stewardship Committee and full Board on cybersecurity matters quarterly. We also have processes by which certain cybersecurity incidents are escalated within the Company and may be reviewed by a designated management committee and, where appropriate, reported in a timely manner to the Board.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]	true

Summary of Accounting Policies

Summary of Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Recoverability of Goodwill and Indefinite-Lived Assets	Recoverability of Goodwill and Indefinite-Lived Intangible Assets The Company assesses the recoverability of the carrying amount of its reporting unit goodwill and other indefinite-lived intangible assets either qualitatively or quantitatively annually during the third quarter of its fiscal year using June 30 balances or whenever events or changes in circumstances indicate that the carrying amount of the asset may not be fully recoverable. Recoverability of the carrying amount of goodwill is measured at the reporting unit level. The Company assesses the recoverability of finite-lived intangible assets in the same manner as for property, plant and equipment. Impairment losses are generally recorded in Other (charges) gains, net in the consolidated statements of operations. When assessing the recoverability of goodwill and other indefinite-lived intangible assets, the Company may first assess qualitative factors in determining whether it is more likely than not that the fair value of a reporting unit, including goodwill, or another indefinite-lived intangible asset is less than its carrying amount. The qualitative evaluation is an assessment of multiple factors, including the current operating environment, financial performance and market considerations. The Company may elect to bypass this qualitative assessment for some or all of its reporting units or other indefinite-lived intangible assets and perform a quantitative test, based on management's judgment. In performing a quantitative analysis of goodwill, the Company measures the recoverability of goodwill for each reporting unit using the income approach based on a discounted cash flow model incorporating discount rates commensurate with the risks involved or a combination of the income approach and the market approach using the guideline public company method, which is classified as a Level 3 fair value measurement. The key assumptions used in the discounted cash flow valuation model include discount rates, revenue growth rates, tax rates, cash flow projections and terminal value rates. Discount rates, revenue growth rates and cash flow projections are the most sensitive and susceptible to change as they require significant management judgment. Discount rates used are similar to the rates estimated by the weighted average cost of capital ("WACC") considering any differences in company-specific risk factors. Revenue growth rates and cash flow projections are based on historical trends and expected growth drivers such as macroeconomic trends in the industries and territories in which the reporting units operate. The Company may engage third-party valuation consultants to assist with this process.
Pension and Other Postretirement Obligations	Pension and Other Postretirement Obligations The Company recognizes a balance sheet asset or liability for each of its pension and other postretirement benefit plans equal to the plan's funded status as of a December 31 measurement date. The amounts recognized in the consolidated financial statements related to pension and other postretirement benefits are determined on an actuarial basis. Various assumptions are used in the calculation of the actuarial valuation of the employee benefit plans. These assumptions include the discount rate, compensation levels, expected long-term rates of return on plan assets and trends in health care costs. In addition, actuarial consultants use factors such as withdrawal and mortality rates to estimate the projected benefit obligation. The Company applies the long-term expected rate of return to the fair value of plan assets and immediately recognizes in operating results the change in fair value of plan assets and net actuarial gains and losses annually in the fourth quarter of each fiscal year and whenever a plan is required to be remeasured. Events requiring a plan remeasurement will be recognized in the quarter in which such remeasurement event occurs. The remaining components of pension and other postretirement plan net periodic benefit costs are recorded on a monthly basis. The Company allocates the service cost and amortization of prior service cost (or credit) components of its pension and postretirement plans to its business segments. Interest cost, expected return on assets and net actuarial gains and losses are considered financing activities managed at the corporate level and are recorded to Other Activities. The Company believes the expense allocation appropriately matches the cost incurred for active employees to the respective business segment. Other postretirement benefit plans provide medical and life insurance benefits to retirees who meet minimum age and service requirements. The key determinants of the accumulated postretirement benefit obligation are the discount rate and the health care cost trend rate. • Discount Rate As of the measurement date, the Company determines the appropriate discount rate used to calculate the present value of future cash flows currently expected to be required to settle the pension and other postretirement benefit obligations. The discount rate is generally based on the yield on high-quality corporate fixed-income securities. The Company engages third-party consultants to assist with this process. In the U.S., the rate used to discount pension and other postretirement benefit plan liabilities is based on a yield curve developed from market data of approximately 400 Aa-grade non-callable bonds (unless accompanied by a make whole provision) at the measurement date. This yield curve has discount rates that vary based on the duration of the obligations. The estimated future cash flows for the pension and other benefit obligations were matched to the corresponding rates on the yield curve to derive a weighted average discount rate. Outside of the U.S., a similar approach of discounting pension and other postretirement benefit plan liabilities is used based on the high quality corporate bonds available in each market. There are some exceptions to this methodology, namely in locations where there is a sparse corporate bond market, and in such cases the discount rate takes into account yields of government bonds at the appropriate duration. • Expected Long-Term Rate of Return on Assets The Company determines the long-term expected rate of return on plan assets by considering the current target asset allocation, as well as the historical and expected rates of return on various asset categories in which the plans are invested. A single long-term expected rate of return on plan assets is then calculated for each plan as the weighted average of the target asset allocation and the long-term expected rate of return assumptions for each asset category within each plan. The expected rate of return is assessed annually. • Investment Policies and Strategies The investment objectives for the Company's pension plans are to earn, over a moving 20-year period, a long-term expected rate of return, net of investment fees and transaction costs, sufficient to satisfy the benefit obligations of the plan, while at the same time maintaining adequate liquidity to pay benefit obligations and proper expenses, and meet any other cash needs, in the short- to medium-term. The equity and debt securities objectives are to provide diversified exposure across the U.S. and global equity and fixed income markets, and to manage the risks and returns of the plans through the use of multiple managers and strategies. The fixed income strategies are designed to reduce liability-related interest rate risk by investing in bonds that match the duration and credit quality of the plan liabilities where possible. The financial objectives of the qualified pension plans are established in conjunction with a comprehensive review of each plan's liability structure. The Company's asset allocation policy is based on detailed asset/liability analysis. In developing investment policy and financial goals, consideration is given to each plan's demographics, the returns and risks associated with current and alternative investment strategies and the current and projected cash, expense and funding ratios of each plan. Investment policies must also comply with local statutory requirements as determined by each country. A formal asset/liability study of each plan is undertaken approximately every three to five years or whenever there has been a material change in plan demographics, benefit structure or funding status and investment market. The Company has adopted a long-term investment horizon such that the risk and duration of investment losses are weighed against the long-term potential for appreciation of assets. Although there cannot be complete assurance that these objectives will be realized, it is believed that the likelihood for their realization is reasonably high, based upon the asset allocation chosen and the historical and expected performance of the asset classes utilized by the plans. The intent is for investments to be broadly diversified across asset classes, investment styles, market sectors, investment managers, developed and emerging markets and securities in order to moderate portfolio volatility and risk. Investments may be in separate accounts, commingled trusts, mutual funds and other pooled asset portfolios provided they all conform to fiduciary standards. External investment managers are hired to manage pension assets. Investment consultants assist with the screening process for each new manager hired. Over the long-term, the investment portfolio is expected to earn returns that exceed a composite of market indices that are weighted to match each plan's target asset allocation. The portfolio return should also (over the long-term) meet or exceed the return used for actuarial calculations in order to meet the future needs of each plan.
Income Taxes	Income Taxes The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and net operating loss and tax credit carryforwards. The amount of deferred taxes on these temporary differences is determined using the tax rates that are expected to apply to the period when the asset is realized or the liability is settled, as applicable, based on tax rates and laws in the respective tax jurisdiction enacted as of the balance sheet date. The Company reviews its deferred tax assets for recoverability and establishes a valuation allowance based on historical taxable income, projected future taxable income, remaining carryforward periods, applicable tax strategies and the expected timing of the reversals of existing temporary differences. A valuation allowance is provided when it is more likely than not (likelihood of greater than 50%) that some portion or all of the deferred tax assets will not be realized. The Company considers many factors when evaluating and estimating its tax positions and tax benefits, which may require periodic adjustments and which may not accurately anticipate actual outcomes. Tax positions are recognized only when it is more likely than not (likelihood of greater than 50%), based on technical merits, that the positions will be sustained upon examination. Tax positions that meet the more-likely-than-not threshold are measured using a probability weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement. Whether the more-likely-than-not recognition threshold is met for a tax position is a matter of judgment based on the individual facts and circumstances of that position evaluated in light of all available evidence and technical authorities in the relevant jurisdiction. The Company recognizes interest and penalties related to uncertain tax positions in Income tax (provision) benefit in the consolidated statements of operations.
Consolidation Principles	Consolidation Principles The consolidated financial statements have been prepared in accordance with U.S. GAAP for all periods presented and include the accounts of the Company and its majority owned subsidiaries over which the Company exercises control. All intercompany accounts and transactions have been eliminated in consolidation.
Estimates and Assumptions	Estimates and Assumptions The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of net sales, expenses and allocated charges during the reporting period. Significant estimates pertain to impairments of goodwill, intangible assets and other long-lived assets, purchase price allocations, restructuring costs and other (charges) gains, net, income taxes, pension and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates. Purchase Accounting The Company recognizes the identifiable tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date. The excess of purchase price over the aggregate fair values is recorded as goodwill. Intangible assets are valued using the relief from royalty, multi-period excess earnings and discounted cash flow methodologies, which are considered Level 3 measurements. The relief from royalty method estimates the Company's theoretical royalty savings from ownership of the intangible asset. Key assumptions used in this method include discount rates, royalty rates, growth rates, sales projections and terminal value rates. Key assumptions used in the multi-period excess earnings method include discount rates, retention rates, growth rates, sales projections, expense projections and contributory asset charges. Key assumptions used in the discounted cash flow valuation model include discount rates, growth rates, tax rates, cash flow projections and terminal value rates. All of these methodologies require significant management judgment and, therefore, are susceptible to change. The Company calculates the fair value of the identifiable tangible and intangible assets acquired and liabilities assumed to allocate the purchase price at the acquisition date. The Company may use the assistance of third-party valuation consultants.
Variable Interest Entities	Variable Interest Entities The Company assesses whether it has a variable interest in legal entities in which it has a financial relationship and, if so, whether or not those entities are variable interest entities ("VIEs"). A VIE is an entity with insufficient equity at risk for the entity to finance its activities without additional subordinated financial support or in which equity investors lack the characteristics of a controlling financial interest. If an entity is determined to be a VIE, the Company evaluates whether it is the primary beneficiary. The primary beneficiary analysis is a qualitative analysis based on power and economics. The Company concludes that it is the primary beneficiary and consolidates the VIE if the Company has both (i) the power to direct the activities of the VIE that most significantly influence the VIE's economic performance, and (ii) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. The Company has a joint venture, Fairway Methanol LLC ("Fairway"), with Mitsui & Co., Ltd., of Tokyo, Japan ("Mitsui"), in which the Company owns 50% of Fairway, for the production of methanol at the Company's integrated chemical plant in Clear Lake, Texas. Fairway is a VIE in which the Company is the primary beneficiary. Accordingly, the Company consolidates the venture and records a noncontrolling interest for the share of the venture owned by Mitsui. Fairway is included in the Company's Acetyl Chain segment. As of December 31, 2024 and 2023, the carrying amount of the total assets associated with Fairway included in the consolidated balance sheets were $574 million and $626 million, respectively, made up primarily of $491 million and $529 million, respectively, of property, plant and equipment. The Company holds variable interests in entities that supply certain raw materials and services to the Company. The variable interests primarily relate to cost-plus contractual arrangements with the suppliers and recovery of capital expenditures for certain plant assets plus a rate of return on such assets. Liabilities for such supplier recoveries of capital expenditures have been recorded as finance lease obligations. The entities are not consolidated because the Company is not the primary beneficiary of the entities as it does not have the power to direct the activities of the entities that most significantly impact the entities' economic performance. The Company's maximum exposure to loss as a result of its involvement with these VIEs as of December 31, 2024 and 2023 was $208 million, related primarily to the recovery of capital expenditures for certain property, plant and equipment.
Fair Value Measurements	Fair Value Measurements The Company determines fair value based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers assumptions that market participants would use when pricing the asset or liability. Market participant assumptions are categorized by a three-tiered fair value hierarchy which prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. If a financial instrument uses inputs that fall in different levels of the hierarchy, the instrument will be categorized based upon the lowest level of input that is significant to the fair value calculation. Valuations for fund investments, such as pooled-type investments and registered investment companies, which do not have readily determinable fair values, are typically estimated using a net asset value provided by a third party as a practical expedient. The levels of inputs used to measure fair value are as follows: Level 1 - unadjusted quoted prices for identical assets or liabilities in active markets accessible by the Company Level 2 - inputs that are observable in the marketplace other than those inputs classified as Level 1 Level 3 - inputs that are unobservable in the marketplace and significant to the valuation
Cash and Cash Equivalents	Cash and Cash Equivalents All highly liquid investments with original maturities of three months or less are considered cash equivalents.
Inventories	Inventories Inventories, including stores and supplies, are stated at the lower of cost and net realizable value. Cost for inventories is determined using the first-in, first-out method. Cost includes raw materials, direct labor and manufacturing overhead. Cost for stores and supplies is primarily determined by the average cost method.
Investments in Affiliates	Investments in Affiliates Investments in equity securities where the Company can exercise significant influence over operating and financial policies of an investee, which is generally considered when an investor owns 20% or more of the voting stock of an investee, are accounted for under the equity method of accounting. Investments in equity securities where the Company does not exercise significant influence are accounted for at fair value or, if such investments do not have a readily determinable fair value, an election may be made to measure them at cost after considering observable price changes for similar instruments, minus impairment, if any. The Company determined it cannot exercise significant influence over certain investments where the Company owns greater than a 20% interest due to local government investment in and influence over these entities, limitations on the Company's involvement in the day-to-day operations and the present inability of the entities to provide timely financial information prepared in accordance with U.S. GAAP. Further, these investments were determined not to have a readily determinable fair value. Accordingly, these investments are accounted for using the alternative measure described above. In certain instances, the financial information of the Company's equity investees is not available on a timely basis. Accordingly, the Company records its proportional share of the investee's earnings or losses on a consistent lag of no more than one quarter. When required to assess the recoverability of its investments in affiliates, the Company estimates fair value using a discounted cash flow model. The Company may engage third-party valuation consultants to assist with this process.
Property, Plant and Equipment, Net	Property, Plant and Equipment, Net Land is recorded at historical cost. Buildings, machinery and equipment, including capitalized interest, and property under finance lease agreements, are recorded at cost less accumulated depreciation. The Company records depreciation and amortization in its consolidated statements of operations as either Cost of sales, Selling, general and administrative expenses or Research and development expenses consistent with the utilization of the underlying assets. Depreciation is calculated on a straight-line basis over the following estimated useful lives of depreciable assets: Land improvements 20 years Buildings and improvements 30 years Machinery and equipment 20 years Leasehold improvements are amortized over 10 years or the remaining life of the respective lease, whichever is shorter Accelerated depreciation is recorded when the estimated useful life is shortened. Ordinary repair and maintenance costs, including costs for planned maintenance turnarounds, that do not extend the useful life of the asset are charged to earnings as incurred. Fully depreciated assets are retained in property and depreciation accounts until sold or otherwise disposed. In the case of disposals, assets and related depreciation are removed from the accounts, and the net amounts, less proceeds from disposal, are included in earnings. The Company assesses the recoverability of the carrying amount of its property, plant and equipment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. An impairment loss would be assessed when estimated undiscounted future cash flows from the operation and disposition of the asset group are less than the carrying amount of the asset group. Asset groups have identifiable cash flows and are largely independent of other asset groups. Measurement of an impairment loss is based on the excess of the carrying amount of the asset group over its fair value. The Company calculates the fair value using a discounted cash flow model incorporating discount rates commensurate with the risks involved for the asset group, which is classified as a Level 3 fair value measurement. The key assumptions used in the discounted cash flow valuation model include discount rates, growth rates, tax rates, cash flow projections and terminal value rates. Discount rates, growth rates and cash flow projections involve significant judgment and are based on management's estimate of current and forecasted market conditions and cost structure. Impairment losses are generally recorded in Other (charges) gains, net in the consolidated statements of operations.
Definite-lived Intangible Assets	Definite-lived Intangible Assets Customer-related intangible assets and other intangible assets with finite lives are amortized on a straight-line basis over their estimated useful lives, which range from eight
Derivative and Hedging Instruments	Derivative and Hedging Instruments The Company manages its exposures to interest rates, foreign exchange rates and commodity prices through a risk management program that includes the use of derivative financial instruments. The Company does not use derivative financial instruments for speculative trading purposes. The fair value of derivative instruments other than foreign currency forwards and swaps is recorded as an asset or liability on a net basis at the balance sheet date. • Interest Rate Risk Management The Company entered into a forward-starting interest rate swap to mitigate the risk of variability in the benchmark interest rate for debt issued in 2021. The interest rate swap agreement was designated as a cash flow hedge. Accordingly, to the extent the cash flow hedges were effective, changes in the fair value of the interest rate swap were included in gain (loss) from cash flow hedges within Accumulated other comprehensive income (loss), net in the consolidated balance sheets. • Foreign Exchange Risk Management Certain subsidiaries of the Company have assets and liabilities denominated in currencies other than their respective functional currencies, which creates foreign exchange risk. The Company also is exposed to foreign currency fluctuations on transactions with third-party entities as well as intercompany transactions. The Company minimizes its exposure to foreign currency fluctuations by entering into foreign currency forwards and swaps. These foreign currency forwards and swaps are generally not designated as hedges. Gains and losses on foreign currency forwards and swaps entered into to offset foreign exchange impacts on intercompany balances are included in Other income (expense), net in the consolidated statements of operations. Gains and losses on foreign currency forwards and swaps entered into to offset foreign exchange impacts on all other assets and liabilities are included in Foreign exchange gain (loss), net in the consolidated statements of operations. The Company uses non-derivative financial instruments that may give rise to foreign currency transaction gains or losses to hedge the foreign currency exposure of net investments in foreign operations. Accordingly, the effective portion of gains and losses from remeasurement of the non-derivative financial instrument is included in foreign currency translation within Accumulated other comprehensive income (loss), net in the consolidated balance sheets. Gains and losses are reclassified to earnings in the period the hedged investment is sold or liquidated. The Company entered into cross-currency swaps to synthetically convert certain United States dollar ("USD") borrowings to euro ("EUR") borrowings in 2019 and 2022. The cross-currency swap agreements are designated as a net investment hedge. Accordingly, to the extent the net investment hedges are effective, changes in the fair value of the cross-currency swap are included in foreign currency translation within Accumulated other comprehensive income (loss), net in the consolidated balance sheets. Gains and losses are reclassified to earnings in the period the hedged investment is sold or liquidated. The Company entered into cross-currency swaps to effectively convert certain USD borrowings to Japanese yen ("JPY") and EUR borrowings in 2023. The cross-currency swap agreements were designated as fair value hedges. Accordingly, to the extent the fair value hedges are effective, changes in the fair value attributable to changes in the excluded components are included in gain (loss) from fair value hedges within Accumulated other comprehensive income (loss), net in the consolidated balance sheets. The value of the excluded components is recognized in earnings using a systematic and rational method by accruing the current-period swap settlements into earnings each reporting period. The Company entered into cross-currency swaps to synthetically convert certain USD borrowings to Chinese yuan ("CNY") borrowings in 2024. The cross-currency swap agreements are designated as a net investment hedge. Accordingly, to the extent the net investment hedges are effective, changes in the fair value of the cross-currency swap are included in foreign currency translation within Accumulated other comprehensive income (loss), net in the consolidated balance sheets. Gains and losses are reclassified to earnings in the period the hedged investment is sold or liquidated. • Commodity Risk Management The Company has exposure to the prices of commodities in its procurement of certain raw materials. The Company manages its exposure to commodity risk primarily through the use of long-term supply agreements, multi-year purchasing and sales agreements and forward purchase contracts. The Company regularly assesses its practice of using forward purchase contracts and other raw material hedging instruments in accordance with changes in economic conditions. Forward purchases and swap contracts for raw materials are principally settled through physical delivery of the commodity. For qualifying contracts, the Company has elected to apply the normal purchases and normal sales exception based on the probability at the inception and throughout the term of the contract that the Company would not net settle and the transaction would result in the physical delivery of the commodity. Accordingly, realized gains and losses on these contracts are included in the cost of the commodity upon the settlement of the contract. The Company also uses commodity swaps to hedge the risk of fluctuating price changes in certain raw materials and in which physical settlement does not occur. These commodity swaps fix the variable fee component of the price of certain commodities. All or a portion of these commodity swap agreements may be designated as cash flow hedges. Accordingly, to the extent the cash flow hedges are effective, changes in the fair value of commodity swaps are included in gain (loss) from cash flow hedges within Accumulated other comprehensive income (loss), net in the consolidated balance sheets. Gains and losses are reclassified to earnings in the period that the hedged item affects earnings.
Asset Retirement Obligations	Asset Retirement Obligations Periodically, the Company will conclude a site no longer has an indeterminate life based on long-lived asset impairment triggering events and decisions made by the Company. Accordingly, the Company will record asset retirement obligations associated with such sites. To measure the fair value of the asset retirement obligations, the Company will use the expected present value technique, which is classified as a Level 3 fair value measurement. The expected present value technique uses a set of cash flows that represent the probability-weighted average of all possible cash flows based on the Company's judgment. The Company uses the following inputs to determine the fair value of the asset retirement obligations based on the Company's experience with fulfilling obligations of this type and the Company's knowledge of market conditions: (a) labor costs; (b) allocation of overhead costs; (c) profit on labor and overhead costs; (d) effect of inflation on estimated costs and profits; (e) risk premium for bearing the uncertainty inherent in cash flows, other than inflation; (f) time value of money represented by the risk-free interest rate commensurate with the timing of the associated cash flows; and (g) nonperformance risk relating to the liability, which includes the Company's own credit risk. The asset retirement obligations are accreted to their undiscounted values until the time at which they are expected to be settled. The Company has identified but not recognized asset retirement obligations related to certain of its existing operating facilities. Examples of these types of obligations include demolition, decommissioning, disposal and restoration activities. Legal obligations exist in connection with the retirement of these assets upon closure of the facilities or abandonment of the existing operations. However, the Company currently plans on continuing operations at these facilities indefinitely and therefore, a reasonable estimate of fair value cannot be determined at this time. In the event the Company considers plans to abandon or cease operations at these sites, an asset retirement obligation will be reassessed at that time. If certain operating facilities were to close, the related asset retirement obligations could significantly affect the Company's results of operations and cash flows.
Environmental Liabilities	Environmental Liabilities The Company manufactures and sells a diverse line of chemical products throughout the world. Accordingly, the Company's operations are subject to various hazards incidental to the production of industrial chemicals including the use, handling, processing, storage and transportation of hazardous materials. The Company recognizes losses and accrues liabilities relating to environmental matters if available information indicates that it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. Depending on the nature of the site, the Company accrues through 15 years, unless the Company has government orders or other agreements that extend beyond 15 years. The Company estimates environmental liabilities on a case-by-case basis using the most current status of available facts, existing technology, presently enacted laws and regulations and prior experience in remediation of contaminated sites. Recoveries of environmental costs from other parties are recorded as assets when their receipt is deemed probable. An environmental liability related to cleanup of a contaminated site might include, for example, a provision for one or more of the following types of costs: site investigation and testing costs, cleanup costs, costs related to soil and water contamination resulting from tank ruptures and post-remediation monitoring costs. These undiscounted liabilities do not take into account any claims or recoveries from insurance. The measurement of environmental liabilities is based on the Company's periodic estimate of what it will cost to perform each of the elements of the remediation effort. The Company utilizes third parties to assist in the management and development of cost estimates for its sites. Changes to environmental regulations or other factors affecting environmental liabilities are reflected in the consolidated financial statements in the period in which they occur.
Loss Contingencies	Loss Contingencies When determinable, the Company accrues a liability for loss contingencies deemed probable of occurring for which an amount can be reasonably estimated. For certain potentially material loss contingencies, the Company is sometimes unable to estimate and accrue a loss deemed probable of occurring. For such matters, the Company discloses an estimate of the possible loss, range of loss or a statement that such estimate cannot be made. Because the Company's evaluation and assessment of critical facts and circumstances surrounding a contingent loss often occurs well in advance of the matter's final determination, there is an inherent subjectivity and unpredictability involved in estimating, accounting for and reporting contingent losses. Generally, the less progress made in the resolution of a contingent loss matter or the broader the range of potential outcomes, the more difficult it is for the Company to estimate, accrue and report a loss. For example, the Company may disclose certain information about a plaintiff's legal claim against the Company that is alleged in the plaintiff's pleadings or otherwise publicly available. While information of this type may provide more insight into the potential magnitude of a matter, it may not necessarily be indicative of the Company's estimate of probable or possible loss. In addition, some of the Company's contingent loss exposures may be eligible for reimbursement under the provisions of its insurance coverage. The Company does not consider the potential availability of insurance coverage in determining its probable or possible loss estimates. As a result of these factors among others, the Company's ultimate contingent loss exposure may be higher or lower, and possibly materially so, than the Company's recorded probable loss accruals and disclosures of possible losses.
Revenue Recognition	Revenue Recognition Revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied. The majority of the Company's contracts have a single performance obligation to transfer products. Accordingly, the Company recognizes revenue when title and risk of loss have been transferred to the customer, generally at the time of shipment of products. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products and is generally based upon a negotiated, formula, list or fixed price. The Company sells its products both directly to customers and through distributors generally under agreements with payment terms typically less than 90 days. The Company has elected to account for shipping and handling as activities to fulfill the promise to transfer the good. As such, shipping and handling fees billed to customers in a sales transaction are recorded in Net sales and shipping and handling costs incurred are recorded in Cost of sales. The Company has elected to exclude from Net sales any value add, sales and other taxes which it collects concurrent with revenue-producing activities. • Contract Estimates The nature of certain of the Company's contracts gives rise to variable consideration, which may be constrained, including retrospective volume-based rebates to certain customers. The Company issues retrospective volume-based rebates to customers when they purchase a certain volume level, and the rebates are applied retroactively to prior purchases. The Company also issues prospective volume-based rebates to customers when they purchase a certain volume level, and the rebates are applied to future purchases. Prospective volume-based rebates represent a material right within the contract and therefore are considered to be separate performance obligations. For both retrospective and prospective volume-based rebates, the Company estimates the level of volumes based on anticipated purchases at the beginning of the period and records a rebate accrual for each purchase toward the requisite rebate volume. These estimated rebates, which are reassessed each reporting period, are included in the transaction price of the Company's contracts with customers as a reduction to Net sales and are included in Current Other liabilities in the consolidated balance sheets ( Note 10 ). The majority of the Company's revenue is derived from contracts (i) with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount in which it has the right to invoice as product is delivered. The Company has elected the practical expedient not to disclose the value of remaining performance obligations associated with these types of contracts. However, the Company has certain contracts that represent take-or-pay revenue arrangements in which the Company's performance obligations extend over multiple years. As of December 31, 2024, the Company had $936 million of remaining performance obligations related to take-or-pay contracts. The Company expects to recognize approximately $451 million of its remaining performance obligations as Net sales in 2025, $249 million in 2026, $128 million in 2027 and the balance thereafter. The Company has certain contracts which contain performance obligations which are immaterial in the context of the contract with the customer. The Company has elected the practical expedient not to assess whether these promised goods or services are performance obligations. • Contract Balances Contract liabilities primarily relate to advances or deposits received from the Company's customers before revenue is recognized. These amounts are recorded as deferred revenue and are included in Current and Noncurrent Other liabilities in the consolidated balance sheets. The Company does not have any material contract assets as of December 31, 2024.
Research and Development	Research and Development The costs of research and development are charged as an expense in the period in which they are incurred.
Leases	Leases The Company leases certain real estate, fleet assets, warehouses and equipment. Leases with an initial term of 12 months or less ("short-term leases") are not recorded on the consolidated balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term. The Company determines if an arrangement is a lease at inception. Operating lease right-of-use ("ROU") assets and operating lease liabilities are recognized based on the present value of lease payments over the lease term at commencement date. Because most of the Company's leases do not provide an implicit rate of return, the Company uses its imputed collateralized rate based on the information available at commencement date in determining the present value of lease payments. The estimated rate is based on a risk-free rate plus a risk-adjusted margin. Operating lease ROU assets are comprised of the lease liability plus prepaid rents and are reduced by lease incentives or deferred rents. The Company has lease agreements with non-lease components which are not bifurcated. Most leases include one or more options to renew, with renewal terms that can extend the lease term from one
Functional and Reporting Currencies	Functional and Reporting Currencies For the Company's international operations where the functional currency is other than the U.S. dollar, assets and liabilities are translated using period-end exchange rates, while the statement of operations amounts are translated using the average exchange rates for the respective period. Differences arising from the translation of assets and liabilities in comparison with the translation of the previous periods or from initial recognition during the period are included as a separate component of Accumulated other comprehensive income (loss), net.

Accounting Changes and Error Co

Accounting Changes and Error Corrections (Policies)	12 Months Ended
	Dec. 31, 2024
Accounting Changes and Error Corrections [Abstract]
New Accounting Pronouncements, Policy	The following table provides a brief description of recent Accounting Standard Updates ("ASU") issued by the Financial Accounting Standards Board ("FASB") and final rules issued by the Securities and Exchange Commission ("SEC"): Standard/Final Rule Description Effective Date Effect on the Financial Statements or Other Significant Matters In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses (DISE) and on January 6, 2025, the FASB issued ASU 2025-01, Clarifying the Effective Date. The new guidance requires a public business entity ("PBE") to disclose, on an annual and interim basis, additional information about certain costs and expenses in the notes to financial statements. Specifically, in a tabular disclosure, the amounts of (a) purchases of inventory; (b) employee compensation; (c) depreciation; (d) intangible asset amortization; and (e) depreciation, depletion, and amortization recognized as part of oil- and gas-producing activities (or other amounts of depletion expense) included in each relevant expense caption. Within the same tabular disclosure, a PBE is required to include certain expense, gain, or loss amounts that are already required to be disclosed under U.S. GAAP. Additionally, a PBE is required to disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. The guidance also requires a PBE to disclose the total amount of selling expenses and, in annual reporting periods, an entity's definition of selling expenses. Effective for annual periods beginning after December 15, 2026, and interim periods within annual periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the adoption on its financial statement disclosures. Standard/Final Rule Description Effective Date Effect on the Financial Statements or Other Significant Matters In March 2024, the SEC issued Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors . The final rule will require the disclosure of Scope 1 and Scope 2 greenhouse gas emissions, if material, which will be subject to phased-in assurance requirements, governance of climate-related risks, risk management processes and climate-related targets and goals. Within the notes to financial statements, the final rule requires disclosure of certain climate-related financial statement effects and metrics. Phased-in and effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The SEC stayed the effectiveness of the final rule in April 2024 pending judicial review. The Company is currently evaluating the impact of the adoption on its financial statement disclosures. In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures. The new guidance requires an entity to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Additionally, the guidance requires an entity to disclose annual income taxes paid (net of refunds received) disaggregated by federal (national), state and foreign taxes and disaggregate the information by jurisdiction based on a quantitative threshold. The guidance also requires an entity to disclose income (loss) from continuing operations before income tax expense (benefit) disaggregated between domestic and foreign and income tax expense (benefit) from continuing operations disaggregated by federal (national), state and foreign. Effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact of the adoption on its financial statement disclosures. In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures. The new guidance requires an entity to disclose, on an annual and interim basis, significant segment expenses that are regularly provided to the chief operating decision maker ("CODM") and included within segment profit or loss, as well as an amount of other segment items by reportable segment and a description of its composition. Additionally, the guidance requires an entity to disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The update is required to be applied retrospectively to prior periods presented, based on the significant segment expense categories identified and disclosed in the period of adoption. Effective for annual periods beginning after December 15, 2023, and for interim periods beginning after December 15, 2024. Early adoption is permitted. The Company adopted the new guidance effective for the year ended December 31, 2024. The adoption of the new guidance did not have a material impact to the Company.

Summary of Accounting Policie_2

Summary of Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Schedule of Estimated Useful Lives of Depreciable Assets	Depreciation is calculated on a straight-line basis over the following estimated useful lives of depreciable assets: Land improvements 20 years Buildings and improvements 30 years Machinery and equipment 20 years Leasehold improvements are amortized over 10 years or the remaining life of the respective lease, whichever is shorter

Acquisitions, Dispositions an_2

Acquisitions, Dispositions and Plant Closures (Tables)	12 Months Ended
	Dec. 31, 2024
Acquisitions, Dispositions and Plant Closures [Abstract]
Business Acquisition, Pro Forma Information	Year Ended 2022 (In $ millions) Unaudited Consolidated Pro Forma Results Proforma Net sales 12,614 Proforma Earnings (loss) from continuing operations before tax 888
Schedule of Restructuring and Related Costs	The exit and shutdown costs related to the closure of the PA66 and HPN polymerization units in Uentrop, Germany were as follows: Year Ended 2024 (In $ millions) Restructuring (1) 16 Accelerated depreciation expense (2) 36 Total 52 ______________________________ (1) Included in Other (charges) gains, net in the consolidated statements of operations ( Note 24 ). (2) Included in Cost of sales in the consolidated statements of operations. The exit and shutdown costs related to the closure of the facility in Mechelen, Belgium were as follows: Year Ended 2024 (In $ millions) Restructuring (1) 55 Accelerated depreciation expense (2) 35 Total 90 ______________________________ (1) Included in Other (charges) gains, net in the consolidated statements of operations ( Note 24 ). (2) Included in Cost of sales in the consolidated statements of operations.

Receivables, Net Receivables, N

Receivables, Net Receivables, Net (Tables)	12 Months Ended
	Dec. 31, 2024
Receivables [Abstract]
Schedule of Trade Receivables - Third Party and Affiliates, Net	As of December 31, 2024 2023 (In $ millions) Trade receivables - third party and affiliates 1,137 1,255 Allowance for doubtful accounts - third party and affiliates (16) (12) Trade receivables - third party and affiliates, net 1,121 1,243
Schedule of Non-trade Receivables, Net	As of December 31, 2024 2023 (In $ millions) Non-income taxes receivable 266 270 Income taxes receivable 53 57 Other (1) 174 214 Non-trade receivables, net 493 541 ____________________________ (1) Includes $42 million of non-trade receivables related to the M&M Acquisition as of December 31, 2023.

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2024
Inventory Disclosure [Abstract]
Schedule of Inventories	As of December 31, 2024 2023 (In $ millions) Finished goods 1,605 1,604 Work-in-process 119 160 Raw materials and supplies 560 593 Total 2,284 2,357

Investments in Affiliates (Tabl

Investments in Affiliates (Tables)	12 Months Ended
	Dec. 31, 2024
Investments in and Advances to Affiliates, Schedule of Investments [Abstract]
Schedule of Equity Method Investments	Equity method investments by business segment are as follows: Carrying Share of Dividends and 2024 2023 2024 2023 2022 2024 2023 2022 (In $ millions) Engineered Materials (1) 893 898 182 88 209 (149) (145) (204) Other Activities 56 56 14 14 11 (11) (12) (13) Total 949 954 196 102 220 (160) (157) (217) ____________________________ (1) Engineered Materials includes an equity method investment with losses in excess of its carrying amount due to the Company's guarantee of various debt obligations under agreements with third parties related to an equity affiliate ( Note 19 ). This equity method investment was recorded in Current Other liabilities ( Note 10 ) as of December 31, 2024 and 2023.
Schedule of Equity Securities without Readily Determinable Fair Value	Equity investments without readily determinable fair values by business segment are as follows: Carrying Dividend 2024 2023 2024 2023 2022 (In $ millions) Engineered Materials Acetyl Chain 165 165 127 125 132 Other Activities 5 5 1 1 1 Total 170 170 128 126 133
Schedule of Transactions with Affiliates	Transactions and balances with affiliates are as follows: Year Ended December 31, 2024 2023 2022 (In $ millions) Purchases 452 490 590 Sales and other credits 89 212 72 As of December 31, 2024 2023 (In $ millions) Trade receivables 11 7 Non-trade receivables 30 40 Current notes receivables 65 57 Total due from affiliates 106 104 Short-term borrowings (1) 37 23 Trade payables 25 52 Current Other liabilities 34 34 Total due to affiliates 96 109 ______________________________ (1) The Company has agreements with certain affiliates whereby excess affiliate cash is lent to and managed by the Company at variable interest rates governed by those agreements.

Property, Plant and Equipment_2

Property, Plant and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment, Net [Abstract]
Schedule of Property, Plant and Equipment, Net	As of December 31, 2024 2023 (In $ millions) Land 240 260 Land improvements 91 85 Buildings and building improvements 1,059 1,082 Machinery and equipment 7,745 7,157 Construction in progress 700 1,080 Gross asset value 9,835 9,664 Accumulated depreciation (4,562) (4,080) Net book value 5,273 5,584
Schedule of Capitalized Interest and Depreciation Expense	Capitalized interest costs and depreciation expense are as follows: Year Ended December 31, 2024 2023 2022 (In $ millions) Capitalized interest 30 37 18 Depreciation expense 640 540 399

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Net (Tables)	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Goodwill Engineered Acetyl Total (In $ millions) As of December 31, 2022 6,775 367 7,142 Acquisitions ( Note 4 ) (107) — (107) Dispositions ( Note 4 ) (80) — (80) Exchange rate changes 14 8 22 As of December 31, 2023 (1) 6,602 375 6,977 Impairment losses (1,517) — (1,517) Exchange rate changes (60) (13) (73) As of December 31, 2024 (1) 5,025 362 5,387 ______________________________ (1) Includes accumulated impairment losses of $1.5 billion in the Engineered Materials segment as of December 31, 2024. There were no accumulated impairment losses as of December 31, 2023.
Schedule of Finite-Lived Intangible Assets, Net	Finite-lived intangible assets are as follows: Licenses Customer- Developed Covenants Total (In $ millions) Gross Asset Value As of December 31, 2022 42 2,455 601 55 3,153 Disposition ( Note 4 ) — (60) (1) — (61) Exchange rate changes (1) 42 1 — 42 As of December 31, 2023 41 2,437 601 55 3,134 Exchange rate changes (1) (31) (14) — (46) As of December 31, 2024 40 2,406 587 55 3,088 Accumulated Amortization As of December 31, 2022 (39) (567) (50) (40) (696) Amortization — (120) (43) (1) (164) Disposition ( Note 4 ) — 59 1 — 60 Exchange rate changes 1 (11) (3) (1) (14) As of December 31, 2023 (38) (639) (95) (42) (814) Amortization — (116) (42) (1) (159) Exchange rate changes 1 27 3 — 31 As of December 31, 2024 (37) (728) (134) (43) (942) Net book value 3 1,678 453 12 2,146
Schedule of Indefinite-Lived Intangible Assets, Net	Indefinite-lived intangible assets are as follows: Trademarks (In $ millions) As of December 31, 2022 1,648 Dispositions ( Note 4 ) (14) Exchange rate changes 21 As of December 31, 2023 1,655 Impairment losses (117) Exchange rate changes (43) As of December 31, 2024 1,495
Schedule of Estimated Amortization Expense	Estimated amortization expense for the succeeding five fiscal years is as follows: (In $ millions) 2025 162 2026 162 2027 162 2028 162 2029 157

Current Other Liabilities (Tabl

Current Other Liabilities (Tables)	12 Months Ended
	Dec. 31, 2024
Other Liabilities, Current [Abstract]
Schedule of Current Other Liabilities	As of December 31, 2024 2023 (In $ millions) Benefit obligations ( Note 12 ) 25 25 Customer rebates 92 96 Derivatives ( Note 17 ) 93 90 Interest ( Note 11 ) 222 246 Legal ( Note 19 ) 10 34 Operating leases ( Note 16 ) 79 89 Restructuring ( Note 24 ) 63 18 Salaries and benefits 166 175 Sales and use tax/foreign withholding tax payable 150 128 Investment in affiliates ( Note 7 ) 98 96 Other 122 157 Total 1,120 1,154

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Schedule of Short-term Debt	As of December 31, 2024 2023 (In $ millions) Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates Current installments of long-term debt 1,393 1,025 Short-term borrowings, including amounts due to affiliates (1) 53 146 Revolving credit facilities (2) 55 212 Total 1,501 1,383 ______________________________ (1) The weighted average interest rate was 2.1% and 2.9% as of December 31, 2024 and 2023, respectively. (2) The weighted average interest rate was 3.1% and 3.4% as of December 31, 2024 and 2023, respectively.
Schedule of Long-term Debt	As of December 31, 2024 2023 (In $ millions) Long-Term Debt Senior unsecured notes due 2024, interest rate of 3.500% — 473 Senior unsecured notes due 2024, interest rate of 5.900% — 527 Senior unsecured notes due 2025, interest rate of 1.250% 311 331 Senior unsecured notes due 2025, interest rate of 6.050% 1,000 1,000 Senior unsecured notes due 2026, interest rate of 1.400% 400 400 Senior unsecured notes due 2026, interest rate of 4.777% 1,040 1,105 Senior unsecured notes due 2027, interest rate of 2.125% 518 551 Senior unsecured notes due 2027, interest rate of 6.165% 2,000 2,000 Senior unsecured term loan due 2027 (1) 880 880 Senior unsecured notes due 2028, interest rate of 0.625% 519 552 Senior unsecured notes due 2028, interest rate of 6.350% (2) 1,000 1,000 Senior unsecured notes due 2029, interest rate of 5.337% 519 552 Senior unsecured notes due 2029, interest rate of 6.330% 750 750 Senior unsecured notes due 2030, interest rate of 6.550% (2) 999 999 Senior unsecured notes due 2032, interest rate of 6.379% 1,000 1,000 Senior unsecured notes due 2033, interest rate of 6.700% (2) 1,000 1,000 Pollution control and industrial revenue bonds due at various dates through 2030 (3) 126 127 Bank loans due at various dates through 2030 (4) 320 5 Obligations under finance leases due at various dates through 2054 145 148 Subtotal 12,527 13,400 Unamortized deferred financing costs (5) (56) (74) Current installments of long-term debt (1,393) (1,025) Total 11,078 12,301 ______________________________ (1) The interest rate was 6.047% and 6.943% as of December 31, 2024 and 2023, respectively. (2) On November 14, 2024, S&P Global Ratings downgraded the Company's credit rating to BB+, which had the effect of increasing the interest rates by 25 basis points on the senior unsecured notes due 2028, senior unsecured notes due 2030 and senior unsecured notes due 2033 to 6.600%, 6.800% and 6.950%, respectively, effective November 15, 2024. (3) Interest rates range from 4.1% to 5.0%. (4) The weighted average interest rate was 2.8% and 2.6% as of December 31, 2024 and 2023, respectively. (5) Related to the Company's long-term debt, excluding obligations under finance leases.
Schedule of Balances Available for Borrowing	The Company's debt balances and amounts available for borrowing under its senior unsecured revolving credit facilities are as follows: As of (In $ millions) Revolving Credit Facility Borrowings outstanding — Available for borrowing 1,750 China Revolving Credit Facilities Borrowings outstanding 55 Available for borrowing 171
Schedule of Senior Unsecured Notes Offering	In August 2023, Celanese U.S. completed a public offering of senior unsecured notes registered under the Securities Act as follows (collectively, the "2023 Offering"): Maturity Date Aggregate Principal Discount to Par Interest Rate (In $ millions) November 15, 2028 1,000 99.986% 6.350% November 15, 2030 999 99.950% 6.550% November 15, 2033 1,000 99.992% 6.700%
Schedule of Cash Tender Offer	Also in August 2023, Celanese U.S. completed a cash tender offer for $2.25 billion in aggregate principal amount (the "Tender Offer") as follows: Maturity Date Aggregate Principal Amount Tendered Purchase price per $1,000 principal amount Total Tender Offer Consideration Accrued and Unpaid Interest (In $ millions) (In $ millions) July 5, 2024 1,473 $ 999.92 1,473 12 March 15, 2025 750 $ 1,002.85 752 20 May 8, 2024 27 $ 983.95 27 —
Schedule of Principal Payments	Principal payments scheduled to be made on the Company's debt, including short-term borrowings, are as follows: (In $ millions) 2025 1,501 2026 1,571 2027 3,599 2028 1,537 2029 1,287 Thereafter 3,140 Total 12,635

Benefit Obligations (Tables)

Benefit Obligations (Tables)	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Schedule of Contributions to Defined Contribution Plans	The amount of costs recognized for the Company's defined contribution plans are as follows: Year Ended December 31, 2024 2023 2022 (In $ millions) Defined contribution plans 79 83 62
Schedule of Company's Pension and Post Retirement Benefit Plans	Summarized information on the Company's pension and postretirement benefit plans is as follows: Pension Benefits Postretirement Benefits 2024 2023 2024 2023 (In $ millions) Change in Projected Benefit Obligation Projected benefit obligation as of beginning of period 2,923 2,858 40 38 Service cost 13 11 1 — Interest cost 125 132 1 2 Net actuarial (gain) loss (1) (31) 144 (1) 2 Divestiture (2) — (4) — — Settlements (9) (16) — — Benefits paid (227) (226) (4) (3) Curtailments (7) — (2) — Special termination benefits 1 — — — Exchange rate changes (50) 24 (1) 1 Projected benefit obligation as of end of period 2,738 2,923 34 40 Change in Plan Assets Fair value of plan assets as of beginning of period 2,652 2,625 — — Actual return on plan assets 66 213 — — Employer contributions 50 46 4 3 Divestiture (2) — (2) — — Settlements (9) (16) — — Benefits paid (3) (227) (226) (4) (3) Exchange rate changes (39) 12 — — Fair value of plan assets as of end of period 2,493 2,652 — — Funded status as of end of period (245) (271) (34) (40) Amounts Recognized in the Consolidated Balance Sheets Consist of: Noncurrent Other assets 135 166 — — Current Other liabilities (22) (22) (3) (3) Benefit obligations (358) (415) (31) (37) Net amount recognized (245) (271) (34) (40) Amounts Recognized in Accumulated Other Comprehensive Income Consist of: Net actuarial (gain) loss (4) 28 24 — — Prior service (benefit) cost — — (1) (1) Net amount recognized 28 24 (1) (1) ______________________________ (1) Primarily relates to changes in discount rates. (2) Represents plan obligations and assets contributed to the Nutrinova joint venture ( Note 4 ). (3) Includes benefit payments to nonqualified pension plans of $19 million and $20 million as of December 31, 2024 and 2023, respectively. (4) Relates to the pension plans of the Company's equity method investments.
Schedule of Percentage of US and International Projected Benefit Obligation	The percentage of U.S. and international projected benefit obligation at the end of the period is as follows: Pension Benefits Postretirement Benefits 2024 2023 2024 2023 (In percentages) U.S. plans 71 71 38 37 International plans 29 29 62 63 Total 100 100 100 100
Schedule of Percentage of US and International Fair Value of Plan Assets	The percentage of U.S. and international fair value of plan assets at the end of the period is as follows: Pension Benefits 2024 2023 (In percentages) U.S. plans 74 75 International plans 26 25 Total 100 100
Schedule of Pension Plans with Projected Benefit Obligations in Excess of Plan Assets	Pension plans with projected benefit obligations in excess of plan assets are as follows: As of December 31, 2024 2023 (In $ millions) Projected benefit obligation 711 788 Fair value of plan assets 332 352 Other postretirement plans with accumulated postretirement benefit obligations in excess of plan assets are as follows: As of December 31, 2024 2023 (In $ millions) Accumulated postretirement benefit obligation 34 40
Schedule of Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets	Pension plans with accumulated benefit obligations in excess of plan assets are as follows: As of December 31, 2024 2023 (In $ millions) Accumulated benefit obligation 691 738 Fair value of plan assets 332 329 Other postretirement plans with accumulated postretirement benefit obligations in excess of plan assets are as follows: As of December 31, 2024 2023 (In $ millions) Accumulated postretirement benefit obligation 34 40
Schedule of Accumulated Benefit Obligation for All Defined Benefit Pension Plans	The accumulated benefit obligation for all defined benefit pension plans is as follows: As of December 31, 2024 2023 (In $ millions) Accumulated benefit obligation 2,706 2,882
Schedule of Net Periodic Benefit Costs	The components of net periodic benefit cost are as follows: Pension Benefits Postretirement Benefits 2024 2023 2022 2024 2023 2022 (In $ millions) Service cost 13 11 12 1 — 1 Interest cost 125 132 67 1 2 1 Expected return on plan assets (135) (132) (166) — — — Recognized actuarial (gain) loss 38 63 91 (1) 3 (10) Curtailment (gain) loss (7) — — (2) — — Settlement (gain) loss — 1 — — — — Special termination benefit 1 — — — — — Total 35 75 4 (1) 5 (8)
Schedule of Nonqualified Pension Plans Funded with Nonqualified Trusts	The Company maintains nonqualified pension plans funded with nonqualified trusts for certain U.S. employees as follows: As of December 31, 2024 2023 (In $ millions) Nonqualified Trust Assets Marketable securities 6 5 Noncurrent Other assets, consisting of insurance contracts 18 21 Nonqualified Pension Obligations Current Other liabilities 18 18 Benefit obligations 136 149
Schedule of Expense Related to Nonqualified Pension Plans Included in Net Periodic Benefit Cost, Excluding Returns on Assets	(Income) expense relating to the nonqualified pension plans included in net periodic benefit cost, excluding returns on the assets held by the nonqualified trusts, is as follows: Year Ended December 31, 2024 2023 2022 (In $ millions) Total 6 16 (34)
Schedule of Principal Weighted Average Assumptions Used to Determine Benefit Obligations and Benefit Cost	The principal weighted average assumptions used to determine benefit obligation are as follows: Pension Benefits Postretirement Benefits 2024 2023 2024 2023 (In percentages) Discount Rate Obligations U.S. plans 5.6 5.1 5.5 5.1 International plans 3.1 3.1 4.4 4.1 Combined 4.8 4.5 4.8 4.5 Rate of Compensation Increase U.S. plans N/A N/A International plans 3.1 2.8 Combined 3.1 2.8 The principal weighted average assumptions used to determine net periodic benefit cost are as follows: Pension Benefits Postretirement Benefits 2024 2023 2022 2024 2023 2022 (In percentages) Discount Rate Obligations U.S. plans 5.1 5.5 2.8 5.1 5.4 2.7 International plans 3.1 3.4 1.4 4.1 4.7 2.4 Combined 4.5 4.9 2.5 4.5 5.1 2.5 Discount Rate Service Cost U.S. plans N/A N/A N/A 5.7 5.9 3.5 International plans 2.9 3.5 1.5 3.7 4.4 2.1 Combined 2.9 3.5 1.5 3.7 4.5 2.1 Discount Rate Interest Cost U.S. plans 5.1 5.4 2.2 5.1 5.3 2.0 International plans 3.0 3.4 1.2 4.1 4.7 2.1 Combined 4.5 4.8 2.0 4.4 5.0 2.1 Expected Return on Plan Assets U.S. plans 5.5 5.5 5.5 International plans 4.8 4.4 4.9 Combined 5.3 5.2 5.4 Rate of Compensation Increase U.S. plans N/A N/A N/A International plans 2.8 2.8 2.5 Combined 2.8 2.8 2.5 Interest Crediting Rate U.S. plans 4.1 4.3 1.9 International plans 1.4 1.0 1.0 Combined 4.0 4.3 1.9
Schedule of Health Care Cost Trend Rates	The Company's health care cost trend assumptions for U.S. postretirement medical plan's net periodic benefit cost are as follows: As of December 31, 2024 2023 2022 (In percentages, except year) Health care cost trend rate assumed for next year 7.0 7.3 7.5 Health care cost trend ultimate rate 5.0 5.0 5.0 Health care cost trend ultimate rate year 2032 2032 2032
Schedule of Weighted Average Target Asset Allocations	The weighted average target asset allocations for the Company's pension plans in 2024 are as follows: U.S. International (In percentages) Bonds - domestic to plans 84 38 Equities - domestic to plans 8 19 Equities - international to plans 8 8 Other — 35 Total 100 100
Schedule of Fair Values of Pension Plan Assets	Fair Value Measurement Quoted Prices in Significant Total As of December 31, 2024 2023 2024 2023 2024 2023 (In $ millions) Assets Cash and cash equivalents 12 7 — — 12 7 Derivatives Swaps — — 13 60 13 60 Equity securities U.S. companies 26 21 — — 26 21 International companies 126 148 — — 126 148 Fixed income Corporate debt — — 624 686 624 686 Treasuries, other debt 47 87 1,008 1,013 1,055 1,100 Mortgage backed securities — — 14 13 14 13 Insurance contracts — — 109 104 109 104 Other 3 3 21 19 24 22 Total investments, at fair value (1) 214 266 1,789 1,895 2,003 2,161 Liabilities Derivatives Swaps — — 13 60 13 60 Total liabilities — — 13 60 13 60 Total net assets (2) 214 266 1,776 1,835 1,990 2,101 ______________________________ (1) Certain investments that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy. Total investments, at fair value, for the year ended December 31, 2024 excludes investments in pooled-type investments, registered investment companies and short-term investment funds with fair values of $431 million, $34 million and $35 million, respectively. Total investments, at fair value, for the year ended December 31, 2023 excludes investments in pooled-type investments, registered investment companies and short-term investment funds with fair values of $460 million, $43 million and $31 million, respectively. (2) Total net assets excludes non-financial plan receivables and payables of $20 million and $17 million, respectively, as of December 31, 2024 and $22 million and $5 million, respectively, as of December 31, 2023. Non-financial items include due to/from broker, interest receivables and accrued expenses.
Schedule of Company Commitments to Fund Benefit Obligations	Benefit obligation funding is as follows: Total (In $ millions) Cash contributions to defined benefit pension plans 30 Benefit payments to nonqualified pension plans 18 Benefit payments to other postretirement benefit plans 3
Schedule of Pension Benefits Expected to be Paid from the Plans or From the Company's Assets	Pension and postretirement benefits expected to be paid are as follows: Pension Benefit Payments (1) Company Portion of Postretirement Benefit Cost (2) (In $ millions) 2025 235 3 2026 233 3 2027 227 3 2028 225 2 2029 225 2 2030-2034 1,017 10 ______________________________ (1) Payments are expected to be made primarily from plan assets. (2) Payments are expected to be made primarily from Company assets.

Environmental (Tables)

Environmental (Tables)	12 Months Ended
	Dec. 31, 2024
Environmental Remediation Obligations [Abstract]
Schedule of Environmental Remediation Reserves	The components of environmental remediation liabilities As of December 31, 2024 2023 (In $ millions) Demerger obligations ( Note 19 ) 14 14 Divestiture obligations ( Note 19 ) 14 13 Active sites 23 25 U.S. Superfund sites 10 8 Other environmental remediation liabilities 2 2 Total 63 62
Schedule of Environmental Ownership and Liability Percentages	The Company's ownership interest and environmental liability participation percentages for such liabilities, which cannot be attributed to an InfraServ partner are as follows: As of December 31, 2024 Ownership Liability Reserves (1) (In percentages) (In $ millions) InfraServ GmbH & Co. Gendorf KG 30 10 8 InfraServ GmbH & Co. Hoechst KG 31 42 61 Yncoris GmbH & Co. KG 22 23 1 ______________________________ (1) Gross reserves maintained by the respective entity.

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2024
Stockholders' Equity Note [Abstract]
Schedule of Treasury Stock	Total From Shares repurchased 69,324,429 Average purchase price per share $ 83.71 Amount spent on repurchased shares (in $ millions) $ 5,803 Aggregate Board of Directors repurchase authorizations during the period (in $ millions) $ 6,866
Schedule of Components of Other Comprehensive Income (Loss), Net	Year Ended December 31, 2024 2023 2022 Gross Income Net Gross Income Net Gross Income Net (In $ millions) Foreign currency translation (39) (60) (99) (275) 62 (213) (240) 23 (217) Gain (loss) on derivative hedges 2 (2) — (12) 6 (6) 26 (5) 21 Pension and postretirement benefits gain (loss) (5) — (5) (8) 1 (7) 7 — 7 Total (42) (62) (104) (295) 69 (226) (207) 18 (189)
Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net	Adjustments to Accumulated other comprehensive income (loss), net, are as follows: Foreign Gain (Loss) on Derivative Hedges ( Note 17 ) Pension and Postretirement Benefits Gain (Loss) ( Note 12 ) Accumulated (In $ millions) As of December 31, 2021 (271) (43) (15) (329) Other comprehensive income (loss) before reclassifications (240) 43 7 (190) Amounts reclassified from accumulated other comprehensive income (loss) — (17) — (17) Income tax (provision) benefit 23 (5) — 18 As of December 31, 2022 (488) (22) (8) (518) Other comprehensive income (loss) before reclassifications (275) (3) (8) (286) Amounts reclassified from accumulated other comprehensive income (loss) — (9) — (9) Income tax (provision) benefit 62 6 1 69 As of December 31, 2023 (701) (28) (15) (744) Other comprehensive income (loss) before reclassifications (39) 139 (5) 95 Amounts reclassified from accumulated other comprehensive income (loss) — (137) — (137) Income tax (provision) benefit (60) (2) — (62) As of December 31, 2024 (800) (28) (20) (848)

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Schedule of Earnings (Loss) from Continuing Operations Before Tax by Jurisdiction	Earnings (loss) from continuing operations before tax by jurisdiction are as follows: Year Ended December 31, 2024 2023 2022 (In $ millions) U.S. (2,269) (163) (292) International 1,273 1,346 1,713 Total (996) 1,183 1,421
Schedule of Income Tax Provision (Benefit)	The income tax provision (benefit) consists of the following: Year Ended December 31, 2024 2023 2022 (In $ millions) Current U.S. 79 8 54 International 239 162 306 Total 318 170 360 Deferred U.S. (87) (178) (261) International 279 (782) (588) Total 192 (960) (849) Total 510 (790) (489)
Schedule of Effective Tax Rate Reconciliation	A reconciliation of the significant differences between the U.S. federal statutory tax rate of 21% and the effective income tax rate on income from continuing operations is as follows: Year Ended December 31, 2024 2023 2022 (In $ millions, except percentages) Income tax provision computed at U.S. federal statutory tax rate (209) 248 298 Change in valuation allowance 370 (150) (15) Equity income and dividends (41) (27) (47) (Income) expense not resulting in tax impact, net 327 (9) 2 U.S. tax effect of foreign earnings and dividends 184 384 162 Foreign tax credits (137) (73) (120) Other foreign tax rate differentials (66) (108) (43) Legislative changes (6) (44) — State income taxes, net of federal benefit 12 (8) (2) Recognition of basis differences in investments in affiliates — — 6 Asset transfers between wholly owned foreign affiliates 87 (839) (816) Other, net (11) (164) 86 Income tax provision (benefit) 510 (790) (489) Effective income tax rate (51) % (67) % (34) %
Schedule of Consolidated Deferred Tax Assets and Liabilities	Significant components of the consolidated deferred tax assets and liabilities are as follows: As of December 31, 2024 2023 (In $ millions) Deferred Tax Assets Pension and postretirement obligations 58 61 Accrued expenses 59 56 Inventory 18 (13) Net operating loss carryforwards 752 783 Tax credit carryforwards 222 135 Intangibles and other 757 737 Subtotal 1,866 1,759 Valuation allowance (1) (1,106) (656) Total 760 1,103 Deferred Tax Liabilities Depreciation and amortization 152 152 Investments in affiliates 163 188 Other 127 85 Total 442 425 Net deferred tax assets (liabilities) 318 678 ______________________________ (1) Includes deferred tax asset valuation allowances for the Company's deferred tax assets in Switzerland, Luxembourg, the U.S., Spain, the Netherlands, the United Kingdom, Malta, Mexico, Germany, China, Singapore and France. These valuation allowances relate primarily to net operating loss carryforward benefits, foreign tax credit carryforwards and other net deferred tax assets, all of which may not be realizable.
Schedule of Unrecognized Tax Benefits Roll Forward	Activity related to uncertain tax positions is as follows: Year Ended December 31, 2024 2023 2022 (In $ millions) As of the beginning of the year 224 275 218 Increases (decreases) in tax positions for the current year (3) 10 8 Increases in tax positions for prior years 6 9 102 Decreases in tax positions for prior years (6) (35) (45) Increases (decreases) due to settlements (8) (35) (8) As of the end of the year 213 224 275 Total uncertain tax positions that if recognized would impact the effective tax rate 236 244 274 Total amount of interest expense (benefit) and penalties recognized in the consolidated statements of operations (1) 7 22 10 Total amount of interest expense and penalties recognized in the consolidated balance sheets 77 71 59 ______________________________ (1) This amount reflects interest on uncertain tax positions and release of tax positions due to changes in assessment, statute lapses or audit closures that were reflected in the consolidated statements of operations.

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Lease, Cost [Table Text Block]	The components of lease expense are as follows: Year Ended December 31, Statement of Operations Classification 2024 2023 2022 (In $ millions) Lease Cost Operating lease cost 99 99 66 Cost of sales / Selling, general and administrative expenses Short-term lease cost 18 19 19 Cost of sales / Selling, general and administrative expenses Variable lease cost 17 13 15 Cost of sales / Selling, general and administrative expenses Finance lease cost Amortization of leased assets 20 21 19 Cost of sales Interest on lease liabilities 8 10 11 Interest expense Sublease income — — 2 Other income (expense), net Total net lease cost 162 162 132
Assets and liabilities, lessee [Table Text Block]	Supplemental consolidated balance sheet information related to leases is as follows: As of December 31, Balance Sheet Classification 2024 2023 (In $ millions) Leases Assets Operating lease assets 388 422 Operating lease ROU assets Finance lease assets 119 154 Property, plant and equipment, net Total leased assets 507 576 Liabilities Current Operating 79 89 Current Other liabilities Finance 23 24 Short-term borrowings and current installments of long-term debt Noncurrent Operating 294 325 Operating lease liabilities Finance 122 124 Long-term debt Total lease liabilities 518 562
Supplemental lease information [Table Text Block]	As of December 31, 2024 2023 Weighted-Average Remaining Lease Term (years) Operating leases 8.4 8.6 Finance leases 7.7 7.8 Weighted-Average Discount Rate Operating leases 3.3 % 3.5 % Finance leases 5.6 % 6.2 %
CashFlowLessee [Table Text Block]	Supplemental consolidated cash flow information related to leases is as follows: Year Ended December 31, 2024 2023 2022 (In $ millions) Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases 90 92 52 Operating cash flows from finance leases 8 10 11 Financing cash flows from finance leases 24 24 25 ROU assets obtained in exchange for finance lease liabilities ( Note 20 ) 27 2 28 ROU assets obtained in exchange for operating lease liabilities 70 58 93
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	Maturities of lease liabilities are as follows: As of December 31, 2024 Operating Leases Finance Leases (In $ millions) 2025 90 30 2026 74 27 2027 49 23 2028 41 20 2029 39 19 Later years 131 71 Total lease payments 424 190 Less amounts representing interest (51) (45) Total lease obligations 373 145
Finance Lease, Liability, Maturity [Table Text Block]	Maturities of lease liabilities are as follows: As of December 31, 2024 Operating Leases Finance Leases (In $ millions) 2025 90 30 2026 74 27 2027 49 23 2028 41 20 2029 39 19 Later years 131 71 Total lease payments 424 190 Less amounts representing interest (51) (45) Total lease obligations 373 145

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Changes in Fair Value of Derivatives	Information regarding changes in the fair value of the Company's derivative and non-derivative instruments is as follows: Gain (Loss) Gain (Loss) Recognized Statement of Operations Classification Year Ended December 31, Year Ended December 31, 2024 2023 2022 2024 2023 2022 (In $ millions) Designated as Cash Flow Hedges Commodity swaps — (5) 39 (2) 2 23 Cost of sales Interest rate swaps — — — (7) (7) (7) Interest expense Foreign currency forwards — 5 2 — 5 1 Cost of sales Total — — 41 (9) — 17 Designated as Fair Value Hedges Cross-currency swaps (1) 142 (1) — 146 9 — Foreign exchange gain (loss), net Designated as Net Investment Hedges (2) Foreign currency denominated debt ( Note 11 ) 153 (106) (22) — — — N/A Cross-currency swaps ( Note 11 ) 147 (174) (92) — — — N/A Total 300 (280) (114) — — — Not Designated as Hedges Foreign currency forwards and swaps — — — (26) (19) (2) Foreign exchange gain (loss), net; Other income (expense), net ______________________________ (1) In conjunction with the 2023 Offering ( Note 11 ) in August 2023, the Company entered into a cross-currency swap to effectively convert $500 million of the issued notes into a Japanese yen-denominated borrowing at prevailing yen interest rates, maturing on July 15, 2029. The swap qualifies and has been designated as a fair value hedge of the Company's foreign currency exchange rate exposure on the long-term debt of its Japanese yen-denominated subsidiary. Additionally, in conjunction with the 2023 Offering ( Note 11 ) in August 2023, the Company entered into cross-currency swaps to effectively convert $1.0 billion of the issued notes into 5-year and 7-year euro-denominated borrowings at prevailing euro interest rates, maturing on November 15, 2028 and November 15, 2030, respectively. The swaps qualify and have been designated as fair value hedges of the Company's foreign currency exchange rate exposure on the long-term debt of its euro-denominated subsidiary. (2) Concurrently with the offering of certain unsecured notes in July 2022 ( Note 11 ), the Company entered into cross-currency swaps to effectively convert $2.0 billion and $500 million of the issued notes into a euro-denominated borrowing at prevailing euro interest rates, maturing on July 15, 2027 and July 15, 2032, respectively. The swaps and €1.5 billion of certain unsecured euro notes offered in July 2022 qualify and have been designated as net investment hedges of the Company's foreign currency exchange rate exposure on the net investments of certain of its euro-denominated subsidiaries. Additionally, on April 11, 2024, the Company entered into cross-currency swaps to effectively convert its $1.0 billion senior unsecured notes due 2033 ( Note 11 ) into Chinese yuan-denominated borrowings at prevailing yuan interest rates, maturing on November 15, 2033. The swaps qualify and have been designated as net investment hedges of the Company's foreign currency exchange rate exposure on the net investment of certain of its Chinese yuan-denominated subsidiaries.
Offsetting Assets	Information regarding the gross amounts of the Company's derivative instruments and the amounts offset in the consolidated balance sheets is as follows: As of December 31, 2024 2023 (In $ millions) Derivative Assets Gross amount recognized 250 183 Gross amount offset in the consolidated balance sheets — — Net amount presented in the consolidated balance sheets 250 183 Gross amount not offset in the consolidated balance sheets 38 40 Net amount 212 143
Offsetting Liabilities	As of December 31, 2024 2023 (In $ millions) Derivative Liabilities Gross amount recognized 273 440 Gross amount offset in the consolidated balance sheets — — Net amount presented in the consolidated balance sheets 273 440 Gross amount not offset in the consolidated balance sheets 38 40 Net amount 235 400
Schedule of Notional Amounts of Net Foreign Exchange Exposure by Currency	The total U.S. dollar equivalents of net foreign exchange exposure related to (short) long foreign exchange forward contracts outstanding by currency are as follows: 2025 Maturity (In $ millions) Currency Brazilian real (36) British pound sterling 86 Canadian dollar 13 Chinese yuan 438 Euro 229 Hungarian forint 14 Indian rupee (25) Indonesian rupiah (11) Japanese yen 22 Korean won 216 Mexican peso 107 Singapore dollar 34 Swedish krona (9) Swiss franc (313) Thai baht (8) Other (6) Total 751

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis	Fair Value Measurement Significant Other Observable Inputs (Level 2) Other assets Other liabilities Notional Amount Current Noncurrent Current Noncurrent (In millions) (In $ millions) As of December 31, 2024 Derivatives Designated as Cash Flow Hedges Commodity swaps $ 48 4 37 — — Derivatives Designated as Fair Value Hedges Cross-currency swaps $ 1,500 46 43 11 — Derivatives Designated as Net Investment Hedges Cross-currency swaps € 4,564 88 — 56 134 Cross-currency swaps ¥ 7,268 21 — 7 26 Derivatives Not Designated as Hedges Foreign currency forwards and swaps $ 2,777 11 — 19 20 Total 170 80 93 180 As of December 31, 2023 Derivatives Designated as Cash Flow Hedges Commodity swaps $ 67 5 36 2 — Derivatives Designated as Fair Value Hedges Cross-currency swaps $ 1,500 40 — 11 61 Derivatives Designated as Net Investment Hedges Cross-currency swaps € 5,712 93 — 61 281 Derivatives Not Designated as Hedges Foreign currency forwards and swaps $ 1,954 9 — 16 8 Total 147 36 90 350
Schedule of Carrying Values and Fair Values of Financial Instruments	Carrying values and fair values of financial instruments that are not carried at fair value are as follows: Fair Value Measurement Carrying Significant Unobservable Total As of December 31, 2024 2023 2024 2023 2024 2023 2024 2023 (In $ millions) Equity investments without readily determinable fair values 170 170 — — — — — — Insurance contracts in nonqualified trusts 18 21 18 21 — — 18 21 Long-term debt, including current installments of long-term debt 12,527 13,400 12,470 13,514 145 148 12,615 13,662

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	12 Months Ended
	Dec. 31, 2024
Supplemental Cash Flow Information [Abstract]
Schedule of Supplemental Cash Flow Information	Year Ended December 31, 2024 2023 2022 (In $ millions) Interest paid, net of amounts capitalized 701 780 122 Taxes paid, net of refunds 349 237 273 Noncash Investing and Financing Activities Accrued treasury stock repurchases — — (17) Finance lease obligations ( Note 16 ) 27 2 28 Accrued capital expenditures (21) (26) 40 Asset retirement obligations 2 11 3

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Schedule of Business Segments	Engineered Acetyl Chain Other Eliminations Consolidated (In $ millions) Year Ended December 31, 2024 Net sales 5,607 4,763 (1) — (90) 10,280 Cost of sales (4,371) (3,647) 4 90 (7,924) Gross profit 1,236 1,116 4 — 2,356 Selling, general and administrative expenses (434) (119) (477) — (1,030) Amortization of intangible assets (157) (2) — — (159) Research and development expenses (90) (40) — — (130) Other (charges) gains, net ( Note 24 ) (1,724) — (20) — (1,744) Gain (loss) on disposition of business and assets, net (10) (4) — — (14) Other segment items (2) — — 24 — 24 Operating profit (loss) (1,179) 951 (469) — (697) Depreciation and amortization 510 244 47 — 801 Equity in net earnings (loss) of affiliates 172 10 14 — 196 Capital expenditures 211 151 52 — 414 (3) As of December 31, 2024 Goodwill and intangible assets, net 8,617 411 — — 9,028 Total assets 15,496 5,265 2,096 — 22,857 Engineered Acetyl Chain Other Eliminations Consolidated (In $ millions) Year Ended December 31, 2023 Net sales 6,149 4,884 (1) — (93) 10,940 Cost of sales (4,825) (3,607) 2 93 (8,337) Gross profit 1,324 1,277 2 — 2,603 Selling, general and administrative expenses (435) (118) (522) — (1,075) Amortization of intangible assets (162) (2) — — (164) Research and development expenses (97) (40) (9) — (146) Other (charges) gains, net ( Note 24 ) (56) (4) (8) — (68) Gain (loss) on disposition of business and assets, net 509 (4) (4) — — 505 Other segment items (2) — — 32 — 32 Operating profit (loss) 1,083 1,109 (505) — 1,687 Depreciation and amortization 462 217 27 — 706 Equity in net earnings (loss) of affiliates 83 6 13 — 102 Capital expenditures 237 207 98 — 542 (3) As of December 31, 2023 Goodwill and intangible assets, net 10,525 427 — — 10,952 Total assets 17,930 5,538 3,129 — 26,597 Year Ended December 31, 2022 Net sales 4,024 5,743 (1) — (94) 9,673 Cost of sales (3,249) (4,130) (8) 94 (7,293) Gross profit 775 1,613 (8) — 2,380 Selling, general and administrative expenses (213) (125) (486) — (824) Amortization of intangible assets (57) (3) (2) — (62) Research and development expenses (71) (40) (1) — (112) Other (charges) gains, net ( Note 24 ) (7) — (1) — (8) Gain (loss) on disposition of business and assets, net 2 2 1 — 5 Other segment items (2) — — (1) — (1) Operating profit (loss) 429 1,447 (498) — 1,378 Depreciation and amortization 226 213 23 — 462 Equity in net earnings (loss) of affiliates 202 7 11 — 220 Capital expenditures 178 352 53 — 583 (3) ______________________________ (1) Includes intersegment sales of $90 million, $93 million and $94 million for the years ended December 31, 2024, 2023 and 2022, respectively. (2) Includes Foreign exchange gain (loss), net. (3) Includes a decrease in accrued capital expenditures of $21 million, a decrease in accrued capital expenditures of $26 million and an increase in accrued capital expenditures of $40 million for the years ended December 31, 2024, 2023 and 2022, respectively. (4) Includes a $515 million gain related to the formation of the Nutrinova joint venture included in Gain (loss) on disposition of businesses and assets, net in the consolidated statements of operations ( Note 4 ).
Schedule of Geographical Segments	The Net sales to external customers based on geographic location are as follows: Year Ended December 31, 2024 2023 2022 (In $ millions) Belgium 400 499 251 Brazil 140 140 122 Canada 127 146 120 Greater China 1,984 1,952 1,525 France 68 84 31 Germany 2,201 2,468 2,934 India 155 150 55 Italy 63 77 7 Japan 278 312 87 Mexico 344 361 359 Singapore 1,001 1,146 1,209 South Korea 140 154 68 Spain 50 58 11 Switzerland 294 223 165 United Kingdom 78 86 13 U.S. 2,748 2,821 2,562 Other 209 263 154 Total 10,280 10,940 9,673 Property, plant and equipment, net based on the geographic location of the Company's facilities is as follows: As of December 31, 2024 2023 (In $ millions) Belgium 60 112 Canada 121 121 Greater China 659 568 Germany 795 843 Italy 76 74 Japan 37 43 Mexico 42 44 Netherlands 49 48 Singapore 81 82 South Korea 70 64 Switzerland 57 58 United Kingdom 107 118 U.S. 3,001 3,286 Other 118 123 Total 5,273 5,584

Revenue Recognition (Tables)

Revenue Recognition (Tables)	12 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	Further disaggregation of Net sales by business segment and geographic destination is as follows: Year Ended December 31, 2024 2023 2022 (In $ millions) Engineered Materials North America 1,553 1,780 1,197 Europe and Africa 1,641 1,941 1,538 Asia-Pacific 2,272 2,274 1,180 South America 141 154 109 Total 5,607 6,149 4,024 Acetyl Chain North America 1,526 1,448 1,713 Europe and Africa 1,613 1,680 1,961 Asia-Pacific 1,415 1,543 1,811 South America 119 120 164 Total (1) 4,673 4,791 5,649 ______________________________ (1) Excludes intersegment sales of $90 million, $93 million and $94 million for the years ended December 31, 2024, 2023 and 2022, respectively.

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	12 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Schedule of Earnings (Loss) Per Share	Year Ended December 31, 2024 2023 2022 (In $ millions, except share data) Amounts attributable to Celanese Corporation Earnings (loss) from continuing operations (1,514) 1,969 1,902 Earnings (loss) from discontinued operations (8) (9) (8) Net earnings (loss) (1,522) 1,960 1,894 Weighted average shares - basic 109,273,779 108,848,962 108,380,082 Incremental shares attributable to equity awards (1) — 530,702 855,294 Weighted average shares - diluted 109,273,779 109,379,664 109,235,376 ______________________________ (1) Excludes options to purchase 265,922, 202,876 and 0 shares of Common Stock for the years ended December 31, 2024, 2023 and 2022, respectively, as their effect would have been antidilutive. Excludes 61, 39,465 and 154,172 equity award shares for the years ended December 31, 2024, 2023 and 2022, respectively, as their effect would have been antidilutive. For the year ended December 31, 2024, the Company incurred a net loss from continuing operations, resulting in 239,886 incremental shares attributable to equity awards being excluded from the number of weighted average shares - diluted as their effect would have been antidilutive.

Other (Charges) Gains, Net (Tab

Other (Charges) Gains, Net (Tables)	12 Months Ended
	Dec. 31, 2024
Restructuring and Related Activities [Abstract]
Schedule of Other (Charges) Gains, Net	Year Ended December 31, 2024 2023 2022 (In $ millions) Restructuring (1) (107) (52) (6) Asset impairments (1,639) (2) (15) (14) Plant/office closures 2 (1) 12 Total (1,744) (68) (8) ______________________________ (1) Includes employee termination benefits related to the previously announced closure of the Company's facility in Mechelen, Belgium ( Note 4 ) and the previously announced closure of its polymerization units in Uentrop, Germany ( Note 4 ) for the year ended December 31, 2024, and employee termination benefits primarily related to Company-wide business optimization projects during the years ended December 31, 2024 and 2023. (2) Primarily related to non-cash impairment losses on goodwill and certain trade names, primarily Zytel ® , arising from the Company's goodwill and indefinite-lived intangible assets impairment tests ( Note 9 ).
Schedule of Restructuring Reserve	The changes in the restructuring liabilities by business segment are as follows: Engineered Acetyl Other Total (In $ millions) Employee Termination Benefits As of December 31, 2023 13 2 3 18 Additions 89 1 16 106 Cash payments (40) (2) (13) (55) Other changes (2) (1) — (3) Exchange rate changes (3) — — (3) As of December 31, 2024 57 — 6 63

Description of the Company an_2

Description of the Company and Basis of Presentation (Narrative) (Details)	Dec. 31, 2024
Consolidated Ventures
Schedule of Equity Method Investments [Line Items]
Noncontrolling interest, ownership percentage by parent	100%

Summary of Accounting Policie_3

Summary of Accounting Policies (Pension and Other Postretirement Obligations) (Details)	Dec. 31, 2024
Accounting Policies [Abstract]
Number of Aa-grade non-callable bonds	400

Summary of Accounting Policie_4

Summary of Accounting Policies (Variable Interest Entities) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Schedule of Investments [Line Items]
Total assets	$ 22,857	$ 26,597
Property, plant and equipment (net of accumulated depreciation - 2024: $4,562; 2023: $4,080)	$ 5,273	5,584
Variable Interest Entity, Primary Beneficiary
Schedule of Investments [Line Items]
Ownership percentage	50%
Total assets	$ 574	626
Property, plant and equipment (net of accumulated depreciation - 2024: $4,562; 2023: $4,080)	491	529
Variable Interest Entity, Not Primary Beneficiary
Schedule of Investments [Line Items]
Maximum exposure to loss	$ 208	$ 208

Summary of Accounting Policie_5

Summary of Accounting Policies (Schedule of Estimated Useful Lives of Depreciable Assets) (Details)	Dec. 31, 2024
Land improvements
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	20 years
Buildings and improvements
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	30 years
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	20 years
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]	Useful Life, Shorter of Lease Term or Asset Utility [Member]
Maximum | Leasehold Improvements
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	10 years

Summary of Accounting Policie_6

Summary of Accounting Policies (Definite-lived Intangible Asset Narrative) (Details)	Dec. 31, 2024
Minimum
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	8 years
Maximum
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	30 years

Summary of Accounting Policie_7

Summary of Accounting Policies (Environmental Liabilities Narrative) (Details)	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Environmental liabilities accrual period	15 years

Summary of Accounting Policie_8

Summary of Accounting Policies Summary of Accounting Policies (Revenue Recognition) (Details) $ in Millions	Dec. 31, 2024 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 936
Contract with Customer, Asset, after Allowance for Credit Loss	0
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 451
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 249
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 128
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year

Summary of Accounting Policie_9

Summary of Accounting Policies Summary of Accounting Policies (Leases) (Details)	Dec. 31, 2024
Minimum
Property, Plant and Equipment [Line Items]
Lessee, Operating Lease, Renewal Term	1 year
Maximum
Property, Plant and Equipment [Line Items]
Lessee, Operating Lease, Renewal Term	30 years

Acquisitions, Dispositions an_3

Acquisitions, Dispositions and Plant Closures (Narrative) (Details) $ in Millions		1 Months Ended	2 Months Ended	12 Months Ended
	Nov. 01, 2022 USD ($) employees patent facility	Sep. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Business Acquisition [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax				$ 10,280	$ 10,940	$ 9,673
Earnings (loss) from continuing operations before tax				(996)	1,183	1,421
Gain (loss) on disposition of businesses and assets, net				(14)	505	5
Engineered Materials
Business Acquisition [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax				$ 5,607	6,149	4,024
Nutrinova Joint Venture
Business Acquisition [Line Items]
Gain (loss) on disposition of businesses and assets, net					$ 515
Celanese Corporation | Nutrinova Joint Venture
Business Acquisition [Line Items]
Equity Method Investment, Ownership Percentage		30%
Mitsui & Co. Ltd. | Nutrinova Joint Venture
Business Acquisition [Line Items]
Equity Method Investment, Ownership Percentage		70%
Proceeds from sale of businesses and assets, net		$ 503
Mobility & Materials
Business Acquisition [Line Items]
Business acquisition, percentage of voting interests acquired	100%
Payments to acquire businesses, gross	$ 11,000
Number of facilities | facility	29
Number of patents | patent	850
Entity number of employees | employees	5,000
Business Combination, Pro Forma Information, Interest Expense and Debt Issuance Cost Amortization						366
Net total inventory step up, amortization to cost of sales						66
Revenue from Contract with Customer, Excluding Assessed Tax			$ 430
Earnings (loss) from continuing operations before tax			(80)
Mobility & Materials | Selling, General and Administrative Expenses
Business Acquisition [Line Items]
Business combination, acquisition related costs						117
Mobility & Materials | Acquisition Notes
Business Acquisition [Line Items]
Senior unsecured notes			$ 9,000			$ 9,000

Acquisitions, Dispositions an_4

Acquisitions, Dispositions and Plant Closures (Business Acquisition, Pro Forma Information) (Details) - Mobility & Materials $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($)
Business Acquisition [Line Items]
Proforma Net sales	$ 12,614
Proforma Earnings (loss) from continuing operations before tax	$ 888

Acquisitions, Dispositions an_5

Acquisitions, Dispositions and Plant Closures (Schedule of Restructuring and Related Costs) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024		Dec. 31, 2023	Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]
One Time Termination Benefits		$ 107	[1]	$ 52	$ 6
Uentrop, Germany | Engineered Materials
Restructuring Cost and Reserve [Line Items]
One Time Termination Benefits	[2]	16
Accelerated depreciation expense(2)	[3]	36
Plant Shutdown Costs		52
Mechelen, Belgium | Engineered Materials
Restructuring Cost and Reserve [Line Items]
One Time Termination Benefits	[4]	55
Accelerated depreciation expense(2)	[5]	35
Plant Shutdown Costs		90
Restructuring and Related Cost, Expected Cost		$ 20
[1] Includes employee termination benefits related to the previously announced closure of the Company's facility in Mechelen, Belgium ( Note 4 ) and the previously announced closure of its polymerization units in Uentrop, Germany ( Note 4 ) for the year ended December 31, 2024, and employee termination benefits primarily related to Company-wide business optimization projects during the years ended December 31, 2024 and 2023. Included in Other (charges) gains, net in the consolidated statements of operations ( Note 24 ). Included in Cost of sales in the consolidated statements of operations. Included in Other (charges) gains, net in the consolidated statements of operations ( Note 24 ). Included in Cost of sales in the consolidated statements of operations.

Receivables, Net Receivables,_2

Receivables, Net Receivables, Net (Schedule of Trade Receivables - Third Party and Affiliates, Net) (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Receivables [Abstract]
Trade receivables - third party and affiliates	$ 1,137	$ 1,255
Allowance for doubtful accounts - third party and affiliates	(16)	(12)
Trade receivables - third party and affiliates, net	$ 1,121	$ 1,243

Receivables, Net Receivables,_3

Receivables, Net Receivables, Net (Schedule of Non-trade Receivables, Net) (Details) - USD ($) $ in Millions		Dec. 31, 2024	Dec. 31, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-income taxes receivable		$ 266	$ 270
Income taxes receivable		53	57
Other(1)	[1]	174	214
Non-trade receivables, net		$ 493	541
Mobility & Materials
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other(1)			$ 42
[1] Includes $42 million of non-trade receivables related to the M&M Acquisition as of December 31, 2023.

Inventories (Details)

Inventories (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Finished goods	$ 1,605	$ 1,604
Work-in-process	119	160
Raw materials and supplies	560	593
Total	$ 2,284	$ 2,357

Investments in Affiliates (Narr

Investments in Affiliates (Narrative) (Details)	Dec. 31, 2024 Investment
Investments in and Advances to Affiliates [Line Items]
Number of Equity Method Investments	14
Number of Equity Method Investments Without Readily Determinable Fair Values	4
Minimum | Other Equity Method Investment, Investees
Investments in and Advances to Affiliates [Line Items]
Equity Method Investment, Ownership Percentage	22%
Minimum | Other equity securities without readily determinable fair value investee [Member]
Investments in and Advances to Affiliates [Line Items]
Ownership percentage	8%
Maximum | Other Equity Method Investment, Investees
Investments in and Advances to Affiliates [Line Items]
Equity Method Investment, Ownership Percentage	50%
Maximum | Other equity securities without readily determinable fair value investee [Member]
Investments in and Advances to Affiliates [Line Items]
Ownership percentage	31%

Investments in Affiliates (Sche

Investments in Affiliates (Schedule of Equity Method Investments) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Equity Method Investments [Line Items]
Carrying value		$ 949	$ 954
Equity in net earnings (loss) of affiliates		196	102	$ 220
Dividends and other distributions		(160)	(157)	(217)
Engineered Materials
Schedule of Equity Method Investments [Line Items]
Carrying value	[1]	893	898
Equity in net earnings (loss) of affiliates	[1]	182	88	209
Dividends and other distributions	[1]	(149)	(145)	(204)
Other Activities
Schedule of Equity Method Investments [Line Items]
Carrying value		56	56
Equity in net earnings (loss) of affiliates		14	14	11
Dividends and other distributions		$ (11)	$ (12)	$ (13)
[1] Engineered Materials includes an equity method investment with losses in excess of its carrying amount due to the Company's guarantee of various debt obligations under agreements with third parties related to an equity affiliate ( Note 19 ). This equity method investment was recorded in Current Other liabilities ( Note 10 ) as of December 31, 2024 and 2023.

Investments in Affiliates (Sc_2

Investments in Affiliates (Schedule of Equity Securities Without Readily Determinable Fair Value) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Investments in and Advances to Affiliates [Line Items]
Carrying Value	$ 170	$ 170
Dividend income - equity investments	128	126	$ 133
Acetyl Chain
Investments in and Advances to Affiliates [Line Items]
Carrying Value	165	165
Dividend income - equity investments	127	125	132
Other Activities
Investments in and Advances to Affiliates [Line Items]
Carrying Value	5	5
Dividend income - equity investments	$ 1	$ 1	$ 1

Investments in Affiliates (Sc_3

Investments in Affiliates (Schedule of Transactions with Affiliates) (Details) - Related Party - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Investments in and Advances to Affiliates, Activity [Line Items]
Purchases	$ 452	$ 490	$ 590
Sales and other credits	$ 89	$ 212	$ 72

Investments in Affiliates (Sc_4

Investments in Affiliates (Schedule of Balances with Affiliates) (Details) - USD ($) $ in Millions		Dec. 31, 2024	Dec. 31, 2023
Investments in and Advances to Affiliates, Activity [Line Items]
Trade receivables - third party and affiliates		$ 1,121	$ 1,243
Non-trade receivables, net		493	541
Current notes receivables	[1]	174	214
Short-term borrowings and current installments of long-term debt - third party and affiliates		1,501	1,383
Trade payables - third party and affiliates		1,228	1,510
Other liabilities		1,120	1,154
Total due to affiliates		3,853	4,072
Related Party
Investments in and Advances to Affiliates, Activity [Line Items]
Trade receivables - third party and affiliates		11	7
Non-trade receivables, net		30	40
Current notes receivables		65	57
Total due from affiliates		106	104
Short-term borrowings and current installments of long-term debt - third party and affiliates	[2]	37	23
Trade payables - third party and affiliates		25	52
Other liabilities		34	34
Total due to affiliates		$ 96	$ 109
[1] Includes $42 million of non-trade receivables related to the M&M Acquisition as of December 31, 2023. The Company has agreements with certain affiliates whereby excess affiliate cash is lent to and managed by the Company at variable interest rates governed by those agreements.

Property, Plant and Equipment_3

Property, Plant and Equipment, Net (Schedule of Property, Plant and Equipment, Net) (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Gross asset value	$ 9,835	$ 9,664
Accumulated depreciation	(4,562)	(4,080)
Net book value	5,273	5,584
Land
Property, Plant and Equipment [Line Items]
Gross asset value	240	260
Land improvements
Property, Plant and Equipment [Line Items]
Gross asset value	91	85
Buildings and building improvements
Property, Plant and Equipment [Line Items]
Gross asset value	1,059	1,082
Machinery and equipment
Property, Plant and Equipment [Line Items]
Gross asset value	7,745	7,157
Construction in progress
Property, Plant and Equipment [Line Items]
Gross asset value	$ 700	$ 1,080

Property, Plant and Equipment_4

Property, Plant and Equipment, Net (Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Finance lease, right-of-use asset	$ 119	$ 154

Property, Plant and Equipment_5

Property, Plant and Equipment, Net (Schedule of Capitalized Interest and Depreciation Expense) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment, Net [Abstract]
Capitalized interest	$ 30	$ 37	$ 18
Depreciation expense	$ 640	$ 540	$ 399

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, Net (Schedule of Goodwill) (Details) - USD ($) $ in Thousands		3 Months Ended	9 Months Ended		12 Months Ended
		Dec. 31, 2024	Sep. 30, 2024		Dec. 31, 2024		Dec. 31, 2023
Goodwill
Goodwill, beginning balance			$ 6,977,000	[1]	$ 6,977,000	[1]	$ 7,142,000
Acquisitions							(107,000)
Dispositions							(80,000)
Impairment losses			0		(1,517,000)
Exchange rate changes					(73,000)		22,000
Goodwill, ending balance	[1]	$ 5,387,000			5,387,000		6,977,000
Accumulated impairment losses							0
Engineered Materials
Goodwill
Goodwill, beginning balance			6,602,000	[1]	6,602,000	[1]	6,775,000
Acquisitions							(107,000)
Dispositions							(80,000)
Impairment losses		1,500,000			(1,517,000)
Exchange rate changes					(60,000)		14,000
Goodwill, ending balance	[1]	5,025,000			5,025,000		6,602,000
Accumulated impairment losses		(1,500,000)			(1,500,000)
Acetyl Chain
Goodwill
Goodwill, beginning balance			$ 375,000	[1]	375,000	[1]	367,000
Acquisitions							0
Dispositions							0
Impairment losses					0
Exchange rate changes					(13,000)		8,000
Goodwill, ending balance	[1]	$ 362,000			$ 362,000		$ 375,000
[1] Includes accumulated impairment losses of $1.5 billion in the Engineered Materials segment as of December 31, 2024. There were no accumulated impairment losses as of December 31, 2023.

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, Net (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended	12 Months Ended
	Dec. 31, 2024	Sep. 30, 2024	Sep. 30, 2024	Dec. 31, 2024
Indefinite-lived Intangible Assets [Line Items]
Impairment losses			$ 0	$ 1,517,000
Renewals				0
Maximum | Engineered Materials
Indefinite-lived Intangible Assets [Line Items]
Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount		10%	10%
Trademarks and Trade Names [Member]
Indefinite-lived Intangible Assets [Line Items]
Impairment loss (Note 2)				117,000
Engineered Materials
Indefinite-lived Intangible Assets [Line Items]
Impairment losses	$ (1,500,000)			$ 1,517,000
Engineered Materials | Trademarks and Trade Names [Member]
Indefinite-lived Intangible Assets [Line Items]
Impairment loss (Note 2)	$ 83,000	$ 34,000

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets, Net (Schedule of Finite-Lived Intangible Assets, Net) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Finite-Lived intangible Assets Rollforward
Gross asset value	$ 3,134	$ 3,153
Disposition		(61)
Exchange rate changes	(46)	42
Gross asset value	3,088	3,134	$ 3,153
Accumulated amortization	(814)	(696)
Amortization of Intangible Assets	(159)	(164)	(62)
Disposition (Note 4)		60
Exchange rate changes	(31)	(14)
Accumulated amortization	(942)	(814)	(696)
Net book value	2,146
Licenses
Finite-Lived intangible Assets Rollforward
Gross asset value	41	42
Disposition		0
Exchange rate changes	(1)	(1)
Gross asset value	40	41	42
Accumulated amortization	(38)	(39)
Amortization of Intangible Assets	0	0
Disposition (Note 4)		0
Exchange rate changes	(1)	1
Accumulated amortization	(37)	(38)	(39)
Net book value	3
Customer- Related Intangible Assets
Finite-Lived intangible Assets Rollforward
Gross asset value	2,437	2,455
Disposition		(60)
Exchange rate changes	(31)	42
Gross asset value	2,406	2,437	2,455
Accumulated amortization	(639)	(567)
Amortization of Intangible Assets	(116)	(120)
Disposition (Note 4)		59
Exchange rate changes	(27)	(11)
Accumulated amortization	(728)	(639)	(567)
Net book value	1,678
Developed Technology
Finite-Lived intangible Assets Rollforward
Gross asset value	601	601
Disposition		(1)
Exchange rate changes	(14)	1
Gross asset value	587	601	601
Accumulated amortization	(95)	(50)
Amortization of Intangible Assets	(42)	(43)
Disposition (Note 4)		1
Exchange rate changes	(3)	(3)
Accumulated amortization	(134)	(95)	(50)
Net book value	453
Covenants Not to Compete and Other
Finite-Lived intangible Assets Rollforward
Gross asset value	55	55
Disposition		0
Exchange rate changes	0	0
Gross asset value	55	55	55
Accumulated amortization	(42)	(40)
Amortization of Intangible Assets	(1)	(1)
Disposition (Note 4)		0
Exchange rate changes	0	(1)
Accumulated amortization	(43)	$ (42)	$ (40)
Net book value	$ 12

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets, Net (Schedule of Indefinite-Lived Intangible Assets, Net) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Gross Asset Value
Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Nonrecurring (Income) Expense
Trademarks and Trade Names [Member]
Gross Asset Value
Gross asset value, beginning balance	$ 1,655	$ 1,648
Indefinite-Lived Intangible Assets, Transferred		(14)
Exchange rate changes	43	21
Impairment loss (Note 2)	(117)
Gross asset value, ending balance	$ 1,495	$ 1,655

Goodwill and Intangible Asset_7

Goodwill and Intangible Assets, Net (Schedule of Finite-Lived Intangible Assets, Future Amortization Expense) (Details) $ in Millions	Dec. 31, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2025	$ 162
2026	162
2027	162
2028	162
2029	$ 157

Current Other Liabilities (Deta

Current Other Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Other Liabilities, Current [Abstract]
Benefit obligations (Note 12)	$ 25	$ 25
Customer rebates	92	96
Derivatives (Note 17)	93	90
Interest (Note 11)	222	246
Legal (Note 19)	10	34
Operating leases (Note 16)	79	89
Restructuring (Note 24)	63	18
Salaries and benefits	166	175
Sales and use tax/foreign withholding tax payable	150	128
Investment in affiliates (Note 7)	98	96
Other	122	157
Total	$ 1,120	$ 1,154

Debt (Schedule of Short-term De

Debt (Schedule of Short-term Debt) (Details) - USD ($) $ in Millions		Dec. 31, 2024	Dec. 31, 2023
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates
Current installments of long-term debt		$ 1,393	$ 1,025
Short-term borrowings, including amounts due to affiliates(1)	[1]	53	146
Total		1,501	1,383
Revolving Credit Facility
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates
Revolving credit facilities(2)	[2]	$ 55	$ 212
Weighted average interest rate, short-term borrowings		3.10%	3.40%
Short-term Debt [Member]
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates
Weighted average interest rate, short-term borrowings		2.10%	2.90%
Revolving Credit Facility | Revolving Credit Facility
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates
Revolving credit facilities(2)		$ 0
[1] The weighted average interest rate was 2.1% and 2.9% as of December 31, 2024 and 2023, respectively. The weighted average interest rate was 3.1% and 3.4% as of December 31, 2024 and 2023, respectively.

Debt (Schedule of Long-term Deb

Debt (Schedule of Long-term Debt) (Details) - USD ($) $ in Millions		Feb. 12, 2025	Nov. 15, 2024	Dec. 31, 2024		Dec. 31, 2023	Aug. 31, 2023
Debt Instrument [Line Items]
Obligations under finance leases due at various dates through 2054				$ 145		$ 148
Subtotal				12,527		13,400
Unamortized deferred financing costs(5)	[1]			(56)		(74)
Current installments of long-term debt				(1,393)		(1,025)
Long-term debt, net of unamortized deferred financing costs				11,078		12,301
Senior unsecured notes due 2024, interest rate of 3.500%
Debt Instrument [Line Items]
Senior unsecured notes				$ 0		473
Interest Rate				3.50%
Senior unsecured notes due 2024, interest rate of 5.900%
Debt Instrument [Line Items]
Senior unsecured notes				$ 0		527
Interest Rate				5.90%
Senior unsecured notes due 2025, interest rate of 1.250%
Debt Instrument [Line Items]
Senior unsecured notes				$ 311		331
Interest Rate				1.25%
Senior unsecured notes due 2025, interest rate of 6.050%
Debt Instrument [Line Items]
Senior unsecured notes				$ 1,000		1,000
Interest Rate				6.05%
Senior unsecured notes due 2026, interest rate of 1.400%
Debt Instrument [Line Items]
Senior unsecured notes				$ 400		400
Interest Rate				1.40%
Senior unsecured notes due 2026, interest rate of 4.777%
Debt Instrument [Line Items]
Senior unsecured notes				$ 1,040		1,105
Interest Rate				4.777%
Senior unsecured notes due 2027, interest rate of 2.125%
Debt Instrument [Line Items]
Senior unsecured notes				$ 518		551
Interest Rate				2.125%
Senior unsecured notes due 2027, interest rate of 6.165%
Debt Instrument [Line Items]
Senior unsecured notes				$ 2,000		2,000
Interest Rate				6.165%
Senior unsecured term loan due 2027(1)
Debt Instrument [Line Items]
Senior unsecured notes	[2]			$ 880		$ 880
Interest Rate				6.047%		6.943%
Senior unsecured notes due 2028, interest rate of 0.625%
Debt Instrument [Line Items]
Senior unsecured notes				$ 519		$ 552
Interest Rate				0.625%
Senior unsecured notes due 2028, interest rate of 6.350%(2)
Debt Instrument [Line Items]
Senior unsecured notes				$ 1,000	[3]	1,000
Interest Rate			6.60%	6.35%			6.35%
Debt Instrument, Interest Rate, Increase (Decrease)			0.25%
Senior unsecured notes due 2029, interest rate of 5.337%
Debt Instrument [Line Items]
Senior unsecured notes				$ 519		552
Interest Rate				5.337%
Senior unsecured notes due 2029, interest rate of 6.330%
Debt Instrument [Line Items]
Senior unsecured notes				$ 750		750
Interest Rate				6.33%
Senior unsecured notes due 2030, interest rate of 6.550%(2)
Debt Instrument [Line Items]
Senior unsecured notes				$ 999	[3]	999
Interest Rate			6.80%	6.55%			6.55%
Debt Instrument, Interest Rate, Increase (Decrease)			0.25%
Senior unsecured notes due 2032, interest rate of 6.379%
Debt Instrument [Line Items]
Senior unsecured notes				$ 1,000		1,000
Interest Rate				6.379%
Senior unsecured notes due 2033, interest rate of 6.700%(2)
Debt Instrument [Line Items]
Senior unsecured notes				$ 1,000	[3]	1,000
Interest Rate			6.95%	6.70%			6.70%
Debt Instrument, Interest Rate, Increase (Decrease)			0.25%
Pollution control and industrial revenue bonds due at various dates through 2030(3)
Debt Instrument [Line Items]
Other Long-term debt	[4]			$ 126		127
Pollution control and industrial revenue bonds due at various dates through 2030(3) | Minimum
Debt Instrument [Line Items]
Interest Rate				4.10%
Pollution control and industrial revenue bonds due at various dates through 2030(3) | Maximum
Debt Instrument [Line Items]
Interest Rate				5%
Bank loans due at various dates through 2030(4)
Debt Instrument [Line Items]
Other Long-term debt	[5]			$ 320		$ 5
Long-term Debt, Weighted Average Interest Rate, at Point in Time				2.80%		2.60%
Various senior notes | Maximum | Subsequent Event [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Increase (Decrease)		0.50%
US Credit Agreements | Subsequent Event [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Increase (Decrease)		0.25%
[1] Related to the Company's long-term debt, excluding obligations under finance leases. The interest rate was 6.047% and 6.943% as of December 31, 2024 and 2023, respectively. On November 14, 2024, S&P Global Ratings downgraded the Company's credit rating to BB+, which had the effect of increasing the interest rates by 25 basis points on the senior unsecured notes due 2028, senior unsecured notes due 2030 and senior unsecured notes due 2033 to 6.600%, 6.800% and 6.950%, respectively, effective November 15, 2024. Interest rates range from 4.1% to 5.0%. The weighted average interest rate was 2.8% and 2.6% as of December 31, 2024 and 2023, respectively.

Debt (Senior Credit Facilities

Debt (Senior Credit Facilities Narrative) (Details) ¥ in Millions, $ in Millions

1 Months Ended

3 Months Ended

12 Months Ended

Feb. 11, 2025 USD ($)

Feb. 06, 2025 USD ($)

Nov. 01, 2024 USD ($)

Mar. 31, 2022 USD ($)

Jan. 31, 2023 CNY (¥)

Mar. 31, 2024 CNY (¥)

Dec. 31, 2024

Dec. 19, 2024 CNY (¥)

Dec. 10, 2024 CNY (¥)

Jun. 28, 2024 CNY (¥)

Apr. 07, 2024 CNY (¥)

Dec. 31, 2023 CNY (¥)

Mar. 31, 2023 USD ($)

5 Year Delayed-Draw Term Loan | Term Loan Facility

Debt Instrument [Line Items]

Debt Instrument, Term

5 years

Debt Instrument, Face Amount | $

$ 1,000

Revolving Credit Facility | Revolving Credit Facility

Debt Instrument [Line Items]

Line of Credit Facility, Maximum Borrowing Capacity | $

$ 1,750

Revolving Credit Facility | Revolving Credit Facility | Subsequent Event [Member]

Debt Instrument [Line Items]

Proceeds from Lines of Credit | $

$ 300

Revolving Credit Facility | Revolving Credit Facility | Minimum | Variable Interbank Interest Rate

Debt Instrument [Line Items]

Debt Instrument, Basis Spread on Variable Rate

1%

Revolving Credit Facility | Revolving Credit Facility | Maximum | Variable Interbank Interest Rate

Debt Instrument [Line Items]

Debt Instrument, Basis Spread on Variable Rate

2%

China Revolving Credit Facility | Revolving Credit Facility

Debt Instrument [Line Items]

Line of Credit Facility, Maximum Borrowing Capacity

¥ 1,750

China Revolving Credit Facilities | Revolving Credit Facility

Debt Instrument [Line Items]

Line of Credit Facility, Maximum Borrowing Capacity

¥ 550

¥ 750

China Working Capital Term Loan | China Working Capital Term Loan

Debt Instrument [Line Items]

Debt Instrument, Term

12 months

Debt Instrument, Face Amount

¥ 800

Repayments of Debt

¥ 800

China Working Capital Term Loan | Variable Interbank Interest Rate | China Working Capital Term Loan

Debt Instrument [Line Items]

Debt Instrument, Basis Spread on Variable Rate

0.50%

Bank Loan due 2026 | CNC Working Capital Loan

Debt Instrument [Line Items]

Debt Instrument, Face Amount

¥ 800

Interest Rate

2.80%

CNC Three Year Working Capital Loan | CNC Three Year Working Capital Loan

Debt Instrument [Line Items]

Debt Instrument, Face Amount

¥ 800

Interest Rate

2.75%

November 2024 US Term Loan Credit Agreement | Term Loan Facility

Debt Instrument [Line Items]

Debt Instrument, Term

364 days

Debt Instrument, Face Amount | $

$ 1,000

November 2024 US Term Loan Credit Agreement | Minimum | Term SOFR | Term Loan Facility

Debt Instrument [Line Items]

Debt Instrument, Basis Spread on Variable Rate

1.30%

November 2024 US Term Loan Credit Agreement | Minimum | Base Rate | Term Loan Facility

Debt Instrument [Line Items]

Debt Instrument, Basis Spread on Variable Rate

0.30%

November 2024 US Term Loan Credit Agreement | Maximum | Term SOFR | Term Loan Facility

Debt Instrument [Line Items]

Debt Instrument, Basis Spread on Variable Rate

2.25%

November 2024 US Term Loan Credit Agreement | Maximum | Base Rate | Term Loan Facility

Debt Instrument [Line Items]

Debt Instrument, Basis Spread on Variable Rate

1.25%

CNC December 2024 Facility | Revolving Credit Facility

Debt Instrument [Line Items]

Debt Instrument, Face Amount

¥ 1,000

Senior unsecured notes due 2025, interest rate of 1.250%

Debt Instrument [Line Items]

Interest Rate

1.25%

Senior unsecured notes due 2025, interest rate of 1.250% | Subsequent Event [Member]

Debt Instrument [Line Items]

Repayments of Debt | $

$ 300

Debt (Schedule of Revolving Cre

Debt (Schedule of Revolving Credit Facilities) (Details) - USD ($) $ in Millions		Dec. 31, 2024	Dec. 31, 2023
Revolving Credit Facility
Debt Instrument [Line Items]
Revolving credit facilities(2)	[1]	$ 55	$ 212
Revolving Credit Facility | Revolving Credit Facility
Debt Instrument [Line Items]
Revolving credit facilities(2)		0
Available for borrowing		1,750
China Revolving Credit Facilities | Revolving Credit Facility
Debt Instrument [Line Items]
Revolving credit facilities(2)		55
Available for borrowing		$ 171
[1] The weighted average interest rate was 3.1% and 3.4% as of December 31, 2024 and 2023, respectively.

Debt (Senior Notes) (Details)

Debt (Senior Notes) (Details)	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Debt Instrument, Redemption Price, Percentage	100%

Debt (Schedule of Senior Unsecu

Debt (Schedule of Senior Unsecured Notes Offering) (Details) - USD ($) $ in Millions	Dec. 31, 2024	Nov. 15, 2024	Aug. 31, 2023
Senior unsecured notes due 2028, interest rate of 6.350%(2)
Debt Instrument [Line Items]
Debt Instrument, Face Amount			$ 1,000
Debt Instrument, Discount Price, Percentage			99.986%
Interest Rate	6.35%	6.60%	6.35%
Senior unsecured notes due 2030, interest rate of 6.550%(2)
Debt Instrument [Line Items]
Debt Instrument, Face Amount			$ 999
Debt Instrument, Discount Price, Percentage			99.95%
Interest Rate	6.55%	6.80%	6.55%
Senior unsecured notes due 2033, interest rate of 6.700%(2)
Debt Instrument [Line Items]
Debt Instrument, Face Amount			$ 1,000
Debt Instrument, Discount Price, Percentage			99.992%
Interest Rate	6.70%	6.95%	6.70%

Debt (Schedule of Cash Tender O

Debt (Schedule of Cash Tender Offer) (Details)	1 Months Ended
	Aug. 31, 2023 USD ($)
Debt Instrument [Line Items]
Debt Instrument, Repurchased Face Amount	$ 2,250,000,000
Senior unsecured notes due 2024, interest rate of 5.900%
Debt Instrument [Line Items]
Debt Instrument, Repurchased Face Amount	1,473,000,000
Debt Instrument Tender Purchase Price Per 1000 Principal Amount	999.92
Debt Instrument, Repurchase Amount	1,473,000,000
Interest Expense, Debt	12,000,000
Senior unsecured notes due 2025, interest rate of 6.050%
Debt Instrument [Line Items]
Debt Instrument, Repurchased Face Amount	750,000,000
Debt Instrument Tender Purchase Price Per 1000 Principal Amount	1,002.85
Debt Instrument, Repurchase Amount	752,000,000
Interest Expense, Debt	20,000,000
Senior unsecured notes due 2024, interest rate of 3.500%
Debt Instrument [Line Items]
Debt Instrument, Repurchased Face Amount	27,000,000
Debt Instrument Tender Purchase Price Per 1000 Principal Amount	983.95
Debt Instrument, Repurchase Amount	27,000,000
Interest Expense, Debt	$ 0

Debt (Schedule of Principal Pay

Debt (Schedule of Principal Payments) (Details) $ in Millions	Dec. 31, 2024 USD ($)
Debt Disclosure [Abstract]
2025	$ 1,501
2026	1,571
2027	3,599
2028	1,537
2029	1,287
Thereafter	3,140
Total	$ 12,635

Debt (Accounts Receivable Purch

Debt (Accounts Receivable Purchasing Facility) (Details) - Amended Restated Receivable Purchasing Facility - Secured Debt - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Percentage of fair value of sales receivables	100%
Transfer of financial assets accounted for as sales, amount derecognized	$ 1,500	$ 1,400
Proceeds collected on accounts receivable sold under factoring facilities	1,500	$ 1,300
Trade Receivables Pledged As Collateral	$ 139

Debt (Factoring and Discounting

Debt (Factoring and Discounting Agreements) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Europe Factoring Agreements
Debt Instrument [Line Items]
Transfer Of Financial Assets Treated As Sales, Non-recourse or Limited recourse Basis, Accounts Receivable Percentage	100%
Japan Factoring Agreements
Debt Instrument [Line Items]
Transfer Of Financial Assets Treated As Sales, Non-recourse or Limited recourse Basis, Accounts Receivable Percentage	100%
Singapore Factoring Agreements
Debt Instrument [Line Items]
Transfer Of Financial Assets Treated As Sales, Non-recourse or Limited recourse Basis, Accounts Receivable Percentage	90%
China Factoring Agreements
Debt Instrument [Line Items]
Transfer Of Financial Assets Treated As Sales, Non-recourse or Limited recourse Basis, Accounts Receivable Percentage	100%
China, Europe Japan and Singapore Factoring Agreements
Debt Instrument [Line Items]
Transfer of financial assets accounted for as sales, amount derecognized	$ 700	$ 423
Proceeds collected on accounts receivable sold under factoring facilities	640	407
Master Discounting Agreement
Debt Instrument [Line Items]
Transfer of financial assets accounted for as sales, amount derecognized	$ 100	$ 45

Benefit Obligations Benefit Obl

Benefit Obligations Benefit Obligations (Schedule of Contributions to Defined Contribution Plans) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Retirement Benefits [Abstract]
Defined contribution plans	$ 79	$ 83	$ 62

Benefit Obligations (Schedule o

Benefit Obligations (Schedule of Company's Pension and Post Retirement Benefit Plans) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Amounts Recognized in Accumulated Other Comprehensive Income Consist of:
Net amount recognized		$ 5	$ 7	$ (7)
Pension Plan [Member]
Change in Projected Benefit Obligation
Projected benefit obligation as of beginning of period		2,923	2,858
Service cost		13	11	12
Interest cost		125	132	67
Net actuarial (gain) loss	[1]	(31)	144
Divestiture	[2]	0	(4)
Settlements		(9)	(16)
Benefits paid		(227)	(226)
Curtailments		(7)	0
Special termination benefits		1	0
Exchange rate changes		(50)	24
Projected benefit obligation as of end of period		2,738	2,923	2,858
Change in Plan Assets
Fair value of plan assets as of beginning of period		2,652	2,625
Actual return on plan assets		66	213
Employer contributions		50	46
Defined Benefit Plan, Plan Assets, Divestiture	[2]	0	(2)
Settlements		(9)	(16)
Benefits paid	[3]	(227)	(226)
Exchange rate changes		(39)	12
Fair value of plan assets as of end of period		2,493	2,652	2,625
Funded status as of end of period		(245)	(271)
Amounts Recognized in the Consolidated Balance Sheets Consist of:
Noncurrent Other assets		135	166
Current Other liabilities		(22)	(22)
Liability, Defined Benefit Plan, Noncurrent		358	415
Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position		(245)	(271)
Funded status as of end of period		(245)	(271)
Amounts Recognized in Accumulated Other Comprehensive Income Consist of:
Net actuarial (gain) loss	[4]	28	24
Prior service (benefit) cost		0	0
Net amount recognized		28	24
Other Postretirement Benefits Plan [Member]
Change in Projected Benefit Obligation
Projected benefit obligation as of beginning of period		40	38
Service cost		1	0	1
Interest cost		1	2	1
Net actuarial (gain) loss	[1]	(1)	2
Divestiture	[2]	0	0
Settlements		0	0
Benefits paid		(4)	(3)
Curtailments		(2)	0
Special termination benefits		0	0
Exchange rate changes		(1)	1
Projected benefit obligation as of end of period		34	40	38
Change in Plan Assets
Fair value of plan assets as of beginning of period		0	0
Actual return on plan assets		0	0
Employer contributions		4	3
Defined Benefit Plan, Plan Assets, Divestiture	[2]	0	0
Settlements		0	0
Benefits paid	[3]	(4)	(3)
Exchange rate changes		0	0
Fair value of plan assets as of end of period		0	0	$ 0
Funded status as of end of period		(34)	(40)
Amounts Recognized in the Consolidated Balance Sheets Consist of:
Noncurrent Other assets		0	0
Current Other liabilities		(3)	(3)
Liability, Defined Benefit Plan, Noncurrent		31	37
Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position		(34)	(40)
Funded status as of end of period		(34)	(40)
Amounts Recognized in Accumulated Other Comprehensive Income Consist of:
Net actuarial (gain) loss	[4]	0	0
Prior service (benefit) cost		(1)	(1)
Net amount recognized		(1)	(1)
Supplemental Employee Retirement Plan [Member]
Change in Plan Assets
Benefits paid		$ (19)	$ (20)
[1] Primarily relates to changes in discount rates. Represents plan obligations and assets contributed to the Nutrinova joint venture ( Note 4 ). Includes benefit payments to nonqualified pension plans of $19 million and $20 million as of December 31, 2024 and 2023, respectively. Relates to the pension plans of the Company's equity method investments.

Benefit Obligations (Schedule_2

Benefit Obligations (Schedule of Percentage of US and International Projected Benefit Obligation) (Details)	Dec. 31, 2024	Dec. 31, 2023
Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Percentage of projected benefit obligation	100%	100%
Other Postretirement Benefits Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Percentage of projected benefit obligation	100%	100%
UNITED STATES | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Percentage of projected benefit obligation	71%	71%
UNITED STATES | Other Postretirement Benefits Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Percentage of projected benefit obligation	38%	37%
Foreign Plan [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Percentage of projected benefit obligation	29%	29%
Foreign Plan [Member] | Other Postretirement Benefits Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Percentage of projected benefit obligation	62%	63%

Benefit Obligations (Schedule_3

Benefit Obligations (Schedule of Percentage of US and International Fair Value of Plan Assets) (Details)	Dec. 31, 2024	Dec. 31, 2023
Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Percentage of US and international fair value of plan assets	100%	100%
UNITED STATES
Defined Benefit Plan Disclosure [Line Items]
Percentage of US and international fair value of plan assets	74%	75%
Foreign Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Percentage of US and international fair value of plan assets	26%	25%

Benefit Obligations (Schedule_4

Benefit Obligations (Schedule of Pension Plans with Projected Benefit Obligations in Excess of Plan Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Retirement Benefits [Abstract]
Projected benefit obligation	$ 711	$ 788
Fair value of plan assets	$ 332	$ 352

Benefit Obligations (Schedule_5

Benefit Obligations (Schedule of Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Accumulated benefit obligation	$ 691	$ 738
Fair value of plan assets	332	329
Other Postretirement Benefits Plan [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Accumulated benefit obligation	$ 34	$ 40

Benefit Obligations (Schedule_6

Benefit Obligations (Schedule of Accumulated Benefit Obligation for All Defined Benefit Pension Plans) (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Retirement Benefits [Abstract]
Accumulated benefit obligation	$ 2,706	$ 2,882

Benefit Obligations (Schedule_7

Benefit Obligations (Schedule of Net Periodic Benefit Costs Recognized) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Actuarial (gain) loss on pension and postretirement plans	$ 37	$ 66	$ 81
Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	13	11	12
Interest cost	125	132	67
Expected return on plan assets	(135)	(132)	(166)
Actuarial (gain) loss on pension and postretirement plans	38	63	91
Curtailment (gain) loss	(7)	0	0
Settlement (gain) loss	0	1	0
Special termination benefit	1	0	0
Total	35	75	4
Other Postretirement Benefits Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	1	0	1
Interest cost	1	2	1
Expected return on plan assets	0	0	0
Actuarial (gain) loss on pension and postretirement plans	(1)	3	(10)
Curtailment (gain) loss	(2)	0	0
Settlement (gain) loss	0	0	0
Special termination benefit	0	0	0
Total	$ (1)	$ 5	$ (8)

Benefit Obligations (Schedule_8

Benefit Obligations (Schedule of Nonqualified Pension Plans Funded with Nonqualified Trusts) (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Noncurrent Other assets, consisting of insurance contracts	$ 18	$ 21
Supplemental Employee Retirement Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Noncurrent Other assets, consisting of insurance contracts	18	21
Current Other liabilities	18	18
Benefit obligations	136	149
Supplemental Employee Retirement Plan [Member] | Money Market Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Marketable securities	$ 6	$ 5

Benefit Obligations (Schedule_9

Benefit Obligations (Schedule of Expense Related to Nonqualified Pension Plans Included in Net Periodic Benefit Cost, Excluding Returns on Assets) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Supplemental Employee Retirement Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total	$ 6	$ 16	$ (34)

Benefit Obligations (Schedul_10

Benefit Obligations (Schedule of Principal Weighted Average Assumptions Used to Determine Benefit Obligations and Benefit Cost) (Details)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount rate obligations	4.80%	4.50%
Rate of compensation increase	3.10%	2.80%
Discount rate NPBC	4.50%	4.90%	2.50%
Discount rate NPBC - service cost	2.90%	3.50%	1.50%
Discount rate NPBC - interest cost	4.50%	4.80%	2%
Expected return on plan assets	5.30%	5.20%	5.40%
Rate of compensation increase NPBC	2.80%	2.80%	2.50%
Interest Crediting Rate	4%	4.30%	1.90%
Other Postretirement Benefits Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount rate obligations	4.80%	4.50%
Discount rate NPBC	4.50%	5.10%	2.50%
Discount rate NPBC - service cost	3.70%	4.50%	2.10%
Discount rate NPBC - interest cost	4.40%	5%	2.10%
UNITED STATES
Defined Benefit Plan Disclosure [Line Items]
Expected return on plan assets	5.50%	5.50%	5.50%
Interest Crediting Rate	4.10%	4.30%	1.90%
UNITED STATES | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount rate obligations	5.60%	5.10%
Discount rate NPBC	5.10%	5.50%	2.80%
Discount rate NPBC - interest cost	5.10%	5.40%	2.20%
UNITED STATES | Other Postretirement Benefits Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount rate obligations	5.50%	5.10%
Discount rate NPBC	5.10%	5.40%	2.70%
Discount rate NPBC - service cost	5.70%	5.90%	3.50%
Discount rate NPBC - interest cost	5.10%	5.30%	2%
Foreign Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Rate of compensation increase	3.10%	2.80%
Expected return on plan assets	4.80%	4.40%	4.90%
Rate of compensation increase NPBC	2.80%	2.80%	2.50%
Interest Crediting Rate	1.40%	1%	1%
Foreign Plan [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount rate obligations	3.10%	3.10%
Discount rate NPBC	3.10%	3.40%	1.40%
Discount rate NPBC - service cost	2.90%	3.50%	1.50%
Discount rate NPBC - interest cost	3%	3.40%	1.20%
Foreign Plan [Member] | Other Postretirement Benefits Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount rate obligations	4.40%	4.10%
Discount rate NPBC	4.10%	4.70%	2.40%
Discount rate NPBC - service cost	3.70%	4.40%	2.10%
Discount rate NPBC - interest cost	4.10%	4.70%	2.10%

Benefit Obligations Benefit O_2

Benefit Obligations Benefit Obligations (Schedule of US Health Care Cost Trend Rates) (Details) - UNITED STATES - Postretirement Health Coverage [Member]	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Health Care Cost Trend [Line Items]
Health care cost trend rate assumed for next year	7%	7.30%	7.50%
Health care cost trend ultimate rate	5%	5%	5%
Health care cost trend ultimate rate year	2032	2032	2032

Benefit Obligations (Valuation

Benefit Obligations (Valuation Narrative) (Details)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Expected return on plan assets	5.30%	5.20%	5.40%

Benefit Obligations (Schedul_11

Benefit Obligations (Schedule of Weighted Average Target Asset Allocations) (Details)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
UNITED STATES
Defined Benefit Plan Disclosure [Line Items]
Actual return on plan assets	1.30%
Expected return on plan assets	5.50%	5.50%	5.50%
Weighted average target asset allocations	100%
UNITED STATES | Debt Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Weighted average target asset allocations	84%
UNITED STATES | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Weighted average target asset allocations	8%
UNITED STATES | Equity Securities International To Plans [Member]
Defined Benefit Plan Disclosure [Line Items]
Weighted average target asset allocations	8%
UNITED STATES | Other Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Weighted average target asset allocations	0%
Foreign Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Expected return on plan assets	4.80%	4.40%	4.90%
Weighted average target asset allocations	100%
Foreign Plan [Member] | Debt Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Weighted average target asset allocations	38%
Foreign Plan [Member] | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Weighted average target asset allocations	19%
Foreign Plan [Member] | Equity Securities International To Plans [Member]
Defined Benefit Plan Disclosure [Line Items]
Weighted average target asset allocations	8%
Foreign Plan [Member] | Other Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Weighted average target asset allocations	35%

Benefit Obligations (Schedul_12

Benefit Obligations (Schedule of Fair Values of Pension Plan Assets) (Details) - USD ($) $ in Millions		Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets, fair value non-financial receivables		$ 20	$ 22
Pension plan assets, fair value non-financial payables		17	5
Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets	[1]	1,990	2,101
Total liabilities [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		(13)	(60)
Swaps [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		(13)	(60)
Defined Benefit Plan, Equity Securities, Non-US [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		126	148
Defined Benefit Plan, Cash and Cash Equivalents [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		12	7
Total plan assets [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets	[2]	2,003	2,161
Equities [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		431	460
Swaps [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		13	60
Corporate Debt [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		624	686
Treasuries, Other Debt [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		1,055	1,100
Mortgage Backed Securities [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		14	13
Registered Investment Companies [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		34	43
Short-term Investments [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		35	31
Insurance Contracts [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		109	104
Other [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		24	22
Defined Benefit Plan, Equity Securities, US | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		26	21
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets	[1]	214	266
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Total liabilities [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Swaps [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Defined Benefit Plan, Equity Securities, Non-US [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		126	148
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Defined Benefit Plan, Cash and Cash Equivalents [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		12	7
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Total plan assets [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets	[2]	214	266
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Swaps [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Corporate Debt [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Treasuries, Other Debt [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		47	87
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Mortgage Backed Securities [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Insurance Contracts [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Other [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		3	3
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Defined Benefit Plan, Equity Securities, US | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		26	21
Significant Other Observable Inputs (Level 2) [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets	[1]	1,776	1,835
Significant Other Observable Inputs (Level 2) [Member] | Total liabilities [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		(13)	(60)
Significant Other Observable Inputs (Level 2) [Member] | Swaps [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		(13)	(60)
Significant Other Observable Inputs (Level 2) [Member] | Defined Benefit Plan, Equity Securities, Non-US [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		0	0
Significant Other Observable Inputs (Level 2) [Member] | Defined Benefit Plan, Cash and Cash Equivalents [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		0	0
Significant Other Observable Inputs (Level 2) [Member] | Total plan assets [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets	[2]	1,789	1,895
Significant Other Observable Inputs (Level 2) [Member] | Swaps [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		13	60
Significant Other Observable Inputs (Level 2) [Member] | Corporate Debt [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		624	686
Significant Other Observable Inputs (Level 2) [Member] | Treasuries, Other Debt [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		1,008	1,013
Significant Other Observable Inputs (Level 2) [Member] | Mortgage Backed Securities [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		14	13
Significant Other Observable Inputs (Level 2) [Member] | Insurance Contracts [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		109	104
Significant Other Observable Inputs (Level 2) [Member] | Other [Member] | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		21	19
Significant Other Observable Inputs (Level 2) [Member] | Defined Benefit Plan, Equity Securities, US | Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Total net assets		$ 0	$ 0
[1] Total net assets excludes non-financial plan receivables and payables of $20 million and $17 million, respectively, as of December 31, 2024 and $22 million and $5 million, respectively, as of December 31, 2023. Non-financial items include due to/from broker, interest receivables and accrued expenses. Certain investments that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy. Total investments, at fair value, for the year ended December 31, 2024 excludes investments in pooled-type investments, registered investment companies and short-term investment funds with fair values of $431 million, $34 million and $35 million, respectively. Total investments, at fair value, for the year ended December 31, 2023 excludes investments in pooled-type investments, registered investment companies and short-term investment funds with fair values of $460 million, $43 million and $31 million, respectively.

Benefit Obligations Benefit O_3

Benefit Obligations Benefit Obligations (Schedule of Pension Contributions Expected to be Contributed to the Plans) (Details) $ in Millions	Dec. 31, 2024 USD ($)
Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year	$ 30
Supplemental Employee Retirement Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year	18
Other Postretirement Benefits Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year	$ 3

Benefit Obligations (Schedul_13

Benefit Obligations (Schedule of Pension Benefits Expected to be Paid from the Plans or From the Company's Assets) (Details) $ in Millions	Dec. 31, 2024 USD ($)
Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
2025	$ 235	[1]
2026	233	[1]
2027	227	[1]
2028	225	[1]
2029	225	[1]
2030-2034	1,017	[1]
Other Postretirement Benefits Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
2025	3	[2]
2026	3	[2]
2027	3	[2]
2028	2	[2]
2029	2	[2]
2030-2034	$ 10	[2]
[1] Payments are expected to be made primarily from plan assets. Payments are expected to be made primarily from Company assets.

Environmental (Schedule of Envi

Environmental (Schedule of Environmental Remediation Reserves) (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Environmental Remediation Obligations [Abstract]
Demerger obligations (Note 19)	$ 14	$ 14
Divestiture obligations (Note 19)	14	13
Active sites	23	25
U.S. Superfund sites	10	8
Other environmental remediation liabilities	2	2
Total	$ 63	$ 62
Environmental Loss Contingency, Statement of Financial Position [Extensible Enumeration]	Other liabilities, Other liabilities	Other liabilities, Other liabilities

Environmental (Schedule of En_2

Environmental (Schedule of Environmental Ownership and Liability Percentages) (Details) - USD ($) $ in Millions		Dec. 31, 2024	Dec. 31, 2023
Environmental Disclosure [Line Items]
Reserves		$ 63	$ 62
InfraServ GmbH & Co. Gendorf KG
Environmental Disclosure [Line Items]
Ownership percentage		30%
Liability percentage		10%
Reserves	[1]	$ 8
InfraServ GmbH & Co. Hoechst KG
Environmental Disclosure [Line Items]
Ownership percentage		31%
Liability percentage		42%
Reserves	[1]	$ 61
Yncoris GmbH & Co. KG
Environmental Disclosure [Line Items]
Ownership percentage		22%
Liability percentage		23%
Reserves	[1]	$ 1
[1] Gross reserves maintained by the respective entity.

Environmental Environmental (US

Environmental Environmental (US Superfund Sites Narrative) (Details) - Passaic River, New Jersey [Member] $ in Millions			1 Months Ended		12 Months Ended
	Sep. 30, 2021 USD ($)	Mar. 31, 2016 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2024
Site Contingency [Line Items]
Number of Parties included in USEPA order			40		70
EPA Estimated Cost	$ 441	$ 1,400	$ 71	$ 150
Liability percentage					1%

Stockholders' Equity (Narrative

Stockholders' Equity (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	Feb. 12, 2025	Nov. 04, 2024	Dec. 31, 2024	Dec. 31, 2023
Equity, Class of Treasury Stock [Line Items]
Common stock, par value (in dollars per share)			$ 0.0001	$ 0.0001
Common Stock, Dividends, Decrease, Percentage		95%
Subsequent Event [Member]
Equity, Class of Treasury Stock [Line Items]
Quarterly cash dividend per share	$ 0.03
Cash dividend	$ 3

Stockholders' Equity (Schedule

Stockholders' Equity (Schedule of Treasury Stock) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended			203 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2024
Stockholders' Equity Note [Abstract]
Shares repurchased	0	0	0	69,324,429
Average purchase price per share				$ 83.71
Amount spent on repurchased shares (in $ millions)				$ 5,803
Share repurchase plan, authorized repurchase amount	$ 6,866			$ 6,866

Stockholders' Equity (Schedul_2

Stockholders' Equity (Schedule of Components of Other Comprehensive Income (Loss), Net) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Comprehensive Income (Loss) [Line Items]
Foreign currency translation, gross amount	$ (39)	$ (275)	$ (240)
Foreign currency translation, income tax (provision) benefit	(60)	62	23
Foreign currency translation, net amount	(99)	(213)	(217)
Gain (loss) on cash flow hedges, gross amount	2	(12)	26
Gain (loss) on cash flow hedges, income tax (provision) benefit	2	(6)	5
Gain (loss) on cash flow hedges, net amount	0	(6)	21
Pension and postretirement benefits, gross amount	(5)	(8)	7
Pension and postretirement benefits, income tax (provision) benefit	0	1	0
Pension and postretirement benefits, net amount	(5)	(7)	7
Total other comprehensive income (loss), gross amount	(42)	(295)	(207)
Total other comprehensive income (loss), income tax (provision) benefit	(62)	69	18
Total other comprehensive income (loss), net of tax	$ (104)	$ (226)	$ (189)

Stockholders' Equity (Schedul_3

Stockholders' Equity (Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance as of the beginning of the period	$ (744)	$ (518)	$ (329)
Other comprehensive income (loss) before reclassifications	95	(286)	(190)
Amounts reclassified from accumulated other comprehensive income (loss)	(137)	(9)	(17)
Income tax (provision) benefit	(62)	69	18
Balance as of the end of the period	(848)	(744)	(518)
Foreign Currency Translation [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance as of the beginning of the period	(701)	(488)	(271)
Other comprehensive income (loss) before reclassifications	(39)	(275)	(240)
Amounts reclassified from accumulated other comprehensive income (loss)	0	0	0
Income tax (provision) benefit	(60)	62	23
Balance as of the end of the period	(800)	(701)	(488)
AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance as of the beginning of the period	(28)	(22)	(43)
Other comprehensive income (loss) before reclassifications	139	(3)	43
Amounts reclassified from accumulated other comprehensive income (loss)	(137)	(9)	(17)
Income tax (provision) benefit	(2)	6	(5)
Balance as of the end of the period	(28)	(28)	(22)
Pension and Postretirement Benefits [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance as of the beginning of the period	(15)	(8)	(15)
Other comprehensive income (loss) before reclassifications	(5)	(8)	7
Amounts reclassified from accumulated other comprehensive income (loss)	0	0	0
Income tax (provision) benefit	0	1	0
Balance as of the end of the period	$ (20)	$ (15)	$ (8)

Income Taxes (Schedule of Earni

Income Taxes (Schedule of Earnings (Loss) from Continuing Operations Before Tax by Jurisdiction) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
U.S.	$ (2,269)	$ (163)	$ (292)
International	1,273	1,346	1,713
Earnings (loss) from continuing operations before tax	$ (996)	$ 1,183	$ 1,421

Income Taxes (Schedule of Incom

Income Taxes (Schedule of Income Tax Provision (Benefit)) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Current
U.S.	$ 79	$ 8	$ 54
International	239	162	306
Total	318	170	360
Deferred
U.S.	(87)	(178)	(261)
International	279	(782)	(588)
Total	192	(960)	(849)
Income tax provision (benefit)	$ 510	$ (790)	$ (489)

Income Taxes Income Taxes (Sche

Income Taxes Income Taxes (Schedule of Effective Tax Rate Reconciliation) (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2024	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income tax provision computed at U.S. federal statutory tax rate			$ (209)	$ 248	$ 298
Change in valuation allowance			370	(150)	(15)
Equity income and dividends			(41)	(27)	(47)
(Income) expense not resulting in tax impact, net		$ 319	327	(9)	2
U.S. tax effect of foreign earnings and dividends			184	384	162
Foreign tax credits			(137)	(73)	(120)
Other foreign tax rate differentials			(66)	(108)	(43)
Legislative changes			(6)	(44)	0
State income taxes, net of federal benefit			12	(8)	(2)
Recognition of basis differences in investments in affiliates			0	0	6
Asset transfers between wholly owned foreign affiliates	$ 800		87	(839)	(816)
Other, net			(11)	(164)	86
Income tax provision (benefit)			$ 510	$ (790)	$ (489)
Effective income tax rate			(51.00%)	(67.00%)	(34.00%)

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2022	Jun. 30, 2024	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Tax Credit Carryforward [Line Items]
Asset transfers between wholly owned foreign affiliates	$ 800		$ 87	$ (839)	$ (816)
Deferred Income Taxes and Tax Credits			725
Deferred Tax Assets, Tax Credit Carryforwards, Foreign			230
Other, net			(11)	(164)	86
Effective Income Tax Rate Reconciliation, U.S. Benefits Of Foreign Derived Intangible Income, Amount			0	72	0
Unrecognized Tax Benefit, Decrease resulting from changes in uncertain tax position and impacts of amended tax return filings			(2)	5	63
Tax Credit Carryforward, Amount			200
Alternative Minimum Tax Credit Carryforwards, Before Tax			$ 18
Tax Credit Carryforward, Expiration Date			Dec. 31, 2027
Tax Credit Carryforward, Valuation Allowance			$ 165
US Federal [Member]
Tax Credit Carryforward [Line Items]
Net operating loss carryforwards			$ 15
US Federal [Member] | Minimum
Tax Credit Carryforward [Line Items]
Net operating loss carryforward expiration			Dec. 31, 2036
State [Member]
Tax Credit Carryforward [Line Items]
Net operating loss carryforwards			$ 35
Valuation allowance offset for State net operating loss carryforwards due to uncertain recoverability			24
Foreign Tax Jurisdiction
Tax Credit Carryforward [Line Items]
Net operating loss carryforwards			3,500
Tax Credit Carryforward, Valuation Allowance			338
CHINA
Tax Credit Carryforward [Line Items]
Asset transfers between wholly owned foreign affiliates		$ 87
Net operating loss carryforwards			$ 69
CHINA | Minimum
Tax Credit Carryforward [Line Items]
Net operating loss carryforward expiration			Dec. 31, 2024
CHINA | Maximum
Tax Credit Carryforward [Line Items]
Net operating loss carryforward expiration			Dec. 31, 2029
SWITZERLAND
Tax Credit Carryforward [Line Items]
Net operating loss carryforwards			$ 1,700
Valuation allowance offset for State net operating loss carryforwards due to uncertain recoverability			$ 230
SWITZERLAND | Minimum
Tax Credit Carryforward [Line Items]
Net operating loss carryforward expiration			Dec. 31, 2024
SWITZERLAND | Maximum
Tax Credit Carryforward [Line Items]
Net operating loss carryforward expiration			Dec. 31, 2030
Nutrinova Joint Venture
Tax Credit Carryforward [Line Items]
Other, net				102
Mobility & Materials
Tax Credit Carryforward [Line Items]
Asset transfers between wholly owned foreign affiliates				$ (190)
Other, net					$ 20
Capital Loss Carryforwards			$ 173

Income Taxes (Schedule of Conso

Income Taxes (Schedule of Consolidated Deferred Tax Assets and Liabilities) (Details) - USD ($) $ in Millions		Dec. 31, 2024	Dec. 31, 2023
Deferred Tax Assets
Pension and postretirement obligations		$ 58	$ 61
Accrued expenses		59	56
Deferred Tax Assets, Inventory		18	13
Net operating loss carryforwards		752	783
Tax credit carryforwards		222	135
Other		757	737
Subtotal		1,866	1,759
Valuation allowance	[1]	(1,106)	(656)
Total		760	1,103
Deferred Tax Liabilities
Depreciation and amortization		152	152
Investments in affiliates		163	188
Other		127	85
Total		442	425
Deferred income taxes		$ 318	$ 678
[1] Includes deferred tax asset valuation allowances for the Company's deferred tax assets in Switzerland, Luxembourg, the U.S., Spain, the Netherlands, the United Kingdom, Malta, Mexico, Germany, China, Singapore and France. These valuation allowances relate primarily to net operating loss carryforward benefits, foreign tax credit carryforwards and other net deferred tax assets, all of which may not be realizable.

Income Taxes (Schedule of Unrec

Income Taxes (Schedule of Unrecognized Tax Benefits Roll Forward) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Activity Related To Uncertain Tax Positions [Roll Forward]
As of the beginning of the year		$ 224	$ 275	$ 218
Increases (decreases) in tax positions for the current year			10	8
Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions		(3)
Increases in tax positions for prior years		6	9	102
Decreases in tax positions for prior years		(6)	(35)	(45)
Increases (decreases) due to settlements		(8)	(35)	(8)
As of the end of the year		213	224	275
Total uncertain tax positions that if recognized would impact the effective tax rate		236	244	274
Total amount of interest expense (benefit) and penalties recognized in the consolidated statements of operations(1)	[1]	7	22	10
Total amount of interest expense and penalties recognized in the consolidated balance sheets		$ 77	$ 71	$ 59
[1] This amount reflects interest on uncertain tax positions and release of tax positions due to changes in assessment, statute lapses or audit closures that were reflected in the consolidated statements of operations.

Leases Lease costs (Details)

Leases Lease costs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Operating lease cost	$ 99	$ 99	$ 66
Short-term lease cost	18	19	19
Variable lease cost	17	13	15
Amortization of leased assets	20	21	19
Interest on lease liabilities	8	10	11
Sublease Income	0	0	2
Total net lease cost	$ 162	$ 162	$ 132

Leases Supplemental balance she

Leases Supplemental balance sheet information (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Leases [Abstract]
Operating lease right-of-use assets	$ 388	$ 422
Finance lease, right-of-use asset	119	154
Lease, Right-of-Use Asset	507	576
Operating leases (Note 16)	79	89
Finance Lease, Liability, Current	23	24
Operating lease liabilities	294	325
Finance Lease, Liability, Noncurrent	122	124
Lease Liability	$ 518	$ 562
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Operating lease right-of-use assets	Operating lease right-of-use assets
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property, plant and equipment (net of accumulated depreciation - 2024: $4,562; 2023: $4,080)	Property, plant and equipment (net of accumulated depreciation - 2024: $4,562; 2023: $4,080)
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Other liabilities	Other liabilities
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Short-term borrowings and current installments of long-term debt - third party and affiliates	Short-term borrowings and current installments of long-term debt - third party and affiliates
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Operating lease liabilities	Operating lease liabilities
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Long-term debt, net of unamortized deferred financing costs	Long-term debt, net of unamortized deferred financing costs

Leases Supplemental lease infor

Leases Supplemental lease information (Details)	Dec. 31, 2024	Dec. 31, 2023
Leases [Abstract]
Weighted-average remaining operating leases term	8 years 4 months 24 days	8 years 7 months 6 days
Weighted-average remaining finance leases term	7 years 8 months 12 days	7 years 9 months 18 days
Weighted-average operating leases discount rate	3.30%	3.50%
Weighted-average finance leases discount rate	5.60%	6.20%

Leases Supplemental cash flow i

Leases Supplemental cash flow information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Operating cash flows from operating leases	$ 90	$ 92	$ 52
Operating cash flows from finance leases	8	10	11
Financing cash flows from finance leases	24	24	25
Finance lease obligations	27	2	28
ROU assets obtained in exchange for operating lease liabilities	$ 70	$ 58	$ 93

Leases Maturities of lease liab

Leases Maturities of lease liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
2025	$ 90
2026	74
2027	49
2028	41
2029	39
Later years	131
Total lease payments	424
Less amounts representing interest	(51)
Total lease obligations	373
Finance Lease, Liability, Payment, Due [Abstract]
2025	30
2026	27
2027	23
2028	20
2029	19
Later years	71
Total lease payments	190
Less amounts representing interest	(45)
Total lease obligations	$ 145	$ 148

Derivative Financial Instrume_3

Derivative Financial Instruments (Schedule of Changes in Fair Value of Derivatives) (Details) € in Millions, ¥ in Millions, $ in Millions			1 Months Ended	12 Months Ended
		Jul. 31, 2022 EUR (€)	Aug. 31, 2023 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2024 EUR (€)	Dec. 31, 2024 CNY (¥)	Apr. 11, 2024 USD ($)	Dec. 31, 2023 EUR (€)	Jul. 31, 2022 USD ($)
Foreign currency forwards and swaps | Derivatives Not Designated as Hedges [Member]
Derivative [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax				$ 0	$ 0	$ 0
Gain (loss) recognized in Earnings (loss)				$ (26)	$ (19)	$ (2)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]				Foreign exchange gain (loss), net, Other income (expense), net	Foreign exchange gain (loss), net, Other income (expense), net	Foreign exchange gain (loss), net, Other income (expense), net
Notional Value				$ 2,777	$ 1,954
Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member]
Derivative [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax				0	0	$ 41
Gain (loss) recognized in Earnings (loss)				(9)	0	17
Cash Flow Hedging [Member] | Commodity Contract [Member] | Designated as Hedging Instrument [Member]
Derivative [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax				0	(5)	39
Gain (loss) recognized in Earnings (loss)				$ (2)	$ 2	$ 23
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of Goods and Services Sold	Cost of Goods and Services Sold	Cost of Goods and Services Sold
Notional Value				$ 48	$ 67
Cash Flow Hedging [Member] | Interest Rate Swap [Member] | Designated as Hedging Instrument [Member]
Derivative [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax				0	0	$ 0
Gain (loss) recognized in Earnings (loss)				$ (7)	$ (7)	$ (7)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]				Interest Expense, Operating and Nonoperating	Interest Expense, Operating and Nonoperating	Interest Expense, Operating and Nonoperating
Cash Flow Hedging [Member] | Foreign currency forwards and swaps | Designated as Hedging Instrument [Member]
Derivative [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax				$ 0	$ 5	$ 2
Gain (loss) recognized in Earnings (loss)				$ 0	$ 5	$ 1
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of Goods and Services Sold	Cost of Goods and Services Sold	Cost of Goods and Services Sold
Fair Value Hedging | Currency Swap [Member] | Designated as Hedging Instrument [Member]
Derivative [Line Items]
Gain (loss) recognized in Earnings (loss)	[1]			$ 146	$ 9	$ 0
Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax	[1]			$ 142	$ (1)	$ 0
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]				Foreign exchange gain (loss), net	Foreign exchange gain (loss), net	Foreign exchange gain (loss), net
Notional Value				$ 1,500	$ 1,500
Net Investment Hedging [Member] | Designated as Hedging Instrument [Member]
Derivative [Line Items]
Amount of Ineffectiveness on Net Investment Hedges	[2]			0	0	$ 0
Gain (Loss) On Non-Derivatives and Derivatives Used In Net Investment Hedge	[2]			300	(280)	(114)
Net Investment Hedging [Member] | Currency Swap [Member] | Designated as Hedging Instrument [Member]
Derivative [Line Items]
Gain (loss) recognized in Earnings (loss)	[2]			0	0	0
Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax	[2]			147	(174)	(92)
Notional Value							€ 4,564	¥ 7,268		€ 5,712
Foreign Currency Denominated Debt [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member]
Derivative [Line Items]
Gain (Loss) On Non-Derivative Used In Net Investment Hedge	[2]			153	(106)	(22)
Amount of Ineffectiveness on Net Investment Hedges	[2]			$ 0	$ 0	$ 0
Senior unsecured notes due 2032, interest rate of 6.379% | Net Investment Hedging [Member] | Currency Swap [Member]
Derivative [Line Items]
Notional Value											$ 500
Senior unsecured notes due 2027, interest rate of 6.165% | Net Investment Hedging [Member] | Currency Swap [Member]
Derivative [Line Items]
Notional Value											$ 2,000
Euro Notes Due 2028
Derivative [Line Items]
Debt Instrument, Term			5 years
Euro Notes Due 2030
Derivative [Line Items]
Debt Instrument, Term			7 years
Euro Notes Due 2028 and 2030 | Fair Value Hedging | Currency Swap [Member] | Designated as Hedging Instrument [Member]
Derivative [Line Items]
Notional Value			$ 1,000
Acquisition Notes | Net Investment Hedging [Member]
Derivative [Line Items]
Notional amount of nonderivative instruments | €		€ 1,500
Japanese Notes Due 2029 | Fair Value Hedging | Currency Swap [Member] | Designated as Hedging Instrument [Member]
Derivative [Line Items]
Notional Value			$ 500
Senior unsecured notes due 2033, interest rate of 6.700%(2) | Net Investment Hedging [Member] | Currency Swap [Member] | Designated as Hedging Instrument [Member]
Derivative [Line Items]
Notional Value									$ 1,000
[1] In conjunction with the 2023 Offering ( Note 11 ) in August 2023, the Company entered into a cross-currency swap to effectively convert $500 million of the issued notes into a Japanese yen-denominated borrowing at prevailing yen interest rates, maturing on July 15, 2029. The swap qualifies and has been designated as a fair value hedge of the Company's foreign currency exchange rate exposure on the long-term debt of its Japanese yen-denominated subsidiary. Additionally, in conjunction with the 2023 Offering ( Note 11 ) in August 2023, the Company entered into cross-currency swaps to effectively convert $1.0 billion of the issued notes into 5-year and 7-year euro-denominated borrowings at prevailing euro interest rates, maturing on November 15, 2028 and November 15, 2030, respectively. The swaps qualify and have been designated as fair value hedges of the Company's foreign currency exchange rate exposure on the long-term debt of its euro-denominated subsidiary. Concurrently with the offering of certain unsecured notes in July 2022 ( Note 11 ), the Company entered into cross-currency swaps to effectively convert $2.0 billion and $500 million of the issued notes into a euro-denominated borrowing at prevailing euro interest rates, maturing on July 15, 2027 and July 15, 2032, respectively. The swaps and €1.5 billion of certain unsecured euro notes offered in July 2022 qualify and have been designated as net investment hedges of the Company's foreign currency exchange rate exposure on the net investments of certain of its euro-denominated subsidiaries. Additionally, on April 11, 2024, the Company entered into cross-currency swaps to effectively convert its $1.0 billion senior unsecured notes due 2033 ( Note 11 ) into Chinese yuan-denominated borrowings at prevailing yuan interest rates, maturing on November 15, 2033. The swaps qualify and have been designated as net investment hedges of the Company's foreign currency exchange rate exposure on the net investment of certain of its Chinese yuan-denominated subsidiaries.

Derivative Financial Instrume_4

Derivative Financial Instruments (Schedule of Notional Amounts of Net Foreign Exchange Exposure by Currency) (Details) - Foreign Exchange Contract [Member] $ in Millions	Dec. 31, 2024 USD ($)
Derivative [Line Items]
Total	$ 751
Brazilian real
Derivative [Line Items]
Total	(36)
British pound sterling
Derivative [Line Items]
Total	86
Canadian dollar
Derivative [Line Items]
Total	13
Chinese yuan
Derivative [Line Items]
Total	438
Euro
Derivative [Line Items]
Total	229
Hungarian forint
Derivative [Line Items]
Total	14
Indian rupee
Derivative [Line Items]
Total	(25)
Indonesian rupiah
Derivative [Line Items]
Total	(11)
Japanese yen
Derivative [Line Items]
Total	22
Korean won
Derivative [Line Items]
Total	216
Mexican peso
Derivative [Line Items]
Total	107
Singapore dollar
Derivative [Line Items]
Total	34
Swedish krona
Derivative [Line Items]
Total	(9)
Swiss franc
Derivative [Line Items]
Total	(313)
Thailand, Baht
Derivative [Line Items]
Total	(8)
Other Currency
Derivative [Line Items]
Total	$ (6)

Derivative Financial Instrume_5

Derivative Financial Instruments (Schedule of Offsetting Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Derivative Asset [Abstract]
Gross amount recognized	$ 250	$ 183
Gross amount offset in the consolidated balance sheets	0	0
Net amount presented in the consolidated balance sheets	250	183
Gross amount not offset in the consolidated balance sheets	38	40
Net amount	$ 212	$ 143
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other assets, Other assets	Other assets, Other assets

Derivative Financial Instrume_6

Derivative Financial Instruments (Schedule of Offsetting Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Derivative Liability [Abstract]
Gross amount recognized	$ 273	$ 440
Gross amount offset in the consolidated balance sheets	0	0
Net amount presented in the consolidated balance sheets	273	440
Gross amount not offset in the consolidated balance sheets	38	40
Net amount	$ 235	$ 400
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Other liabilities, Other liabilities	Other liabilities, Other liabilities

Fair Value Measurements (Schedu

Fair Value Measurements (Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) € in Millions, ¥ in Millions, $ in Millions	Dec. 31, 2024 USD ($)	Dec. 31, 2024 EUR (€)	Dec. 31, 2024 CNY (¥)	Dec. 31, 2023 USD ($)	Dec. 31, 2023 EUR (€)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset	$ 212			$ 143
Derivative liability	$ (235)			$ (400)
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Other assets	Other assets	Other assets	Other assets	Other assets
Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other liabilities	Other liabilities	Other liabilities	Other liabilities	Other liabilities
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other assets	Other assets	Other assets	Other assets	Other assets
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]	Other liabilities	Other liabilities	Other liabilities	Other liabilities	Other liabilities
Other Current Assets [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	$ 170			$ 147
Other Noncurrent Assets | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	80			36
Other Current Liabilities [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	(93)			(90)
Other Noncurrent Liabilities [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	(180)			(350)
Derivatives Not Designated as Hedges [Member] | Other Current Assets [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contract, Asset, Fair Value Disclosure	11			9
Derivatives Not Designated as Hedges [Member] | Other Noncurrent Assets | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contract, Asset, Fair Value Disclosure	0			0
Derivatives Not Designated as Hedges [Member] | Other Current Liabilities [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contracts, Liability, Fair Value Disclosure	(19)			(16)
Derivatives Not Designated as Hedges [Member] | Other Noncurrent Liabilities [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contracts, Liability, Fair Value Disclosure	(20)			(8)
Commodity Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notional Value	48			67
Commodity Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Other Current Assets [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset	4			5
Commodity Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Other Noncurrent Assets | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset	37			36
Commodity Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Other Current Liabilities [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	0			(2)
Commodity Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Other Noncurrent Liabilities [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	0			0
Currency Swap [Member] | Fair Value Hedging | Designated as Hedging Instrument [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notional Value	1,500			1,500
Currency Swap [Member] | Fair Value Hedging | Designated as Hedging Instrument [Member] | Other Current Assets [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contract, Asset, Fair Value Disclosure	46			40
Currency Swap [Member] | Fair Value Hedging | Designated as Hedging Instrument [Member] | Other Noncurrent Assets | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contract, Asset, Fair Value Disclosure	43			0
Currency Swap [Member] | Fair Value Hedging | Designated as Hedging Instrument [Member] | Other Current Liabilities [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contracts, Liability, Fair Value Disclosure	(11)			(11)
Currency Swap [Member] | Fair Value Hedging | Designated as Hedging Instrument [Member] | Other Noncurrent Liabilities [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contracts, Liability, Fair Value Disclosure	0			(61)
Currency Swap [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notional Value		€ 4,564	¥ 7,268		€ 5,712
Currency Swap [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Other Current Assets [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contract, Asset, Fair Value Disclosure				93
Currency Swap [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Other Current Assets [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member] | Euro
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contract, Asset, Fair Value Disclosure	88
Currency Swap [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Other Current Assets [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member] | Chinese yuan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contract, Asset, Fair Value Disclosure	21
Currency Swap [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Other Noncurrent Assets | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contract, Asset, Fair Value Disclosure				0
Currency Swap [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Other Noncurrent Assets | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member] | Euro
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contract, Asset, Fair Value Disclosure	0
Currency Swap [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Other Noncurrent Assets | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member] | Chinese yuan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contract, Asset, Fair Value Disclosure	0
Currency Swap [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Other Current Liabilities [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contracts, Liability, Fair Value Disclosure				(61)
Currency Swap [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Other Current Liabilities [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member] | Euro
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contracts, Liability, Fair Value Disclosure	(56)
Currency Swap [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Other Current Liabilities [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member] | Chinese yuan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contracts, Liability, Fair Value Disclosure	(7)
Currency Swap [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Other Noncurrent Liabilities [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contracts, Liability, Fair Value Disclosure				(281)
Currency Swap [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Other Noncurrent Liabilities [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member] | Euro
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contracts, Liability, Fair Value Disclosure	(134)
Currency Swap [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Other Noncurrent Liabilities [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Recurring [Member] | Chinese yuan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign Currency Contracts, Liability, Fair Value Disclosure	(26)
Foreign Exchange Contract [Member] | Derivatives Not Designated as Hedges [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notional Value	$ 2,777			$ 1,954

Fair Value Measurements (Sche_2

Fair Value Measurements (Schedule of Carrying Values and Fair Values of Financial Instruments) (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Value	$ 170	$ 170
Equity Securities, FV-NI and without Readily Determinable Fair Value	0	0
Insurance contracts in nonqualified pension trusts, carrying amount	18	21
Insurance contracts in nonqualified pension trusts, fair value	18	21
Long-term debt, including current installments of long-term debt, carrying amount	12,527	13,400
Long-term debt, including current installments of long-term debt, fair value	12,615	13,662
Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity Securities, FV-NI and without Readily Determinable Fair Value	0	0
Insurance contracts in nonqualified pension trusts, fair value	18	21
Long-term debt, including current installments of long-term debt, fair value	12,470	13,514
Unobservable Inputs (Level 3) [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity Securities, FV-NI and without Readily Determinable Fair Value	0	0
Insurance contracts in nonqualified pension trusts, fair value	0	0
Long-term debt, including current installments of long-term debt, fair value	$ 145	$ 148

Commitments and Contingencies (

Commitments and Contingencies (Equity Affiliates Narrative) (Details) - Dec. 31, 2024 - Financial Guarantee € in Millions, $ in Millions	USD ($)	EUR (€)
Equity affiliates USD debt obligations
Loss Contingencies [Line Items]
Guarantee obligations, maximum exposure | $	$ 145
Equity Affiliates EUR Debt Obligations
Loss Contingencies [Line Items]
Guarantee obligations, maximum exposure | €		€ 31

Commitment and Contingencies (E

Commitment and Contingencies (Environmental and Other Liabilities) (Details) € in Millions, $ in Millions	302 Months Ended
	Dec. 31, 2024 USD ($)	Dec. 31, 2024 EUR (€)
Indemnification Agreements Hoechst [Member]
Loss Contingencies [Line Items]
Number of divestiture agreements	19	19
Indemnification floor amount | €		€ 250
Indemnification ceiling amount | €		€ 750
Indemnification percentage exceeding ceiling amount	33.33%	33.33%
Loss contingency accrual, carrying value, payments | $	$ 117
Indemnification percentage, other	33.33%	33.33%
Divestiture Agreements [Member]
Loss Contingencies [Line Items]
Guarantee obligations, maximum exposure | $	$ 102

Commitments and Contingencies_2

Commitments and Contingencies (Purchase Obligations Narrative) (Details) $ in Millions	Dec. 31, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Unrecorded unconditional purchase obligations	$ 3,700
Unrecorded Unconditional Purchase Obligation, to be Paid, Year One	611
Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two	484
Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three	427
Unrecorded Unconditional Purchase Obligation, to be Paid, Year Four	291
Unrecorded Unconditional Purchase Obligation, to be Paid, Year Five	$ 231

Supplemental Cash Flow Inform_3

Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Supplemental Cash Flow Information [Abstract]
Interest paid, net of amounts capitalized	$ 701	$ 780	$ 122
Taxes paid, net of refunds	349	237	273
Noncash Investing and Financing Activities
Accrued treasury stock repurchases	0	0	(17)
Finance lease obligations	27	2	28
Accrued capital expenditures	(21)	(26)	40
Asset retirement obligations	$ 2	$ 11	$ 3

Segment Information (Schedule o

Segment Information (Schedule of Business Segments) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023		Dec. 31, 2022
Segment Reporting Information [Line Items]
Net sales		$ 10,280	$ 10,940		$ 9,673
Cost of sales		(7,924)	(8,337)		(7,293)
Gross Profit		2,356	2,603		2,380
Selling, General and Administrative Expense		(1,030)	(1,075)		(824)
Amortization of Intangible Assets		(159)	(164)		(62)
Research and Development Expense		(130)	(146)		(112)
Other (charges) gains, net		(1,744)	(68)		(8)
Gain (loss) on disposition of businesses and assets, net		(14)	505		5
Other segment items(2)	[1]	24	32		(1)
Operating profit (loss)		(697)	1,687		1,378
Depreciation and amortization		801	706		462
Equity in net earnings (loss) of affiliates		196	102		220
Capital expenditures	[2]	414	542		583
Goodwill and intangible assets, net		9,028	10,952
Total assets		22,857	26,597
Increase (decrease) in accrued capital expenditures		(21)	(26)		40
Engineered Materials
Segment Reporting Information [Line Items]
Net sales		5,607	6,149		4,024
Equity in net earnings (loss) of affiliates	[3]	182	88		209
Acetyl Chain
Segment Reporting Information [Line Items]
Net sales	[4]	4,673	4,791		5,649
Other Activities
Segment Reporting Information [Line Items]
Equity in net earnings (loss) of affiliates		14	14		11
Operating Segments [Member] | Engineered Materials
Segment Reporting Information [Line Items]
Net sales		5,607	6,149		4,024
Cost of sales		(4,371)	(4,825)		(3,249)
Gross Profit		1,236	1,324		775
Selling, General and Administrative Expense		(434)	(435)		(213)
Amortization of Intangible Assets		(157)	(162)		(57)
Research and Development Expense		(90)	(97)		(71)
Other (charges) gains, net		(1,724)	(56)		(7)
Gain (loss) on disposition of businesses and assets, net		(10)	509	[5]	2
Other segment items(2)	[1]	0	0		0
Operating profit (loss)		(1,179)	1,083		429
Depreciation and amortization		510	462		226
Equity in net earnings (loss) of affiliates		172	83		202
Capital expenditures		211	237		178
Goodwill and intangible assets, net		8,617	10,525
Total assets		15,496	17,930
Operating Segments [Member] | Acetyl Chain
Segment Reporting Information [Line Items]
Net sales	[6]	4,763	4,884		5,743
Cost of sales		(3,647)	(3,607)		(4,130)
Gross Profit		1,116	1,277		1,613
Selling, General and Administrative Expense		(119)	(118)		(125)
Amortization of Intangible Assets		(2)	(2)		(3)
Research and Development Expense		(40)	(40)		(40)
Other (charges) gains, net		0	(4)		0
Gain (loss) on disposition of businesses and assets, net		(4)	(4)		2
Other segment items(2)	[1]	0	0		0
Operating profit (loss)		951	1,109		1,447
Depreciation and amortization		244	217		213
Equity in net earnings (loss) of affiliates		10	6		7
Capital expenditures		151	207		352
Goodwill and intangible assets, net		411	427
Total assets		5,265	5,538
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member] | Other Activities
Segment Reporting Information [Line Items]
Net sales		0	0		0
Cost of sales		4	2		(8)
Gross Profit		4	2		(8)
Selling, General and Administrative Expense		(477)	(522)		(486)
Amortization of Intangible Assets		0	0		(2)
Research and Development Expense		0	(9)		(1)
Other (charges) gains, net		(20)	(8)		(1)
Gain (loss) on disposition of businesses and assets, net		0	0		1
Other segment items(2)	[1]	24	32		(1)
Operating profit (loss)		(469)	(505)		(498)
Depreciation and amortization		47	27		23
Equity in net earnings (loss) of affiliates		14	13		11
Capital expenditures		52	98		53
Goodwill and intangible assets, net		0	0
Total assets		2,096	3,129
Intersegment [Member]
Segment Reporting Information [Line Items]
Net sales		(90)	(93)		(94)
Cost of sales		90	93		94
Gross Profit		0			0
Selling, General and Administrative Expense		0	0		0
Amortization of Intangible Assets		0	0		0
Research and Development Expense		0	0		0
Other (charges) gains, net		0	0		0
Gain (loss) on disposition of businesses and assets, net		0	0		0
Other segment items(2)	[1]	0	0		0
Operating profit (loss)		0	0		0
Depreciation and amortization		0	0		0
Equity in net earnings (loss) of affiliates		0	0		0
Capital expenditures		0	0		0
Goodwill and intangible assets, net		0	0
Total assets		0	0
Intersegment [Member] | Acetyl Chain
Segment Reporting Information [Line Items]
Net sales		$ 90	$ 93		$ 94
[1] Includes Foreign exchange gain (loss), net. Includes a decrease in accrued capital expenditures of $21 million, a decrease in accrued capital expenditures of $26 million and an increase in accrued capital expenditures of $40 million for the years ended December 31, 2024, 2023 and 2022, respectively. Engineered Materials includes an equity method investment with losses in excess of its carrying amount due to the Company's guarantee of various debt obligations under agreements with third parties related to an equity affiliate ( Note 19 ). This equity method investment was recorded in Current Other liabilities ( Note 10 ) as of December 31, 2024 and 2023. Excludes intersegment sales of $90 million, $93 million and $94 million for the years ended December 31, 2024, 2023 and 2022, respectively. Includes a $515 million gain related to the formation of the Nutrinova joint venture included in Gain (loss) on disposition of businesses and assets, net in the consolidated statements of operations ( Note 4 ). Includes intersegment sales of $90 million, $93 million and $94 million for the years ended December 31, 2024, 2023 and 2022, respectively.

Segment Information (Schedule_2

Segment Information (Schedule of Geographical Segments) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 10,280	$ 10,940	$ 9,673
Property, plant and equipment, net	5,273	5,584
BELGIUM
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	400	499	251
Property, plant and equipment, net	60	112
BRAZIL
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	140	140	122
CANADA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	127	146	120
Property, plant and equipment, net	121	121
CHINA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	1,984	1,952	1,525
Property, plant and equipment, net	659	568
FRANCE
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	68	84	31
GERMANY
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	2,201	2,468	2,934
Property, plant and equipment, net	795	843
INDIA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	155	150	55
ITALY
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	63	77	7
Property, plant and equipment, net	76	74
JAPAN
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	278	312	87
Property, plant and equipment, net	37	43
MEXICO
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	344	361	359
Property, plant and equipment, net	42	44
NETHERLANDS
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	49	48
SINGAPORE
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	1,001	1,146	1,209
Property, plant and equipment, net	81	82
KOREA, REPUBLIC OF
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	140	154	68
Property, plant and equipment, net	70	64
SPAIN
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	50	58	11
SWITZERLAND
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	294	223	165
Property, plant and equipment, net	57	58
UNITED KINGDOM
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	78	86	13
Property, plant and equipment, net	107	118
UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	2,748	2,821	2,562
Property, plant and equipment, net	3,001	3,286
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	209	263	$ 154
Property, plant and equipment, net	$ 118	$ 123

Revenue Recognition Disaggregat

Revenue Recognition Disaggregated Revenue (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Net sales		$ 10,280	$ 10,940	$ 9,673
Intersegment [Member]
Disaggregation of Revenue [Line Items]
Net sales		(90)	(93)	(94)
Engineered Materials
Disaggregation of Revenue [Line Items]
Net sales		5,607	6,149	4,024
Acetyl Chain
Disaggregation of Revenue [Line Items]
Net sales	[1]	4,673	4,791	5,649
Acetyl Chain | Intersegment [Member]
Disaggregation of Revenue [Line Items]
Net sales		90	93	94
North America [Member] | Engineered Materials
Disaggregation of Revenue [Line Items]
Net sales		1,553	1,780	1,197
North America [Member] | Acetyl Chain
Disaggregation of Revenue [Line Items]
Net sales		1,526	1,448	1,713
Europe and Africa | Engineered Materials
Disaggregation of Revenue [Line Items]
Net sales		1,641	1,941	1,538
Europe and Africa | Acetyl Chain
Disaggregation of Revenue [Line Items]
Net sales		1,613	1,680	1,961
Asia Pacific [Member] | Engineered Materials
Disaggregation of Revenue [Line Items]
Net sales		2,272	2,274	1,180
Asia Pacific [Member] | Acetyl Chain
Disaggregation of Revenue [Line Items]
Net sales		1,415	1,543	1,811
South America [Member] | Engineered Materials
Disaggregation of Revenue [Line Items]
Net sales		141	154	109
South America [Member] | Acetyl Chain
Disaggregation of Revenue [Line Items]
Net sales		$ 119	$ 120	$ 164
[1] Excludes intersegment sales of $90 million, $93 million and $94 million for the years ended December 31, 2024, 2023 and 2022, respectively.

Earnings (Loss) Per Share (Sche

Earnings (Loss) Per Share (Schedule of Earnings (Loss) Per Share) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations		$ (1,514)	$ 1,969	$ 1,902
Earnings (loss) from discontinued operations		(8)	(9)	(8)
Net earnings (loss) attributable to Celanese Corporation		$ (1,522)	$ 1,960	$ 1,894
Weighted average shares - basic (in shares)		109,273,779	108,848,962	108,380,082
Incremental shares attributable to equity awards	[1]	0	530,702	855,294
Weighted average shares - diluted		109,273,779	109,379,664	109,235,376
Antidilutive securities excluded from computation of earnings per share, amount (in shares)		239,886
Share-based Payment Arrangement, Option [Member]
Amounts attributable to Celanese Corporation
Antidilutive securities excluded from computation of earnings per share, amount (in shares)		265,922	202,876	0
Time Restricted Stock Units (RSUs) [Member]
Amounts attributable to Celanese Corporation
Antidilutive securities excluded from computation of earnings per share, amount (in shares)		61	39,465	154,172
[1] Excludes options to purchase 265,922, 202,876 and 0 shares of Common Stock for the years ended December 31, 2024, 2023 and 2022, respectively, as their effect would have been antidilutive. Excludes 61, 39,465 and 154,172 equity award shares for the years ended December 31, 2024, 2023 and 2022, respectively, as their effect would have been antidilutive. For the year ended December 31, 2024, the Company incurred a net loss from continuing operations, resulting in 239,886 incremental shares attributable to equity awards being excluded from the number of weighted average shares - diluted as their effect would have been antidilutive.

Other (Charges) Gains, Net (Sch

Other (Charges) Gains, Net (Schedule of Other (Charges) Gains, Net) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024		Dec. 31, 2023	Dec. 31, 2022
Restructuring and Related Activities [Abstract]
Restructuring(1)	$ (107)	[1]	$ (52)	$ (6)
Asset impairments	(1,639)	[2]	(15)	(14)
Plant/office closures	2		(1)	12
Other (charges) gains, net	$ (1,744)		$ (68)	$ (8)
[1] Includes employee termination benefits related to the previously announced closure of the Company's facility in Mechelen, Belgium ( Note 4 ) and the previously announced closure of its polymerization units in Uentrop, Germany ( Note 4 ) for the year ended December 31, 2024, and employee termination benefits primarily related to Company-wide business optimization projects during the years ended December 31, 2024 and 2023. Primarily related to non-cash impairment losses on goodwill and certain trade names, primarily Zytel ® , arising from the Company's goodwill and indefinite-lived intangible assets impairment tests ( Note 9 ).

Other (Charges) Gains, Net (S_2

Other (Charges) Gains, Net (Schedule of Restructuring Reserves) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($)
Restructuring Reserve [Roll Forward]
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Nonrecurring (Income) Expense
Employee Termination Benefits [Member]
Restructuring Reserve [Roll Forward]
Reserve as of the beginning of the period	$ 18
Additions	106
Cash payments	(55)
Other changes	(3)
Exchange rate changes	(3)
Reserve as of the end of the period	63
Engineered Materials | Employee Termination Benefits [Member]
Restructuring Reserve [Roll Forward]
Reserve as of the beginning of the period	13
Additions	89
Cash payments	(40)
Other changes	(2)
Exchange rate changes	(3)
Reserve as of the end of the period	57
Acetyl Chain | Employee Termination Benefits [Member]
Restructuring Reserve [Roll Forward]
Reserve as of the beginning of the period	2
Additions	1
Cash payments	(2)
Other changes	(1)
Exchange rate changes	0
Reserve as of the end of the period	0
Other [Member] | Employee Termination Benefits [Member]
Restructuring Reserve [Roll Forward]
Reserve as of the beginning of the period	3
Additions	16
Cash payments	(13)
Other changes	0
Exchange rate changes	0
Reserve as of the end of the period	$ 6